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Zusammenfassung 
 
Die Sepsis- und Meningitis-Erreger Escherichia coli K1 und Neisseria meningitidis 
Serogruppe C sind von einer dicken Polysaccharid-Kapsel umgeben. Die Kapselpoly-
saccharide bestehen aus α2,8- bzw. α2,9-verknüpfter Polysialinsäure (PolySia) und stellen 
für beide Pathogene einen wichtigen Virulenzfaktor dar. In fast 90% aller Serogruppe C 
Stämme ist die Kapsel zusätzlich durch O-Acetylierung an Position C7 oder C8 der Sialin-
säure modifiziert. Das Gen, welches die entsprechende O-Acetyltransferase OatC kodiert, ist 
Teil des Kapselgenkomplexes und weist keinerlei Sequenzhomologie zu anderen Proteinen 
auf. In Escherichia coli K1 wird eine phasenvariable O-Acetylierung des Kapselpoly-
saccharids an den Positionen C7 und C9 der Sialinsäuren beobachtet, die durch das 
Prophagen-kodierte Enzym NeuO katalysiert wird. Die Phasenvariation wird durch eine 
variable Anzahl an Heptanukleotid-Sequenzwiederholungen im 5’-Bereich des neuO-Gens 
vermittelt, wobei ausschließlich Wiederholungen, die ein Vielfaches von drei sind, eine 
vollständige Translation des Enzyms erlauben. Um die O-Acetylierung von PolySia-Kapseln 
biochemisch zu untersuchen, wurden NeuO und OatC rekombinant exprimiert, gereinigt und 
anschließend enzymatisch und strukturell charakterisiert. Im Falle von NeuO erfolgte dies 
vergleichend für vier Enzymvarianten, die durch Allele mit 0, 12, 24 bzw. 36 Heptanukleotid-
Sequenzwiederholungen kodiert werden. Alle Varianten bildeten Hexamere, waren 
enzymatisch aktiv und wiesen eine hohe Substratspezifität für PolySia mit >14 Resten auf. 
Für die katalytische Effizienz wurde eine lineare Korrelation mit der Zahl der Sequenzwieder-
holungen beobachtet und somit ein neuartiger Mechanismus zur Modulation der NeuO-
Aktivität aufgedeckt. Mit Hilfe eines Strukturmodells und der Identifizierung von zwei 
konservierten Aminosäuren, die kritisch für die enzymatische Aktivität sind (His-119 und Trp-
143), konnten deutliche Übereinstimmungen zur Hexapeptidrepeat-Proteinfamilie aufgezeigt 
werden. Im Gegensatz zu NeuO wurde OatC als Homodimer gefunden, wobei die ersten 34 
Aminosäuren eine effiziente Oligomerisierungsdomäne ausbilden, deren Funktion auch in 
einem anderen Proteinkontext erhalten blieb. Die Suche nach Sequenzmotiven führte zur 
Identifikation eines nucleophile elbow-Motivs (GXS286XGG), welches ein Charakteristikum 
der α/β-Hydrolase fold-Enzyme ist. Mittels umfangreicher Mutagenese-Experimente konnte 
eine katalytische Triade identifiziert werden, die aus Ser-286, Asp-376 und His-399 besteht. 
In Übereinstimmung mit einem für α/β-Hydrolase fold-Enzyme typischen Ping-Pong-
Mechanismus, wurde die Bildung eines kovalenten Acetyl-Enzym-Intermediats nachge-
wiesen. Zusammen mit Sekundärstrukturanalysen, die eine α/β-Hydrolase fold-Topologie 
vorhersagen, liefern die gezeigten Daten klare Hinweise, dass OatC zur α/β-Hydrolase fold-
Familie gehört. Dies zeigt, dass OatC evolutionär unabhängig von allen anderen bakteriellen 
Sialinsäure-spezifischen O-Acetyltransferasen entstanden ist. Diesen gemeinsam ist die 
Zugehörigkeit zur Hexapeptidrepeat-Proteinfamilie, einer Gruppe von Acyltransferasen, die 
durch eine linksgängige β-Helix und die Ausbildung katalytischer Trimere gekennzeichnet 
sind. In ersten Kristallisations-Experimenten zur Aufklärung der 3D-Strukturen von PolySia-
spezifischen O-Acetyltransferasen wurden OatC-Kristalle erhalten, die die Streuung von 
Röntgenstrahlen bis zu einer Auflösung von etwa 3,8 Å ermöglichten. 
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Abstract 
 
Escherichia coli K1 and Neisseria meningitidis serogroup C are protected by thick 
polysaccharide capsules composed of α2,8- and α2,9-linked polysialic acid (polySia), 
respectively. Both pathogens cause bacterial sepsis and meningitis and their capsules 
represent major virulence factors. In the majority of the serogroup C strains, the capsular 
polysaccharide is further modified by O-acetylation at C7 or C8 of the sialic acids. The gene 
encoding the corresponding O-acetyltransferase OatC is part of the capsule gene complex 
and shares no sequence similarities with other proteins. In Escherichia coli K1, capsule O-
acetylation at position C7 and C9 of the sialic acids is a phase-variable modification that is 
catalyzed by the prophage-encoded O-acetyltransferase NeuO. Phase-variation is mediated 
by changes in the number of heptanucleotide repeats within the 5’-region of neuO, and full-
length translation is restricted to repeat numbers that are a multiple of three. To understand 
the biochemical basis of polySia capsule O-acetylation, NeuO and OatC were recombinantly 
expressed and purified to homogeneity, allowing the first enzymatic and structural 
characterization of polySia-specific O-acetyltransferases. For NeuO, enzyme variants 
encoded by alleles containing 0, 12, 24 and 36 heptanucleotide repeats were comparatively 
analyzed. All variants assembled into hexamers and were enzymatically active with a high 
substrate specificity towards polySia with >14 residues. The catalytic efficiency increased 
linearly with increasing numbers of repeats, revealing a new mechanism for modulating 
NeuO activity. Homology modeling and identification of two conserved amino acids critical for 
enzymatic activity (His-119 and Trp-143) highlighted a close relationship to the hexapeptide 
repeat family. The meningococcal sialate O-acetyltransferase OatC was found as a 
homodimer, with the first 34 amino acids forming an efficient oligomerization domain that 
worked even in a different protein context. Motif-scanning revealed a nucleophile elbow motif 
(GXS286XGG), which is a hallmark of α/β-hydrolase fold enzymes. In a comprehensive site-
directed mutagenesis approach, a catalytic triad composed of Ser-286, Asp-376, and 
His-399 was identified. Consistent with a double-displacement catalytic mechanism common 
to α/β-hydrolase fold enzymes, a covalent acetyl-enzyme intermediate was found. Together 
with secondary structure prediction showing an α/β-hydrolase fold topology, these data 
provide strong evidence that OatC belongs to the α/β-hydrolase fold family. This 
demonstrates that OatC evolved apart from other bacterial sialate O-acetyltransferases 
which all belong to the hexapeptide repeat family, a class of acyltransferases that adopt a 
left-handed β-helix fold and assemble into catalytic trimers. Initial crystallization approaches 
to solve the 3D-structures of polySia-specific O-acetyltransferases resulted in OatC crystals 
that diffracted X-rays already down to a resolution of approximately 3.8 Å.  
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Chapter 1 - General Introduction 
 
1.1 - Bacterial capsular polysaccharides 
Polysaccharides at the surface of bacteria have important functions in maintaining surface 
charge and structural integrity of the bacterial cell, in providing serum resistance and physical 
protection, and in mediating resistance to desiccation (Guerry and Szymanski, 2008; Curtis 
et al., 2005). Due to their exposed location at the interface of cell and surrounding medium, 
cell-surface glycoconjugates often play a crucial role in host-pathogen interactions (Whitfield 
2006). In gram-negative bacteria, the majority of these glycoconjugates are found as lipo-
polysaccharides (LPS) or capsular polysaccharides (K-antigens) that are linked to the outer 
membrane (Vimr and Steenbergen, 2009; see Figure 1-1).  
 
 
Figure 1-1: Cross-section of an encapsulated bacterium. Electron micrograph of Escherichia  coli K1, 
encapsulated by a capsular polysaccharide composed of polysialic acid (left) (Roth et al., 1993) and schematic 
representation of a gram-negative bacterium surrounded by a polysaccharide capsule (right). 
 
Bacterial capsular polysaccharides have long been accepted as important virulence factors. 
During invasive infections, the interaction between the capsule and the host’s immune 
system may decide about the outcome of the infection (Moxon & Kroll 1990). One of the 
most fascinating features of bacterial capsules is their structural diversity. For example, 
Escherichia coli (E. coli) as well as Streptococcus pneumoniae are capable to express over 
80 chemically and serologically distinct capsules, and a single strain of Bacteroides fragilis is 
able to express multiple capsule types (Krinos et al. 2001). The capsular polysaccharides are 
usually hydrophilic and negatively charged. This allows a high water binding capacity to 
prevent desiccation of the organism and also protects the bacterium against complement-
mediated lysis and phagocytosis (Rick and Silver, 1996; Jann and Jann, 1997; Roberts, 
2000; Curtis et al., 2005).  
Dissertation Anne K. Bergfeld  Chapter 1 – General Introduction 
 
  Page 4 
 
Biosynthesis and assembly of bacterial capsules is a complex process; Activated mono- or 
diphospho-sugars are synthesized in the cytoplasm and incorporated into the nascent 
polysaccharide chain. The polymer is subsequently dislocated through the periplasm and 
attached to components of the outer membrane to shape the cell surface. Despite the 
diversity in capsular polysaccharides, bacteria use only a limited repertoire of biosynthesis 
and assembly strategies (Whitfield et al., 2006). The genes required for bacterial capsule 
biosynthesis and assembly are clustered in capsule gene complexes (designated kps). 
Almost three decades ago, the first kps was cloned from Escherichia coli K1 (Silver et al., 
1981) and meanwhile capsule gene complexes have been described for various gram-
negative bacteria (for review see Whitfield, 2006). The clustering of the capsule genes at a 
single chromosomal locus allows coordinated regulation of all genes involved in  biosynthesis 
and export of capsular polysaccharides (Roberts, 1996). Most gram-negative pathogenic 
bacteria express group 2 capsular polysaccharides, which include several carbohydrate 
structures that resemble vertebrate glycoconjugates such as the K-antigens K1 (α2,8-linked 
polysialic acid), K4 (a substituted chondroitin backbone), and K5 (an N-acetylheparosan 
backbone) of E. coli (Jann and Jann, 1997). Group 2 kps have a common organization 
composed of three regions (Whitfield and Roberts, 1999).  
 
 
Figure 1-2: Organization of the genes required for expression of E. coli K1, K4 and K5 capsules. The kps 
locus comprises a serotype-specific region 2 flanked by two regions that are conserved among all bacteria 
possessing a group 2 kps. Region 1 and 3 gene products are involved in polymer export and translocation, 
whereas region 2 genes encode the enzymes required for biosynthesis of the respective polysaccharide. The neu 
genes encode proteins required for the synthesis of the K1-antigen composed of (8)-α-5-N-
acetylneuraminic acid-(2) (McGuire and Binkley, 1964; Silver et al., 1981). The K5 capsular polysaccharide is a 
heteropolymer composed of the disaccharide repeating unit (4)-β-glucuronyl-(14)-α-N-acetylglucosaminyl 
(1) and is synthesized by the enzymes encoded by the kfi genes (Vann et al., 1981; Petit et al., 1995). The K4 
capsular polysaccharide consists of a backbone with the structure (3)-β-D-glucuronyl-(14)-β-D-N-
acetylgalactosaminyl(1) to which β-fructofuranose is linked at the C-3 position of glucuronic acid (Rodriguez et 
al., 1988) and is built up by the enzymes encoded by the kfo genes (Ninomiya et al., 2002). Figure modified from 
Whitfield, 2006. 
 
Dissertation Anne K. Bergfeld  Chapter 1 – General Introduction 
 
  Page 5 
 
A central region encompasses all genes required for biosynthesis of the serotype-specific 
polysaccharide whereas two flanking regions contain genes essential for transport of the 
polymer across the membranes and attachment to the bacterial surface (Roberts et al., 1996; 
Barrett et al., 2002; Whitfield, 2006; see Figure 1-2). Whereas the gene content of the central 
region varies according to the structure of the formed polymer, the kps gene products that 
are involved in export across the membranes and assembly of the capsule on the cell 
surface are highly conserved among serogroups and species (Whitfield 2006; Vimr and 
Steenbergen, 2009).  
 
1.2 - Polysialic acid capsules 
Sialic acids (Sias) are nine-carbon sugars that are derived from neuraminic acid (see Figure 
1-3). They all carry a carboxylic function at the C1 position and are typically found as terminal 
sugars of N-glycans, O-glycans and glycosphingolipids. Currently, more than 50 naturally 
occurring sialic acids have been described in various kingdoms of life. The diversity of Sias is 
based on a variety of substitutions at positions 4, 5, 7, 8, and 9 of the neuraminic acid 
(Schauer, 2000; Angata and Varki, 2002; Varki and Varki, 2007; see Figure 1-3). The most 
common modification is an N-acetyl group at position C5 which results in the formation of N-
acetylneuraminic acid (Neu5Ac), the most prevalent Sia in humans. Beside N-5-acetylation, 
the most frequently observed substitution is O-acetylation, which can occur on hydroxyl 
groups at position C4, C7, C8, and C9 .  
 
 
Figure 1-3: Structural diversity of Sialic acids. All Sias are nine carbon sugars with a carboxylic function at the 
C1 position and are linked to the underlying glycoconjugate via the C2 position. Various substituents at positions 
4,5,7,8 and 9 combined with different O-glycosidic linkages generate a large set of naturally occurring 
sialoglycoconjugates (modified from Varki and Varki, 2007).  
 
Sias are also found as components of homo- and heteropolymers called polysialic acid 
(polySia). These unusual carbohydrate polymers represent the capsular polysaccharides of  
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several pathogenic bacteria and occur in the animal kingdom as posttranslational 
modification of a limited number of glycoproteins. In vertebrates, polySia joined by α2,8-
linkages is mainly found as dynamically regulated posttranslational modification of the neural 
cell adhesion molecule (NCAM) (Finne et al., 1983; Mühlenhoff et al., 1998). The presence of 
this polyanionic glycan structure with its enormous hydration volume controls NCAM-
mediated interactions, modulates cell-cell interactions, and plays an important role in neural 
plasticity of the adult brain (Weinhold et al., 2005; Hildebrandt et al., 2007; Gascon et al., 
2007; Rutishauser 2008). Although NCAM represents the major polySia acceptor in 
vertebrates, additional polysialylated proteins have been identified such as the scavenger 
receptor CD36 in human milk, the α-subunit of the voltage-sensitive sodium channel in rat 
brain, and neuropilin-2 of maturating human dendritic cells (Yabe et al., 2003; Zuber et al., 
1992; Curreli et al., 2007).   
In bacteria, polySia is found as linear homo- and heteropolymers of different linkages which  
form the capsule of several pathogens (see Figure 1-4). The capsular polysaccharide of 
Neisseria meningitidis (N. meningitidis or meningococcus) of the serogroups W-135 and Y 
are Neu5Ac-containing heteropolymers composed of the disaccharide repeating units (6)-
α-D-Galp-(14)-α-Neu5Ac-(2) and (6)-α-D-Glcp-(14)-α-Neu5Ac-(2), respectively 
(Bhattacharjee et al., 1976). The capsule of N. meningitidis serogroup C is a homopolymer of 
Neu5Ac residues joined by α2,9-linkages, whereas E. coli K1 and serogroup B meningococci 
comprise structurally identical capsular polysaccharides consisting of α2,8-linked Neu5Ac of 
up to 200 residues (Bhattacharjee et al., 1975; Rohr and Troy, 1980; Pelkonen et al., 1988). 
Hence, the polySia found in E. coli K1 and serogroup B meningococci is chemically identical 
to polySia expressed in the host organism (e.g. on NCAM) (Mühlenhoff et al., 1998). Due to 
this antigenic mimicry, these capsules are poorly immunogenic, and no effective 
polysaccharide-based vaccines are available.  
In several K1 strains, modification of the capsule by O-acetylation of the Neu5Ac residues in 
positions O7 and O9 was observed (Ørskov et al., 1979). With the single exception of 
N. meningitidis serogroup B, O-acetylation of the polySia capsules have also been found in 
serogroup C, W-135, and Y meningococci (see Figure 1-4).  
In the capsular polysaccharide of serogroup C meningococci, the O-acetyl groups are 
distributed between position C7 and C8 of Neu5Ac residues, whereas in serogroups W-135 
and Y, O-acetylation is found at positions C7 and C9 of the capsular sialic acids 
(Bhattacharjee et al., 1976; Jennings et al., 1977; Lemercinier and Jones, 1996). Studies 
from the United Kingdom demonstrated capsule O-acetylation for 88% and 79% of the 
serogroup C and Y strains, respectively, whereas only 8% of the W-135 strains displayed O-
acetylated capsules (Borrow et al., 2000; Longworth et al., 2002). 
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Figure 1-4: Polysaccharide structures of E. coli K1 and N. meningitidis serogroup B, C, W-135, and Y. 
Positions, where O-acetyl groups were found are shown in red (Bhattacharjee et al., 1975; Bhattacharjee et al., 
1976; Ørskov et al., 1979; Lemercinier and Jones, 1996). The percentage of strains that comprised O-acetylated 
capsular polysaccharides (OAc+) in a study from the UK are indicated (Borrow et al., 2000; Longworth et al., 
2002). 
 
Although O-acetylation influences size and net charge of the capsular polysaccharides, the 
biological relevance of this modification with regard to pathogenicity is still largely unclear. In 
the case of E. coli K1, capsule O-acetylation is associated with increased immunogenicity, 
but nevertheless, a correlation between O-acetylation and increased virulence was observed 
in patients with bacteraemia (Frasa et al., 1993). Because O-acetylated Sias are more 
resistant to hydrolysis by sialidases, capsule O-acetylation may favor colonization of E. coli 
K1 in the intestinal tract (Ørskov et al., 1979). For N. meningitidis serogroups C and Y, an 
inverse correlation between immunogenicity and the level of capsule O-acetylation was 
observed, whereas no impact on immunogenicity was found for the O-acetylated capsular 
polysaccharide of serogroup W-135 meningococci (Michon et al., 2000; Fusco et al., 2007; 
Gudlavalleti et al., 2007). These findings suggest that for serogroup C and Y meningococci, 
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capsule O-acetylation may play a general role in masking immunogenic epitopes and thereby 
enabling escape from immune surveillance. However, as shown recently, capsule O-
acetylation does not impair recognition of serogroup C, W-135, and Y meningococci by 
human dendritic cells, indicating that modulatory effects of capsule O-acetylation on immune 
recognition are restricted to the humoral immune response (Villwock et al., 2008).  
 
1.3 - Genetic basis of capsule O-acetylation in Escherichia coli K1 
E. coli is a versatile enterobacterium which can be subdivided into (i) nonpathogenic 
commensal strains, (ii) pathogenic intestinal strains and (iii) pathogenic extraintestinal strains 
(Russo and Johnson, 2000). This classification is mainly based on the presence or absence 
of particular DNA regions that are associated with certain pathotypes. This genetic 
information belongs to the flexible E. coli genome, which includes genetic elements like 
plasmids, bacteriophages and genomic islands, that are frequently acquired by horizontal 
gene transfer (Dobrindt, 2005). Extraintestinal E. coli (ExPEC) strains possess virulence 
traits that allow invasion, colonization and induction of diseases outside of the 
gastrointestinal tract. ExPEC are responsible for several human diseases including urinary 
tract infections, sepsis, pneumonia, surgical site infections and neonatal meningitis (Smith et 
al., 2007). Concerning the mortality and morbidity of ExPEC infections, these pathogens 
have a great impact on the public health systems, with an economic cost of several billion 
dollars annually (Russo and Johnson, 2003). In the United States, more than 50% of all 
cases of neonatal sepsis and meningitis that are caused by gram-negative enteric bacteria 
were due to ExPEC strains, and approximately 80% of those strains were carrying the K1 
capsular antigen (Pong and Bradley, 1999; Bonacorsi et al., 2003; Johnson et al., 2002). The 
K1 capsule has long been accepted as a major virulence factor of ExPEC (Johnson and 
Russo, 2005; Freitag et al., 2005). The K1 capsular polysaccharide consists of α2,8-linked 
Neu5Ac with chain lengths of 160-230 residues (Pelkonen et al., 1988). Neonatal immune 
responses to polySia-carrying bacteria such as E. coli K1 are most likely restricted due to the 
structural identity of the capsule to polySia found in vertebrates (Rohr and Troy, 1980; 
Mühlenhoff et al., 1998; Stein et al., 2006). Development of an E. coli K1-caused meningitis 
is a multistage process, initiated by colonization of the mucosa of the newborns 
gastrointestinal tract and followed by translocation into the blood stream after passage of the 
mucosal membrane (Kim et al., 2001; Kim et al., 2003; Kim et al., 2005). In the circulation, 
the K1-capsule is essential for survival and multiplication of the pathogen as it protects the 
bacterium from humoral and cellular components of the immune system (Cross et al., 1986; 
Mushtaq et al., 2004; Bortolussi et al., 1979; Mushtaq et al., 2005). After reaching a specific 
threshold level of bacteraemia, the pathogen adheres to brain microvascular endothelial cells 
which form the blood-brain-barrier (BBB). Subsequently, E. coli K1 crosses this barrier by 
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transcytosis through ligand-receptor interactions, host cytoskeletal rearrangements and the 
activation of different signaling pathways, without affecting the integrity of the BBB (Kim, 
2003; Kim et al., 2005; Galanakis et al., 2006; Kim et al., 2008). The pathogen is able to 
transverse the BBB irrespective of the presence or absence of the K1 capsule, but only 
encapsulated bacteria survive the transcytosis (Kim et al., 1992; Hoffman et al., 1999). After 
reaching the subarachnoid space, E. coli K1 multiplies and elicits host inflammatory 
responses in the meninges which ultimately results in meningitis (Kim et al., 2003; Xie et al., 
2004; Kim et al., 2005). After invasion of the central nervous system, the bacterium ceases 
the expression of the protective capsular polysaccharide, indicating, that the capsule is 
dispensable after the neuropathogen colonized a protected niche (Zelmer et al., 2008; 
Guerry and Szymanski, 2008).  
Interestingly, several E. coli K1 strains are able to further modify their protective polySia 
capsule by O-acetylation (Ørskov et al., 1979; Higa and Varki, 1988; Deszo et al., 2005; see 
Figure 1-2). This surface modification was first observed in 1979 by Ørskov and coworkers 
and it was shown that certain K1 strains were capable to switch between an O-acetylated 
(OAc+) and a non O-acetylated (OAc-) capsule form with a constantly high frequency of 1:50 
to 1:20 (Ørskov et al., 1979). Later on, enzymatic activity of a polySia-specific O-
acetyltransferase was proved but the genomic basis of capsule O-acetylation remained an 
enigma (Higa and Varki, 1988). All attempts to purify the endogenous enzyme required 
detergent extraction, and after partial purification on DEAE-Sepharose, further isolation steps 
abolished the enzymatic activity (Higa and Varki, 1988). In 2005, analysis of the partially 
sequenced genome of the E. coli K1 strain RS218 (http://www.genome.wisc.edu) revealed 
the presence of a 40 kb prophage (termed CUS-3) which is integrated into the argW gene of 
the bacterial genome (Deszo et al., 2005). Based on sequence similarities and genomic 
organization, CUS-3 was characterized as a P22-like phage (Stummeyer et al., 2006). All 
members of this family of temperent phages comprise one or more lysogenic conversion 
genes located between tailspike and integrase gene. The corresponding translation products 
modify surface structures of the host, a common strategy to prevent superinfection by 
homologous phages (Stummeyer et al., 2006; Allison and Verma, 2000). In the equivalent 
locus, CUS-3 harbors the neuO gene, which was shown to mediate the phase-variable O-
acetylation of the polySia capsule of E. coli K1 (Deszo et al., 2005; see Figure 1-5). 
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Figure 1-5: Genomic localization of the neuO gene. The neuO gene is part of the 40kb CUS-3 genome which 
is integrated into the argW tRNA gene of E. coli K1 strain RS218 (Deszo et al., 2005). Part of the second half of 
the CUS-3 genome encompassing virion, lysogenic conversion and integrase genes is shown in comparison with 
the corresponding genome parts of Salmonella phage P22, Coliphage HK620 and Shigella phage Sf6. The 
lysogenic conversion gene(s) (shown in pink) are flanked by a  tailspike (dark grey) and an integrase (light grey) 
gene. Location of phage attachment sites (attP) is indicated by an arrow. Figure modified from Stummeyer et al., 
2006. 
 
Consequently, O-acetylation of the K1-capsule is restricted to E. coli K1 strains that harbor 
the CUS-3 prophage. Analysis of 111 clinical E. coli K1 isolates revealed that over 60% of 
the strains comprised the neuO gene (King et al., 2007).  
Sequence analysis of the neuO gene threw light on the puzzling observation that certain K1 
strains were able to switch between OAc+ and OAc- capsule forms. This phase variation is 
mediated by a variable number of heptanucleotide repeats (VNTRs) of the sequence  
 
 
 
Figure 1-6: Sequence elements mediating phase-variable expression of neuO. Schematic representation of 
the VNTR region of neuO showing alleles with 13 (top) and 12 (bottom) 5’-AAGACTC-3’ repeats (boxed). Three 
heptanucleotide repeats encode one protein heptad (gray). During DNA replication, changes in the number of 
nucleotide repeats can arise through slipped-strand mispairing. 
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5’-AAGACTC-3’ which are located two base pairs downstream of the starting ATG (Deszo et 
al., 2005; see Figure 1-6). VNTR loci are among the most variable regions of many bacterial 
genomes and arise through slippage and mispairing during DNA replication due to 
occasional DNA polymerase dissociation (van Belkum et al., 1998; Henderson et al., 1999; 
Martin et al., 2005; Lukacova et al., 2007). In the case of neuO, gain or loss of complete 
VNTRs due to slipped-strand mispairing results in an ‘all or non’ control mechanism of 
enzyme expression. Translation of functional NeuO is restricted to neuO alleles that harbor a 
repeat number divisible by three (phase ON), whereas all other repeat numbers move the 
start codon out of frame resulting in truncated and thereby inactive translation products 
(phase OFF) (Deszo et al., 2005).  
 
1.4 - Genetic basis of polySia O-acetylation in Neisseria meningitidis  
N. meningitidis is a major cause of septicaemia and meningitis worldwide with incidence 
rates varying from 1 to 1000 cases per 100,000 (van Deuren et al., 2000 ; Stephens, 2007). 
Meningococci are a transitory colonizer of the human nasopharynx, which represents the 
sole reservoir (Yazdankhah and Caugant, 2004). With up to 20% healthy carriers at any one 
time, meningococci are common commensals that only occasionally are responsible for life-
threatening diseases (Greenfield et al., 1971; Caugant et al., 1994; Stephens, 1999; Janda & 
Knapp, 2003). Only a few hyper-invasive genetic clones of the species are pathogenic and 
may rapidly result in countrywide outbreaks of meningitis (Raymond et al., 1997; Swartley et 
al., 1997; Maiden et al., 1998; Vogel et al., 2000; Yazdankhah et al., 2004; Caugant, 2008). 
In contrast to most bacteria, meningococci spontaneously produce a vast number of genetic 
variants, also in the absence of environmental changes or stimuli (Davidsen and Tonjum, 
2006). The frequent genomic alterations (e.g. exchange of genetic islands by horizontal gene 
transfer, slipped-strand mispairing of repetitive nucleotides, intergenic recombination events 
or insertion sequence element movement) have drastic consequences on host-pathogen 
interactions, impacting structural and antigenic changes in surface components that are 
crucial for adherence and invasion (Davidsen and Tonjum, 2006; Caugant, 2008; Hotopp et 
al., 2006; Kahler et al., 2001). The pathogenesis of meningococcal meningitis starts with 
colonization of the human nasopharynx, followed by adherence to and invasion of epithelial 
cells by endocytosis enabling passage across the epithelial barrier into the bloodstream 
(Stephens and Farley, 1991; Yazdankhah and Caugant, 2004; Stephens, 2007). 
Meningococci that are able to survive and multiply in the circulation belong to the limited 
number of pathogens capable of crossing the blood-brain barrier to gain access to the 
cerebrospinal fluid (Cartwright and Ala’Aldeen, 1997; Doran et al., 2005). Despite appropriate 
treatment, meningitis caused by invasive meningococci remains a prevalent disease with a 
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case-fatality rate of 10% and high morbidity among survivors (Connolly and Noah, 1999; 
Tzeng and Stephens, 2000; Brandtzaeg and van Deuren, 2002; Goldrace et al., 2003).  
Based on the structure of the capsular polysaccharide, meningococci are classified into 
thirteen distinct serogroups (Gotschlich et al., 1969). Serogroups A, B, C, W-135, X, and Y 
are currently associated with significant pathogenic potential and are responsible for over 
90% of the invasive diseases worldwide (Rosenstein et al., 2001; Djibo et al., 2003; Boisier 
et al., 2007; Stephens, 2007; see Figure 1-7).  
 
Figure 1-7: Global serogroup distribution of invasive meningococcal disease (modified from Stephens, 
2007). 
 
The polysaccharide capsules play contrasting roles in meningococcal pathogenesis. On the 
one hand side, the disease-associated capsules protect the bacteria from phagocytosis and 
complement-mediated lysis and are therefore essential for survival and multiplication of the 
pathogen in the bloodstream (Jarvis and Vedros, 1987; Vogel et al., 1996; Spinosa et al., 
2007). On the other hand, the presence of a thick polysaccharide capsule masks the 
meningococcal adhesins and invasins and thereby inhibits colonization and invasion of the 
nasopharynx (Hammerschmidt et al., 1996b). Expression of the capsule is dependent on 
both the possession and the expression of the capsular genes located in the kps (Frosch et 
al., 1989; see Figure 1-8). The capsular genes are located within a genomic island of 
horizontally transferred DNA, explaining acquisition and loss of the kps among strains 
(Parkhill et al., 2000; Tettelin et al., 2000; Schön et al., 2008). Moreover, expression of genes 
involved in capsule biosynthesis is regulated by phase variation via slipped-strand mispairing 
or reversible insertion of mobile elements (Hammerschmidt et al., 1996a; Hammerschmidt et 
al., 1996b). There is evidence that meningococci display an adaptive response upon contact 
to epithelial cells involving transcriptional regulators to down-regulate capsule expression 
during the early stages of the infection to facilitate adhesion to and invasion of the host cells 
(Deghmane et al., 2002; Deghmane et al., 2003).  
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Among the six clinically important meningococcal serogroups, four serogroups, i.e. B, C, W-
135 und Y, express sialic acid containing capsular polysaccharides (Rosenstein et al., 2001; 
Jódar et al., 2002; Boisier et al., 2007; see part 1.2). The group B capsular polysaccharide 
represents a homopolymer of α2,8-linked Sia which is structurally identical to polySia found 
in the human host, whereas the group C capsule is a homopolymer of α2,9-linked Sia 
(Bhattacharjee et al., 1975; see Figure 1-2). Serogroups W-135 und Y express 
heteropolymeric capsules composed of the disaccharide repeating units (6)-α-D-Galp-
(14)-α-Neu5Ac-(2) and (6)-α-D-Glcp-(14)-α-Neu5Ac-(2), respectively 
(Bhattacharjee et al., 1976; see Figure 1-2). Effective meningococcal glycoconjugate 
vaccines targeting the serogroup A, C, Y and W135 polysaccharides are currently available 
(Pace and Pollard, 2007).  
Among the polySia containing capsules, polysaccharides of serogroup C, W-135, and Y can 
be found O-acetylated as described in part 1.2 (Bhattacharjee et al., 1975; Bhattacharjee et 
al., 1976; Lemercinier and Jones, 1996; see Figure 1-2). Although the biological role of 
polySia O-acetylation with regard to pathogenicity is still unclear, recent findings suggest a 
general impact of capsule O-acetylation in masking immunogenic epitopes to circumvent the 
hosts immune system (Michon et al., 2000; Fusco et al., 2007; Gudlavalleti et al., 2007; 
Villwock et al., 2008). Even though O-acetylation of meningococcal capsular sialic acids is 
known for decades, there is almost no information on the enzymes catalyzing this 
modification. Only one report on the capsule specific O-acetyltransferase activity in 
serogroup C meningococci is available (Vann et al., 1978). In this study, spheroplast 
membranes of serogroup C meningococcal were used as an enzyme source, and Vann and 
coworkers demonstrated that the endogenous sialate O-acetyltransferase transfers acetyl 
groups from acetyl-CoA to endogenous membrane bound as well as to exogenous soluble 
serogroup C capsular polysaccharide (Vann et al., 1978). However, reports on the isolation 
and further characterization of this enzyme are missing and no information is available on 
endogenous sialate O-acetyltransferase activity in serogroup W-135 and Y meningococci. 
The lack of information on these enzymes is also due to the fact that the genetic basis of 
polySia capsule O-acetylation was discovered only recently (Claus et al., 2004). In 2004, the 
genes encoding the respective O-acetyltransferases of serogroup C, W-135 and Y 
meningococci were identified (Claus et al., 2004; Vogel et al., 2004), which was at that time 
the first identification of genes that encode sialic acid-specific O-acetyltransferases. The O-
acetyltransferase genes of meningococcal serogroups C, W-135 and Y are located 
downstream of the polySia biosynthesis genes as part of the serotype specific region A 
within the capsule gene complexes (see Figure 1-8).  
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Figure 1-8: Genetic organization of the capsule biosynthesis and transport loci of N. meningitidis 
serogroups C, W-135, and Y. The capsule transport operon (ctrA-D) as well as the genes lipA/lipB are involved 
in transport of the polymer across the membranes (shown in blue) and are conserved among Neisseria species. 
Region A comprises all genes required for biosynthesis of the serotype-specific capsular polysaccharide and is 
highlighted in green. The enzymes encoded by siaA–C synthesize CMP-activated Sia and are conserved among 
the Sia-producing serogroups. Polysialyltransferases, which synthesize the serogroup-specific polysaccharide, 
are encoded by siaD, and vary from serogroup to serogroup. The oat genes responsible for capsule O-acetylation 
are located downstream of siaD (shown in pink). The capsule gene locus is located between the genes tex 
(shown in grey) and galE (shown in black) and is regarded as a genetic island taken up by horizontally transferred 
DNA (Tettelin et al., 2000; Parkhill et al., 2000). Region A is shown from strains Fam18 (NmC; Bentley et al., 
2007), 2232 (NmW-135; Claus et al., 2004) and 2227 (NmY; Claus et al., 2004). 
 
Notably, the serogroups W-135 and Y comprise an identical O-acetyltransferase gene, which 
was therefore designated oatWY. The previously described widespread occurrence of OAc- 
W-135 and Y capsule forms was found to correlate with the presence of non-functional 
oatWY genes (e.g. due to insertion sequence elements) (Claus et al., 2004). The gene 
encoding the polySia specific O-acetyltransferase of serogroup C meningococci was termed 
oatC. Surprisingly, no sequence similarities between oatC and oatWY were detectable, 
although the two meningococcal genes are located at similar loci and have closely related 
functions. In line with the fact that N. meningitidis contains more genes that undergo phase 
variation than any pathogen studied to date and the observation that the kps is among the 
most variable regions, it is no surprise that also expression of oatC can be switched on and 
off. The presence of two homopolymeric tracts with seven nucleotides each allows phase 
variation with a frequency of approx. 1:20,000 that is most likely due to slipped-strand 
mispairing (Claus et al., 2004).  
Identification of the genetic basis of capsule O-acetylation in E. coli K1 and serogroup C, W-
135, and Y meningococci now enables the production of recombinant enzymes, thereby 
facilitating the biochemical and structural characterization of polySia-specific 
O-acetyltransferases.  
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1.5 - Objectives 
The aim of the present study was the molecular characterization of bacterial polySia-specific 
O-acetyltransferases. For this purpose, two genetically unrelated enzymes were chosen as 
model proteins: the prophage-encoded O-acetyltransferase NeuO, responsible for polySia 
capsule modification in E. coli K1 and OatC, the O-acetyltransferase that catalyzes 
modification of capsular sialic acids in serogroup C meningococci. For both enzymes, 
protocols for the recombinant expression, purification, and determination of enzymatic 
activity were established. Combined with the generation of site-specific mutants, this allowed 
the first biochemical characterization of polySia-specific O-acetyltransferases and the 
analysis of structure-function relationships. Points that were addressed included (i) 
determination of donor- and acceptor-substrate specificities, (ii) identification of structural and 
kinetic features that highlight phylogenetic relationships to known protein families, (iii) kinetic 
analysis of naturally occurring NeuO variants to investigate the biological impact of variations 
in the primary sequence and in the number of N-terminal RLKTQDS heptads, (iv) and 
crystallization of OatC to reveal first insight into the tertiary structure of a sialate 
O-acetyltransferase. 
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Escherichia coli K1 is one of the main organisms causing bacterial sepsis and meningitis in 
neonates. The pathogen is protected by a thick capsular polysaccharide composed of α2,8-
linked polysialic acid, which represents the major virulence factor. In several K1 strains, 
phase-variable O-acetylation of the sialic acid residues was observed, a modification that is 
catalyzed by the prophage-encoded O-acetyltransferase NeuO. The reversible switch 
between an on and off phase is mediated by changes in the number of heptanucleotide 
repeats in the 5’-coding region of the neuO gene since only repeat numbers that are a 
multiple of three allow full-length translation of neuO. During the on phase, the nucleotide 
repeats are translated into tandem copies of an RLKTQDS heptad. Previous attempts to 
isolate the endogenous enzyme failed and almost no information on the biochemical basis of 
K1 capsule O-acetylation was available. Therefore, my work was aiming at developing 
expression and purification strategies to isolate active recombinant NeuO. In parallel, I 
established two independent in vitro assays and determined donor and acceptor substrate 
specificities of NeuO as well as the minimal acceptor length. To investigate the role of N-
terminal NeuO extensions by variable numbers of RLKTQDS heptads, I purified NeuO 
variants containing 0, 4, 8, and 12 heptads and performed a comparative kinetic analysis for 
these variants. Homology modeling predicted a left-handed parallel β-helix (LβH) as the 
central fold of NeuO, indicating that the enzyme is a member of the LβH-family of 
acyltransferases. To confirm this model and to gain insight into structure-function-
relationships, I generated site-specific mutants and compared enzymatic activity and 
quaternary structure of purified wild-type and mutant forms of NeuO. 
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   Escherichia coli K1 is a leading pathogen in neonatal 
sepsis and meningitis. The K1 capsule, composed of 
α2,8-linked polysialic acid, represents the major 
virulence factor. In some K1 strains, phase-variable O-
acetylation of the capsular polysaccharide is observed, a 
modification that is catalyzed by the prophage-encoded 
O-acetyltransferase NeuO. Phase variation is mediated 
by changes in the number of  heptanucleotide repeats 
within the 5’-coding region of neuO, and full-length 
translation is restricted to repeat numbers that are a 
multiple of three. To understand the biochemical basis of 
K1 capsule O-acetylation, NeuO encoded by alleles 
containing 0, 12, 24, and 36 repeats was expressed and 
purified to homogeneity via a C-terminal hexahistidine 
tag. All NeuO variants assembled into hexamers and 
were enzymatically active with a high substrate 
specificity toward polysialic acid with >14 residues. 
Remarkably, the catalytic efficiency (kcat/Kmdonor) 
increased linearly with increasing numbers of repeats, 
revealing a new mechanism for modulating NeuO 
activity. Using homology modeling, we predicted a three-
dimensional structure primarily composed of a left-
handed parallel β-helix with one protruding loop. Two 
amino acids critical for catalytic activity were identified 
and corresponding alanine substitutions, H119A and 
W143A, resulted in a complete loss of activity without 
affecting the oligomerization state. Our results indicate 
that in NeuO typical features of an acetyltransferase of 
the left-handed β-helix family are combined with a 
unique regulatory mechanism based on variable N-
terminal protein extensions formed by tandem copies of 
an RLKTQDS heptad. 
 
 
 
   Escherichia coli K1 is one of the main organisms 
causing bacterial sepsis and meningitis during the 
neonatal period (1–3). The pathogenesis of E. coli 
meningitis is a complex process involving colonization of 
the gastrointestinal tract, intestinal translocation, 
bacteremia, passage of the blood-brain barrier, and 
invasion of the arachnoidal space (4). Cell culture 
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experiments indicated that transfer across the blood-brain 
barrier is mediated by transcytosis through brain 
endothelial cells (5, 6) and that, in contrast to other 
bacterial agents causing meningitis, E. coli K1 invades 
meningioma cells directly, leading to rapid cell death 
before an inflammatory response can be induced (7). 
Despite advances in diagnostics and therapeutics of 
neonatal infections, E. coli neonatal meningitis is still 
characterized by high rates of mortality and a high 
incidence of permanent neurological sequelae in those 
that survive (8, 9). E. coli K1 is protected by a thick layer 
of capsular polysaccharide, which is the major virulence 
factor important for serum resistance and vital passage of 
the blood-brain barrier (5, 10, 11). The K1 capsule 
consists of polysialic acid (polySia) formed by the most 
prevalent sialic acid of humans, 5-N-acetyl neuraminic 
acid (Neu5Ac). Up to 200 residues are joined in α2,8-
glycosidic linkages, resulting in a linear homopolymer that 
is structurally identical to polySia of the host organism 
(12, 13). Due to this antigenic mimicry, the K1 capsule is 
poorly immunogenic, and no effective polysaccharide-
based vaccines are available.  
   In several K1 strains, modification of the capsule by O-
acetylation of the Neu5Ac residues in positions O-7 and 
O-9 was observed (14–16). This modification is phase-
variable, and individual strains can switch between O-
acetylated (OAc+) and non-O-acetylated (OAc-) capsule 
variants (14). Although associated with increased 
immunogenicity, modification of the K1 capsule by O-
acetylation correlates with increased virulence in patients 
with bacteremia (17). Because O-acetylated polySia 
resists hydrolysis by neuraminidases, capsule O-acety-
lation may favor colonization of the intestinal tract (14).  
   O-Acetylation of the K1 capsule is catalyzed by an 
acetyl-CoA-dependent O-acetyltransferase with 
preferential acceptor specificity toward polySia with >14 
residues (15). The corresponding gene (neuO) is part of a 
40-kb prophage of the P22 family, and phase variation is 
mediated by changes in the overall length of variable 
number of tandem repeats (VNTRs) within the 5’-coding 
region (16, 18). VNTR loci are among the most variable 
regions of many bacterial genomes and arise through 
slippage and mispairing during DNA replication due to 
occasional DNA polymerase dissociation (19, 20). In the 
neuO-positive K1 strains reported so far, 14–39 copies of 
the heptanucleotide unit 5’-AAGACTC-3’ were inserted 
two nucleotides downstream of the start codon (16). Only 
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repeat numbers that are a multiple of three allow full-
length translation of neuO (phase on), whereas other 
numbers move the start codon out of frame resulting in 
truncated and thereby inactive translation products 
(phase off). In the case of full-length translation, the 
presence of VNTRs will lead to significant N-terminal 
protein extensions with every three tandem 
heptanucleotides encoding an RLKTQDS heptad. 
Comparison of 10 different OAc+ K1 strains indicated that 
VNTR-encoded protein extensions may affect NeuO 
activity (16). However, direct analysis of the enzymatic 
activity in bacterial lysates is hampered by the high 
frequency of phase variation, and thus far, isolation of 
endogenous NeuO failed (15). In the present study, we 
succeeded in purification of active recombinant enzyme, 
forming the basis for a detailed biochemical 
characterization of NeuO. Functional and structural 
analyses of variants encoded by neuO alleles with 0, 12, 
24, and 36 heptanucleotide repeats revealed that NeuO 
shares the typical features of an acyltransferase of the 
left-handed-β-helix (LβH) superfamily and assembles into 
hexamers that might be formed by dimerization of two 
trimers. In contrast to other members of the LβH family, 
NeuO activity is regulated by changes in the number of 
N-terminal RLKTQDS heptads and the catalytic efficiency 
gradually increases with the length of this VNTR-encoded 
protein extension. 
 
EXPERIMENTAL PROCEDURES 
   Materials - E. coli K1 strains A160 and C375 were 
kindly provided by M. Achtman and F. Ørskov, 
respectively. pET expression vectors and E. coli 
BL21(DE3) were obtained from Novagen. CMP-Neu5Ac, 
Neu5Ac, colominic acid, 5,5’-dithiobis(2-nitrobenzoic 
acid) (Ellman’s reagent), acetyl-, propionyl-, and butyryl-
CoA were purchased from Sigma. Isolated sialic acid 
dimers, trimers, tetramers, pentamers, and hexamers 
were obtained from Nacalai-Tesque (Tokyo, Japan).  
   Cloning of the Capsule-specific O-Acetyltransferase of 
E. coli K1 - In parallel to Deszo et al. (16), we identified 
the capsule-specific O-acetyltransferase of E. coli K1 in 
the unfinished genome of strain RS218 (serotype 
O18ac:H7:K1, University of Wisconsin) by screening for 
homologies to the amino acid sequence of the sialic acid 
O-acetyltransferase of serogroup W-135 and Y 
meningococci (oatWY, accession number Y13969). A 
corresponding DNA-sequence of the identified gene was 
amplified by PCR from genomic DNA of the O-acetylation 
positive K1 strain C375. The gene was termed oatK1, 
and the sequence was submitted to the 
DDBJ/EMBL/GenBankTM databases under the accession 
number AJ783705. DNA sequencing revealed the 
presence of 18 heptanucleotide repeats and that the 
coding region is identical to neuO published by Deszo et 
al. (16).  
   Homology Modeling - The structural fold of NeuO was 
predicted by the program 3D-PSSM (21), a profile-based 
method that relies on multiple sequence and multiple 
structural alignments. Highest scores were obtained for 
the structural model based on homology to the E. coli 
maltose O-acetyltransferase(PDB accession number 
1ocx), and all structural data were visualized by the 
PyMOL Molecular Graphics System.  
 
   Generation of NeuO Expression Plasmids - Constructs 
for the expression of wild-type NeuO were constructed in 
pET22b-Strep. In this modified pET22b vector, the 
original pelB leader sequence was exchanged by the 
sequence encoding an N-terminal Strep tag II 
(WSHPQFEK). NeuO without heptanucleotide repeats 
was amplified by PCR using genomic E. coli K1 DNA as a 
template and the primer pair MM275/MM282 (5’-CGGGA-
TCCATGTCGTTTTCCGTTGATG-3’, 5’-GTCCGCTCGA-
GTTGCGTGAGCTTCGCATG-3’). BamHI and XhoI sites 
(underlined) in forward and reverse primers, respectively, 
were used for subcloning of the PCR products into the 
BamHI/ XhoI sites of pET22b-Strep, resulting in 
constructs with an N-terminal Strep tag II and a C-
terminal hexahistidine tag. NeuO variants with hepta-
nucleotide repeats were amplified by PCR using the 
primer pair MM301 (5’-CGGGATCCATGTTAAGACTCA-
AGACTC-3’ and MM282 and genomic DNA of an E. coli 
K1 strain harboring an neuO gene with 36 hepta-
nucleotide repeats as a template. The forward primer 
MM301 covers two heptanucleotide repeats and, 
therefore, can bind randomly within the repeat stretch 
resulting in a wide variety of PCR products containing 2–
36 heptanucleotide repeats. PCR products of different 
length were subcloned by BamHI/XhoI sites into pET22b-
Strep as described above. Constructs containing 12, 24, 
and 36 repeats were selected, and the number of 
heptanucleotide repeats was confirmed by sequencing. 
   Site-directed Mutagenesis - Site-directed mutagenesis 
was performed by PCR using the QuikChange site-
directed mutagenesis kit (Stratagene) following the 
manufacturer’s guidelines and the following primer pairs: 
MM295/MM296 to introduce the amino acid exchange 
H119A (5’-GCGTGCATCAGATGGCGCGCCTATATTTG-
ATATTC-3’ and 5’-GAATATCAAATATAGGCGCGCCAT-
CTGATGCAC-GC-3’) and MM278/MM279 for the 
mutation W143A (5’-CATTATATCTAGTTACGTAGCGG-
TAGGGAGAAATGTCTC-3’ and 5’-GAGACATTTCTCCC-
TACCGCTACGTAACTAGAT-ATAATG-3’). BamHI/XhoI 
fragments of the corresponding PCR products were 
subcloned in pET22b-Strep for recombinant expression in 
E. coli BL21(DE3). The identity of all constructs was 
confirmed by sequencing. 
   Expression and Purification of Recombinant NeuO - 
Freshly transformed E. coli BL21(DE3) were cultivated at 
37 °C in Luria-Bertani (LB)-medium containing 200 µg/ml 
carbenicillin. At an optical density (A600) of 0.6 expression 
was induced by adding 0.1 mM isopropyl 1-thio-β-D-
galactopyranoside and bacteria were harvested 2 h after 
induction. Purification was performed by immobilized Ni2+-
affinity chromatography using HisTrap-chelating HP 
columns (GE Healthcare). Bacteria were resuspended in 
binding buffer (20 mM Tris-HCl, pH 8.0/500 mM NaCl/40 
mM imidazole) and lysed by sonication, and the soluble 
fraction was applied to a 1-ml column according to the 
manufacturer’s instructions. After washing with 25 ml of 
binding buffer, proteins were eluted with a linear 
imidazole gradient of 40–500 mM imidazole in binding 
buffer. Imidazole was removed by gel filtration using a 
HiPrep 26/10 desalting column (GE Healthcare) 
equilibrated with 100 mM Tris-HCl, pH 8.0/150 mM NaCl. 
   In Vitro Assay for the Determination of NeuO Activity - 
NeuO activity was determined in a spectrophotometric  
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assay according to Alpers et al. (22). In a total volume of 
100 µl, the standard reaction mixture contained 20 mM 
Tris-HCl, pH7.5, 25 mM EDTA, 4 mM 5,5’-dithiobis(2-
nitrobenzoic acid), 2 mg/ml colominic acid, and 1 mM 
acetyl-CoA, and the reaction was initiated by adding 24 
pmol of purified enzyme. The reaction was performed at 
25 °C and monitored continuously at 405 nm in half-area 
96-well plates (Greiner) using a PowerWave 340 
microplate spectrophotometer (BioTek). For comparison 
of NeuO activity toward colominic acid, CMP-Neu5Ac, 
Neu5Ac, and Neu5Ac oligomers of different length, the 
concentrations of all acceptor substrates were normalized 
to equal sialic acid content (6.85 mM) and thereby to an 
equal number of acceptor sites. For quantification of the 
sialic acid content, oligomers were hydrolyzed to free 
sialic acid by treatment with 100 mM trifluoroacetic acid 
for 4 h at 80 °C followed by the thiobarbituric acid assay 
according to Skoza and Mohos (23) using Neu5Ac as 
standard.  
   Kinetic Analysis - The acceptor and donor kinetics were 
measured on purified NeuO variants using the 
spectrophotometric assay described above. The steady-
state parameters, Km and kcat, were determined by 
holding one substrate at saturating concentration while 
the concentration of the second substrate was varied. 
Twelve different concentrations of donor (0.025–2 mM 
acetyl-CoA) and acceptor substrate (2–215 µM colominic 
acid) were used. Kinetic parameters were obtained by 
fitting the initial rate data to the Michaelis-Menten 
equation using nonlinear regression analysis with Prism 
4.0 software (GraphPad Software, Inc.).  
   Analysis of NeuO Activity in Vivo - NeuO lacking the 
VNTR region was amplified by PCR using the primers 
HC412 (5’-GCGCGCGGATCCCGTTTTCCGTTGATGAT-
AATGGG-3’) and HC406 (5’-GCGCGCCTGCAGTATTT-
ATTGCGTGAGCTTCGC-3’) containing BamHI and PstI 
sites (underlined), respectively. The above described 
pET-based plasmids containing neuO encoding either 
wild-type or mutated variants with the amino acid 
exchanges H119A and W143A were used as a template. 
PCR products were ligated into BamHI/PstI sites of 
pQE32(Qiagen), and the identity of all constructs was 
confirmed by DNA sequencing. The resulting plasmids 
were transformed into E. coli K1 strain A160, which lacks 
endogenous neuO. Bacteria were grown on LB-agar 
containing 100 µg/ml ampicillin and 20 µl of a bacterial 
suspension (optical density at 600 nm = 0.1) were added 
to each well of a microtiter plate (Greiner) coated with 
poly-D-lysine (Sigma). After drying, bacteria were fixed 
with 0.05% glutaraldehyde in phosphate-buffer saline. 
Capsule expression and modification by O-acetylation 
was monitored in an enzyme-linked immunosorbent 
assay as described previously (24) using the following 
monoclonal antibodies (mAbs): mAb735 (25), which is 
specific for α2,8-linked polySia (OAc+ and OAc- forms), 
and mAb 58-5 (Monosan), which binds exclusively to the 
O-acetylated form of the K1 antigen.  
   Determination of the Minimal Acceptor Substrate 
Length - In a final volume of 50 µl, 200 µg of colominic 
acid was incubated with 1.3 µg of purified NeuO in the 
presence of [14C]acetyl-CoA (GE Healthcare) for 1 h at 
37°C. The reaction mixture was separated by high 
percentage PAGE, and the degree of polymerization of 
  
 
the smallest radioactively labeled acceptor molecule was 
determined by autoradiography. For generation of a 
radioactively labeled oligosialic acid marker ladder, the 
solid-phase fixed polysialyltransferase ST8SiaIV/PST-1 
was autopolysialylated in vitro in the presence of CMP-
[14C]Neu5Ac (GE Healthcare) as described (26). After 
removal of unbound substrate, radioactively labeled sialic 
acid oligomers were released by partial endosialidase 
cleavage.  
   Analysis of Polysialic Acid by High Percentage PAGE - 
Sialic acid oligomers and polymers were separated on 
25% polyacrylamide gels as described (27). 
Electrophoresis was performed for 4 h at 4 °C and 400 V, 
using 14-cm gels (0.8-mm thick). Immediately after 
electrophoresis, acrylamide gels were vacuumdried and 
exposed to Hyperfilm-MP (GE Healthcare).  
   SDS-PAGE, Silver Staining, and Immunoblotting – 
SDS-PAGE was performed under reducing conditions 
using 2.5% (v/v) β-mercaptoethanol. Silver staining and 
Western blot analysis were performed as described 
previously (28). For detection of the hexahistidine tag, 
penta-His antibody (Qiagen) was used at a concentration 
of 1 µg/ml. Strep-tagged proteins were detected with 
StrepTactin-AP conjugate (IBA) at a 1:4000 dilution.  
   Size-exclusion Chromatography - The quaternary 
structure of wild-type and mutant NeuO was determined 
on a Superdex 200 HR 10/30 column (GE Healthcare). 
The column was equilibrated with 100 mM Tris-HCl, pH 
8.0/150 mM NaCl and calibrated with molecular mass 
standards (Sigma) thyroglobulin (669 kDa), β-amylase 
(200 kDa), alcohol dehydrogenase (150 kDa), bovine ser-
um albumin (66 kDa), carbonic anhydrase (29 kDa), and 
cytochrome C (12.4 kDa). 1 mg of affinity-purified wild-
type or mutant NeuO was applied to the column, and the 
eluted protein was monitored by absorbance at 280 nm.  
 
RESULTS 
   Purification of NeuO Variants with Variable N-terminal 
Protein Extensions - In all OAc+ E. coli K1 strains 
investigated so far, neuO contains VNTRs located two 
nucleotides downstream of the start codon (16). As 
shown in Fig. 1A, full-length translation and thereby 
expression of active NeuO depend on repeat numbers 
that are divisible by three. In the case of full-length 
translation, every three tandem heptanucleotides encode 
an RLKTQDS heptad.  
   To investigate the role of N-terminal heptads on protein 
expression and activity, a set of neuO alleles with 0, 12, 
24, and 36 heptanucleotide repeats was generated, and 
the corresponding translation products were termed 
NeuO+0, NeuO+12, NeuO+24, and NeuO+36, 
respectively. Each variant was expressed in E. coli 
BL21(DE3) with an N-terminal Strep- and a C-terminal 
hexahistidine tag (see Fig. 1B for schematic 
representation). Recombinant proteins were isolated by 
immobilized metal affinity chromatography (IMAC) using 
the C-terminal hexahistidine tag. Notably, high imidazole 
concentrations (≥450 mM) were required for the elution of 
all variants, indicating tight adsorption to the IMAC matrix. 
Because NeuO was unstable under these conditions, 
fractions eluted from the IMAC column were loaded 
immediately onto a Sephadex G-25 column to remove 
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imidazole. Using this purification protocol, all NeuO 
variants were purified to homogeneity (Fig. 1, C and D). 
Silver staining revealed single bands with an apparent 
molecular mass consistent with the calculated mass of 
the respective variant (Fig. 1, B and D). Western blot 
analysis using StrepTactin and anti-penta-His antibody 
(Fig. 1D, middle and right panel) revealed that neuO 
alleles with 12, 24, and 36 heptanucleotide units were 
translated in full-length proteins with the expected N-
terminal extensions of 28, 56, and 84 amino acids, 
respectively,  and no  proteolytic cleavage  or degradation 
 
and without heptad repeats was determined in a modified 
Alpers assay (22). In this spectrophotometric assay, the 
transfer of acetyl groups from acetyl-CoA to polySia is 
followed by measuring the appearance of the free 
sulfhydryl group of CoA-SH with Ellman’s reagent. 
Reactions were initiated by adding equimolar amounts of 
purified NeuO+0, NeuO+12, NeuO+24, or NeuO+36, and 
the optical density was monitored at 405 nm. Under the 
applied conditions of high donor and acceptor substrate 
concentrations, NeuO+0 and NeuO+12 showed 
comparable enzymatic activities (Fig. 1E),  demonstrating 
of the heptad region was 
observed. From 1-liter cultures, 
2.5 mg of purified NeuO+0 was 
obtained (Fig. 1B). Expression 
levels and protein yields 
increased with increasing 
numbers of VNTRs, suggesting 
that heptads contribute to 
protein stability. Because the 
insertion of 12, 24, and 36 
nucleotide repeats increases 
the molecular mass of the 
translation products by 13, 25, 
and 37%, respectively, protein 
yields were compared on the 
molar level revealing a 2-fold 
higher protein yield for 
NeuO+36 than for NeuO+0 
(Fig. 1B).  
   It is worth noting that none of 
the NeuO variants bound 
significantly to a StrepTactin 
column, although the N-terminal 
Strep tag was detectable by 
Western blotting (Fig. 1D, 
middle panel). This observation 
indicates that in native NeuO 
the N terminus is not 
accessible. Remarkably, this 
finding was irrespective of the 
presence or absence of heptad 
repeats (data not shown). For 
the unequivocal detection of 
full-length proteins, we kept the 
Strep tag in all used constructs. 
Direct comparison of NeuO with 
and without the Strep tag 
revealed that this tag did not 
affect NeuO activity (data not 
shown).  
   N-terminal Heptads Are 
Dispensable for Enzymatic 
Activity of Isolated NeuO - After 
demonstrating that 
heptanucleotide repeats are 
translated in stable protein 
extensions, we asked whether 
RLKTQDS heptads are 
essential for enzymatic activity 
of NeuO. To investigate this 
point, the O-acetyltransferase 
activity of NeuO variants with  
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TABLE 1 
Kinetic parameters of NeuO variants with different numbers of heptad repeats  
NeuO activity was measured in the spectrophotometric assay at pH 7.5 and 25 °C. Donor kinetics were determined using 0.025-2mM acetyl-CoA 
with colominic acid at 2 mg/ml. Acceptor kinetics were determined using 0.015–2 mg/ml colominic acid (corresponding to 0.05-6.85 mM sialic acid 
residues) with acetyl-CoA at 2 mM. The steady-state parameters, Km and kcat, were determined from initial velocity measurements from at least 
three independent experiments measured in triplicate and values are given as mean ± S.D. 
 
Donor  Acceptora NeuO variant Donor substrate Km kcat kcat /Km  Km kcat kcat /Km 
  mM s-1 s-1 mM-1  mM s-1 s-1 mM-1 
+ 0 Acetyl-CoA 0.40  ± 0.01 0.51  ± 0.05 1.28  1.17  ± 0.14 1.99  ± 0.08 1.70 
+ 12 Acetyl-CoA 0.22  ± 0.04 0.56  ± 0.07 2.54  1.10  ± 0.14 1.85  ± 0.14 1.68 
+ 24 Acetyl-CoA 0.27  ± 0.01 1.07  ± 0.11 3.95  1.00  ± 0.04 2.57  ± 0.11 2.57 
+ 36 Acetyl-CoA 0.22  ± 0.05 1.16  ± 0.16 5.26  1.06  ± 0.12 3.84  ± 0.10 3.62 
+ 36 Propionyl-CoA 0.22  ± 0.02 0.09  ± 0.01 0.40     
a
 For acceptor kinetics, acceptor substrate concentrations were given as mM sialic acid residues. 
  
 
 
 
FIGURE 2. Effect of heptad repeats on the catalytic efficiency of 
NeuO. Catalytic efficiencies for the donor (A) and the acceptor 
substrate (B) were determined for NeuO encoded by alleles containing 
0, 12, 24, and 36 heptanucleotide repeats (see Table 1), and the 
obtained kcat/Km values were plotted versus the number of 
heptanucleotide repeats. 
 
that N-terminal RLKTQDS heptads are dispensable for 
enzymatic activity. Interestingly, increased activities 
were observed for NeuO+24 and NeuO+36, indicating 
that VNTR-encoded protein extensions influence the 
enzymatic properties of NeuO.  
   RLKTQDS Heptad Repeats Increase the Catalytic 
Efficiency of NeuO - To further investigate the effect of 
heptad repeats on the activity of NeuO, substrate 
kinetics of purified NeuO variants with and without 
RLKTQDS repeats were compared. In a first step, 
steady-state kinetic constants of NeuO+0, NeuO+12, 
NeuO+24, and NeuO+36 were determined for the donor 
substrate using 12 different concentrations of acetyl-
CoA. All kinetic analyses were performed at 25 °C and 
yielded linear Lineweaver-Burk plots (see supplemental 
Figs. S1 and S2). The donor Km value of NeuO+0 was 
determined to be 0.4 mM (Table 1), whereas all Km 
values of heptad-containing variants were decreased by 
almost 50%. Vmax and thereby kcat values slightly 
increased with the number of heptads leading to a 2.3-
fold higher kcat for NeuO+36 compared with NeuO+0.  
   A lower Km value in combination with an increased kcat 
resulted in a 4-fold higher catalytic efficiency (kcat/Kmdonor) 
of NeuO+36 compared with NeuO+0 (Table 1). 
Remarkably, kcat/Kmdonor values increased linearly with 
the number of heptad repeats (Fig. 2A). These results 
suggest that the presence of heptad repeats result in 
gradual changes in enzyme conformation allowing an 
increase in enzyme-donor substrate affinity and 
facilitation of the reaction rate.  
   In a second step, kinetic parameters for the acceptor 
were determined using 12 different polySia 
concentrations. As an acceptor substrate, we used 
colominic acid, a commercially available mixture of 
oligomeric α2,8-linked sialic acid. Analysis of the batch 
used in the present study revealed oligomer lengths 
ranging from 2 to over 60 residues and an average 
degree of polymerization (DP) of 32. To acknowledge 
the fact that colominic acid is heterogeneous in polymer  
 
 
 
length, and that longer polymers contain more acceptor 
sites than shorter chains, acceptor concentrations were 
expressed as concentration of total sialic acids. Because 
acceptor affinities may vary with polySia chain length and 
also between internal and terminal sialic acids residues,  
 
FIGURE 1. Purification of NeuO variants containing VNTR-encoded heptad repeats. A, schematic representation of the VNTR region of neuO 
showing alleles with 13 (top) and 12 (bottom) 5’-AAGACTC-3’ repeats. RLKTQDS heptads encoded by 3 heptanucleotide repeats are highlighted 
by gray boxes. B, schematic representation of NeuO variants encoded by alleles containing 0, 12, 24, and 36 repeats. The VNTR-encoded heptad 
region is shown in black, and N-terminal Strep- and C-terminal hexahistidine tag are shown in light and dark gray, respectively. All variants were 
expressed in E. coli BL21(DE3), and proteins were purified by IMAC on an Ni2+-chelating column. The amount of purified protein obtained from a 
1-liter culture is given as mean ± S.D. from three independent experiments. C, purification of NeuO lacking the VNTR region. After expression in 
E. coli BL21(DE3), NeuO+0 was isolated by IMAC. Purification steps were monitored by 14% SDS-PAGE and Coomassie staining, including 
aliquots of bacterial lysate (lane 1), flow through of the IMAC column (lane 2), wash fractions (lanes 3 and 4), NeuO eluted from IMAC column 
(lane 5), and purified NeuO after subsequent imidazole removal by gel filtration (lane 6). D, analysis of affinity-purified NeuO variants encoded by 
alleles containing 0, 12, 24, and 36 heptanucleotide repeats. Equal protein amounts of each variant were separated by 14% SDS-PAGE and 
analyzed by silver staining (left panel) and Western blotting using StrepTactin-AP for detection of the N-terminal Strep tag (middle panel) or anti-
penta-His antibody for detection of the C-terminal hexahistidine tag (right panel). E, enzymatic activities of NeuO variants encoded by alleles 
containing the indicated number of heptanucleotide repeats. NeuO activity was determined spectrophotometrically in a modified Alpers assay 
using 24 pmol of purified protein. 
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TABLE 2 
Acceptor specificity of NeuO 
Relative enzymatic activities of purified NeuO+0 and NeuO+36 were 
determined in the presence of different acceptor substrates. All 
acceptor substrates were used at a concentration of 6.85 mM of total 
sialic acids, and the activity obtained for colominic acid was set to 
100%. Values are mean ± S.D. from two independent experiments 
measured in triplicate. 
 
 
Relative enzymatic activity  Acceptor 
      NeuO+0  NeuO+36                
  %  
Colominic acid 100.0  ± 1.3 100.0  ± 1.7  
Neu5Ac 0.4  ± 0.2 0.9  ± 0.9  
(-8-Neu5Ac-α2-)2 0.9  ± 0.3 0.6  ± 0.4  
(-8-Neu5Ac-α2-)3 1.0  ± 0.7 0.1  ± 1.0  
(-8-Neu5Ac-α2-)4 0.2  ± 0.5 0.3  ± 0.8  
(-8-Neu5Ac-α2-)5 0.6  ± 1.0 0.2  ± 1.2  
(-8-Neu5Ac-α2-)6 1.1  ± 1.3 0.3  ± 0.7  
CMP-Neu5Ac 0.6  ± 0.7 2.1  ± 1.3  
  
 
 
 
 
FIGURE 3. Determination of the minimal acceptor length. Purified 
NeuO+36 was incubated with colominic acid and [14C]acetyl-CoA. The 
reaction mixture was separated by 25% PAGE, and radioactively 
labeled products were visualized by autoradiography (lane 1). The 
shortest detectable sialic acid oligomer is marked by an arrow. For 
size determination, radioactively labeled sialic acid oligomers with DP 
3–18 were used as a marker (lane 2). 
 
acceptor Km values will represent average values. For 
NeuO+0, the acceptor Km value was determined to be 
1.17 mM (Table 1). In contrast to the donor Km values, no 
significant differences in Kmacceptor were observed for 
NeuO variants with and without heptad repeats. 
Therefore, the kcat/Kmacceptor value was only 2-fold higher 
for NeuO+36 compared with NeuO+0 (Table 1), and the 
catalytic efficiency also increased with the number of 
repeats (Fig. 2B).  
   Donor Specificity of NeuO - In addition to acetyl-CoA, 
the alternative acyl donors propionyl-CoA and butyryl-
CoA were assayed as substrates for NeuO. Butyryl-CoA 
turned out to be a very poor substrate, and even at a 
concentration of 1 mM, no transfer activity was observed. 
Propionyl-CoA, however, was used as a donor substrate. 
Similar to the results obtained with acetyl-CoA, increased 
enzymatic activities were monitored for NeuO+36 
compared with NeuO+0 (data not shown). Kinetic 
parameters were evaluated only for NeuO+36, and 
results are summarized in Table 1 (bottom row).  
   Interestingly, identical Km values were obtained for 
acetyl- and propionyl-CoA, indicating that the binding 
pocket for the donor substrate can accommodate the 
larger acyl-chain of propionyl-CoA. However, a 13-fold 
decrease in kcat was observed for propionyl-CoA, 
indicating that the free energy for the transition state of 
the rate-limiting step is significantly higher for propionyl-
CoA compared with acetyl-CoA.  
   Acceptor Specificity of NeuO - To investigate the 
acceptor substrate specificity of NeuO, the enzymatic 
activity of purified enzyme was monitored in the presence 
of sialic acid monomers (Neu5Ac), activated sialic acid 
(CMP-Neu5Ac), and a set of short α2,8-linked sialic acid 
oligomers with defined DPs in the range of dimer to 
hexamer. Because different kinetic properties were 
observed for NeuO variants with and without heptad 
repeats, acceptor substrate specificities were analyzed in 
parallel for NeuO+0 and NeuO+36. In contrast to 
colominic acid, none of the assayed compounds was 
used as an acceptor (Table 2). This result demonstrates 
that NeuO is highly specific for polySia and that even an 
α2,8-linked sialic acid hexamer is too short for NeuO-
catalyzed O-acetylation.  
   To determine the minimal acceptor length of NeuO, we 
performed a radioactive incorporation assay. Purified 
NeuO+0 and NeuO+36 were incubated in the presence of 
14C-labeled acetyl-CoA and colominic acid as acceptor  
 
 
 
substrate. After separation by high percentage PAGE, 
reaction products were visualized by autoradiography. 
Because only those oligomers modified by O-acetylation 
will become radioactively labeled, the length of the 
shortest visible oligomer will represent the minimal 
acceptor length required. As a size marker, 14C-labeled 
polySia was partially digested with endosialidase, 
resulting in an oligomer ladder starting with DP 3 (26). 
For the two enzyme variants, NeuO+0 and NeuO+36, 
reaction products of similar length were obtained and 
results are shown for NeuO+36 as an example (Fig. 3). 
Faint radioactive  signals became visible for oligomers 
with DP 14 –16, and strong signals were obtained for 
oligomers >16 residues. Together, these results 
demonstrate high acceptor substrate specificity of NeuO 
for sialic acid oligomers >14 residues.  
   Homology Modeling of the Catalytic Part of NeuO - 
Primary sequence analysis of NeuO revealed similarity to 
the hexapeptide repeat family of acyltransferases (16, 
29). Proteins of this family are characterized by tandem 
repeats of a hexapeptide with the consensus motif [LIV]- 
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FIGURE 4. Homology model of NeuO in comparison with the crystal structure of MAT. A, 
ribbon representation of MAT (PDB accession number 1ocx; side view of the monomer). B, trimeric 
organization of MAT (top view), with the three subunits shown in green, red, and blue. The location 
of His-113 and Trp-137, which are part of the active site, are indicated by arrows. C, three-
dimensional model of NeuO lacking VNTR-encoded heptads (side view of the monomer). The 
model was obtained by using the program 3D-PSSM (21) with the structure of MAT as a template. 
D, the predicted structure of the NeuO monomer (purple) was modeled into the trimer of MAT 
(gray). The locations of His-119 and Trp-143 of NeuO are indicated by arrows. All structural data 
were visualized by PyMOL. 
  
 
catalytic histidine of the next 
subunit (Fig. 4B). In the predicted 
NeuO model, His-119 and Trp-
143 are located at equivalent 
positions, suggesting similar 
functions in enzymatic catalysis.  
   Identification of Catalytic 
Residues - To prove whether His-
119 and Trp-143 are crucial for 
enzymatic activity of NeuO, single 
alanine substitutions were 
performed. For both mutations, 
H119A and W143A, variants with 
and without 36 heptanucleotide 
repeats were generated, and the 
resulting proteins were expressed 
in E. coli BL21(DE3) with N-
terminal Strep- and C-terminal 
hexahistidine tags. For either 
variant, similar expression levels 
than for the corresponding wild-
type proteins were observed (data 
not shown), indicating that the 
introduced amino acid exchanges 
did not affect the stability of 
NeuO. The four mutant variants 
were purified to homogeneity (Fig. 
5A) and assayed for enzymatic 
activity.  However,  in  contrast  to  
[GAED]-X2-[STAV]-X, which forms alternating short β-
strands and tight turns resulting in a triangular left-handed 
β-helix (LβH) (30). All members of the hexapeptide 
acyltransferase superfamily assemble into catalytic 
trimers with three symmetrically arranged catalytic sites 
at the interface between the monomers.  
   To gain first insight into the structure of a polySia 
modifying O-acetyltransferase, homology models of 
NeuO lacking heptad repeats were generated using the 
program 3D-PSSM (21). The best structural match with 
an E-value of 2.2 x 10-4 (≥95% certainty) was obtained 
with the crystal structure of the maltose O-
acetyltransferase (MAT) of E. coli (Protein Data Bank 
number 1ocx) (31) (see supplemental Fig. S3). The 
obtained model consists primarily of an LβH fold with five 
and one-third triangular coils (Fig. 4). The LβH domain 
covers the central and C-terminal part of NeuO (amino 
acids 61–216) and is interrupted by a single loop formed 
by residues 116–133 (Fig. 4C). For the first 60 amino 
acids of NeuO, however, only poor predictions were 
obtained, indicating structural differences between the N-
terminal parts of NeuO and MAT. The LβH domain of 
MAT is N-terminally capped by three α-helices (residues 
1–55), whereas only one α-helix was predicted for NeuO. 
   Notably, two amino acids that are part of the active site 
of MAT were highly conserved in NeuO. His-113, which 
corresponds to His-119 in NeuO, is located in the loop 
that protrudes between β-sheets four and five. This 
residue is proposed to abstract the proton from the 
hydroxyl group of the acceptor prior to acetyl transfer (31, 
32). Trp-137, which corresponds to Trp-143 in NeuO, is 
located in a β-sheet of the LβH domain and is involved in 
binding of acetyl-CoA (31, 32). In the homo-trimer, the 
tryptophan of one subunit is located opposite to the  
 
 
the wild-type forms of NeuO+0 and NeuO+36, no 
enzymatic activity was detected for the corresponding 
mutant forms (Fig. 5B). In addition to the in vitro analysis, 
the activity of NeuO variants was studied in vivo. To 
circumvent phase variation, the in vivo approach was 
restricted to variants lacking the VNTR region. 
Corresponding wild-type and mutant forms were cloned 
into the expression vector pQE32, and the resulting 
plasmids were transformed into E. coli K1 strain A160. As 
shown by PCR analysis, this strain lacks endogenous 
neuO (data not shown). Consequently, the expressed K1 
capsule is OAc-negative as confirmed by an enzyme-
linked immunosorbent assay using two capsule-specific 
antibodies: (i) mAb 735 (25), which binds to α2,8-linked 
polySia irrespective of the presence or absence of O-
acetylation, and (ii) mAb 58-5, which recognizes 
exclusively the O-acetylated form of the K1 antigen (Fig. 
5C). O-Acetylation of the K1 capsule of strain A160 was 
only observed after expression of wild-type NeuO. By 
contrast, no capsule O-acetylation was detected after 
expression of NeuO-H119A and NeuO-W143A, although 
K1 expression per se was not affected (Fig. 5C). 
Together, these results demonstrate that His-119 and 
Trp-143 are essential for NeuO activity in vitro and in 
vivo.  
   NeuO Assembles into Hexamers - The quaternary 
structure of all known hexapeptide acyltransferases is 
trimeric with the exception of the serine acetyltransferase 
(SAT) of E. coli and Haemophilus influenzae, which 
adopts a hexameric structure that is formed by dimers of 
trimers (33–35). Because trimerization is prerequisite for 
activity of hexapeptide acyltransferases, we asked 
whether the introduced mutations H119A and W143A 
induced conformational changes that prevent  
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FIGURE 6. Quaternary structure of NeuO. The oligomeric state of 
purified NeuO+36 and the corresponding mutants H119A and W143A 
was analyzed by size exclusion chromatography on a Superdex 200 
column. Void volume (Vo) and elution positions of standard proteins 
are indicated by arrows. 
 
 
 
FIGURE 5. Identification of amino acid residues critical for NeuO 
activity. A, the single amino acid exchanges H119A and W143A were 
introduced into NeuO+0 (left panel) and NeuO+36 (right panel). After 
expression in E. coli BL21(DE3) and affinity purification on Ni2+-
chelating columns, wild-type (wt) and mutant forms were analyzed by 
14% SDS-PAGE and silver staining (upper panel) or Western blotting 
using anti-penta-His antibody (lower panel). B, the enzymatic 
activities of NeuO+0 (wt), NeuO+36 (wt+36), and the corresponding 
mutants H119A and W143A were determined spectrophotometrically 
in the modified Alpers assay using equimolar concentrations of each 
purified protein. Data represent mean values ± S.D. of three 
independent experiments measured in triplicates. C, in vivo analysis 
of NeuO mutants. E. coli K1 strain A160 (Ø), which lacks endogenous 
neuO, was transformed with the empty vector pQE32 (mock), pQE32-
based plasmids containing wild-type neuO lacking the VNTR region 
(wt), and the corresponding mutant variants H119A and W143A. 
Bacteria were analyzed for O-acetylated capsular polysaccharide by 
an enzyme-linked immunosorbent assay using mAb 58-5 (black bars). 
K1 capsule expression was controlled using mAb 735 (gray bars), 
which recognizes both OAc+ and OAc- forms of the K1 antigen. 
Negative controls were performed using bovine serum albumin 
instead of primary antibody. 
 
 
oligomerization and thereby abolished enzymatic activity 
of NeuO. Therefore, the quaternary structure of wild- type 
and mutant NeuO was determined by size-exclusion 
chromatography, and results are shown for variants 
based on neuO alleles with 36 heptanucleotide repeats 
(Fig. 6). For wild-type NeuO+36, a molecular mass of 217 
kDa was determined corresponding to an oligomeric state 
  
 
 
of 5.9. Although the shape of NeuO is not yet known, this 
result indicates that NeuO is another example of a 
hexapeptide acyltransferase that assembles into 
hexamers. Similar to the structure of SAT, NeuO 
hexamers might be formed by dimers of trimers. Notably, 
both mutants, H119A and W143A, showed an identical 
oligomeric state, demonstrating that the introduced amino 
acid exchanges did not interfere with complex assembly. 
In summary, our data indicate that alanine substitution of 
His-119 and Trp-143 did not result in substantial 
alterations in the overall structure of NeuO. However, 
exchange of either residue completely abolished activity, 
suggesting that both amino acids are part of the active 
site. 
 
DISCUSSION 
   Surface sialic acids are a common component and 
virulence factor of a variety of pathogenic bacteria (36). In 
many cases, modification by O-acetylation has been 
observed and might play an important role in 
immunogenicity and survival in the host organism (14, 
37–42). In the present study, we succeeded for the first 
time in purification and characterization of a polySia-
specific O-acetyltransferase. NeuO, which is essential for 
O-acetylation of the capsular polysaccharide of E. coli K1, 
was purified to homogeneity using a C-terminal 
hexahistidine tag. Previous attempts to purify 
endogenous NeuO required detergent extraction, and, 
after partial purification on DEAE-Sepharose, further 
isolation steps abolished activity (15). By contrast, 
recombinant NeuO was obtained from the soluble protein 
fraction, and the isolated enzyme was enzymatically 
active as demonstrated in a spectrophotometric assay 
and by incorporation of radioactively labeled acetyl 
groups into polySia. A possible explanation for the 
different outcome during purification of endogenous and 
recombinant NeuO is that, in E. coli K1, efficient O-
acetylation of the capsular polysaccharide might depend  
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on tight association of NeuO with the polySia 
biosynthesis and transport machinery. In this case, 
detergent might be required to dissociate NeuO from the 
membrane-bound protein complex, a step that can be 
omitted if NeuO is expressed in an E. coli strain lacking 
the K1 capsular polysaccharide gene complex.  
   The idea that in vivo NeuO-dependent O-acetylation 
occurs exclusively during or after polymerization of the 
polysaccharide but not on polySia building blocks is 
supported by our finding that in vitro neither Neu5Ac nor 
CMP-Neu5Ac served as acceptor substrates for NeuO. In 
line with the initial observation made by Higa and Varki 
(15), purified NeuO was highly specific for sialic acid 
oligomers with more than 14 residues, and efficient O-
acetylation seemed to depend on oligomers with DP >16. 
However, to understand the structural basis of the 
acceptor specificity, further studies, including detailed 
product analyses and characterization of the protein-
carbohydrate interactions are required.  
   Using homology modeling followed by mutational 
analysis, we characterized NeuO as a typical member of 
the superfamily of hexapeptide acyltransferases. 
Enzymes of this family use phosphopantothenyl-based 
cofactors to transfer acetyl, succinyl, or long chain fatty 
acyl groups to free hydroxyl or amino groups of a variety 
of acceptor substrates. All family members contain 
tandem-repeated imperfect copies of a hexapeptide 
repeat sequence with the consensus motif [LIV]-[GAED]-
X2-[STAV]-X (29, 30). Several members of the family 
have been crystallized, and the solved structures 
revealed that this characteristic hexapeptide repeat 
sequence encodes folding of a lefthanded parallel β-helix 
domain (31, 43–50). In all known cases, hexapeptide 
acyltransferases assemble into catalytic trimers with three 
symmetrical active sites, which are located at the 
interfaces of two subunits formed by a loop protruding out 
of one LβH domain embracing the LβH domain of the 
neighboring monomer. Based on the structural 
characteristics, the hexapeptide repeat family is also 
called LβH family and includes not only acyltransferases 
but also a zinc-dependent γ-carbonic anhydrase (51).  
   The homology modeling performed in the present study 
indicated close structural similarity of NeuO to MAT (31), 
which is closely related to the lacA-encoded galactoside 
O-acetyltransferase (GAT) of E. coli (45). Similar to MAT 
and GAT, the predicted model of NeuO contains a short 
LβH domain with five and one-third triangular coils and 
one protruding loop. Two amino acid residues, which are 
critical for activity of MAT and GAT, were found in 
equivalent positions in the NeuO model: His-119 located 
in the protruding loop and Trp-143 located within a β-
sheet of the LβH domain. Subsequent single alanine 
substitutions completely abolished NeuO activity in vitro 
and in vivo, indicating important roles in catalysis. All 
acyltransferases of the LβH family crystallized so far 
posses a catalytic histidine located in a loop embracing 
the adjacent subunit. The predicted role of this residue is 
to abstract a proton from the acceptor hydroxyl group, 
facilitating the attack of the resulting carbonyl by the acyl-
donor (32, 52). The second critical amino acid identified 
in the model of NeuO, Trp-143, is conserved only in a 
subset of acetyltransferases, including MAT, GAT, 
xenobiotic acetyltransferases, and the Rhizobium  
 
 
leguminosarum nodulation factor NodL (31, 32, 44, 53). 
In GAT, replacement of the corresponding Trp-139 by 
phenylalanine abolished the intrinsic fluorescence quench 
observed on acetyl-CoA binding (32), and the crystal 
structure of the binary complex of GAT with acetyl-CoA 
revealed a direct contact between the indole side chain of 
Trp-139 and the phosphopantothenyl arm of the cofactor 
(45). In addition to donor binding, Trp-139 may serve to 
position the catalytic histidine relative to the hydroxyl 
group of the acceptor and alter its pKa (45). In line with 
this dual role in donor binding and positioning of the 
catalytic histidine, a complete loss of NeuO activity was 
observed when Trp-143 was substituted by alanine. 
Together, these results provided convincing evidence that 
NeuO consists primarily of an LβH fold with His-119 and 
Trp-143 as part of the active site.  
   Using size-exclusion chromatography, we 
demonstrated that NeuO assembles into hexamers. So 
far, the only example of an LβH-acyltransferase with a 
quaternary structure other than trimeric is SAT (54). 
Similar to NeuO, SAT of E. coli and H. influenzae adopts 
a hexameric structure, and the solved crystal structures 
revealed that two SAT trimers assemble into hexamers 
with the dimer of trimers interface formed by the N-
terminal α-helical domain (34, 35). The observation that a 
Strep tag placed at the N terminus of NeuO was not 
accessible for purification might be an indication that, also 
in NeuO, the N-terminal domain is involved in 
dimerization of NeuO trimers.  
   Recently, several genes encoding sialic acid specific O-
acetyltransferases have been cloned by us and others: (i) 
oatC responsible for O-acetylation of the α2,9-linked 
polySia capsule of N. meningitidis of serogroup C (55); (ii) 
oatWY, involved in O-acetylation of sialic acids within the 
galactose and glucose containing heteropolymeric 
polySia capsules of serogroup W-135 and Y 
meningococci, respectively (55); (iii) neuO of E. coli K1 
(16); (iv) neuD of group B streptococci required for O-
acetylation of terminal α2,3-linked sialic acids capping the 
group B streptococci capsule (56); and (v) neuD of 
Campylobacter jejuni, which was shown to O-acetylate 
terminal α2,8- linked sialic acids of the bacterial lipo- 
oligosaccharide (42). With the notable exception of OatC, 
which shares no sequence similarity to any known protein 
in the data base, all other sialic acid-specific O-
acetyltransferases were found to contain hexapeptide 
repeat sequences, indicating that these proteins are all 
members of the LβH family. However, the NeuD proteins 
might form a separate branch within the family, because 
amino acid sequence alignments revealed the lack of a 
potential catalytic histidine, which might be substituted by 
a lysine residue (56).  
   Although NeuO shares the typical features of the LβH-
family, the present study revealed a unique regulatory 
mechanism based on changes in VNTR-encoded N-
terminal protein extensions. The neuO gene is 
characterized by the presence of a variable number of 
heptanucleotide repeats within the coding region (16). 
Because only repeat numbers that are a multiple of three 
allow full-length translation and thereby capsule O-
acetylation, changes in the overall number provide a 
reversible switch between an on and off phase. 
Oscillation between OAc+ and OAc- variants might permit 
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adaptation to changes in environmental conditions. 
However, our results demonstrate that this is not a simple 
“all-or-none” mechanism. By expressing neuO alleles 
containing 0, 12, 24, and 36 heptanucleotide repeats, we 
found that VNTRs are translated in stable N-terminal 
protein extensions that affect the actual enzymatic activity 
of the translation product. Every three heptanucleotide 
repeats encode an RLKTQDS heptad, and, in the 
presence of 36 heptanucleotide repeats, the translation 
product is N-terminally elongated by 12 heptads, which 
account for 37% of the total molecular mass. The 
presence of RLKTQDS heptads was not essential for 
NeuO activity but decreased the Km for acetyl-CoA by 
~50% without affecting the Km for the acceptor substrate. 
Remarkably, a linear correlation between the catalytic 
efficiency (kcat/Kmdonor) and the number of repeats was 
observed. Thus, stochastic genetic variation generated by 
VNTRs during the on phase is translated in protein 
variation that provides a gradual modification of NeuO 
activity.  
   kcat/Km may be considered as a measure of the apparent 
first-order rate constant for enzyme-substrate interaction 
and reflects the affinity between enzyme and substrate to 
form a complex. Thus, the results are consistent with the 
interpretation that the presence of heptad repeats leads to 
a change in enzyme conformation with the resultant 
increase in enzyme donor substrate affinity and facilitation 
of the reaction rate.  
   As suggested by Deszo et al. (16), heptad repeats may 
assemble into a triple coiled-coil. In the hexameric NeuO 
complex, variation in the length of such a coil might 
gradually change the subunit arrangement and, thereby, 
the conformation of the catalytic sites formed at the 
subunit interfaces of each trimer. However, the complete 
arrangement of all six subunits and the structure of the 
heptad repeats will only unequivocally be solved by 
analyzing the crystal structure of the NeuO complex.  
   In vivo, direct analysis of NeuO activity is hampered by 
frequent oscillation between on and off phases. However, 
comparison of 10 different OAc+ K1 strains indicated that 
VNTR-encoded protein extensions affect NeuO activity 
also in vivo, and the highest activities were found in strains 
expressing neuO alleles with >21 heptanucleotide repeats 
(16). The analysis of capsular polysaccharides from four 
individual OAc+ K1 strains revealed different degrees of O-
acetylation ranging from 5 to 85% (14, 15). Remarkably, 
the lowest O-acetyl content and lowest activity were found 
in a strain without detectable phase variation (14, 15), 
indicating that, in vivo, modulation of NeuO activity has an 
impact on the degree of capsule O-acetylation.  
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SUPPLEMENTAL FIGURES  
 
 
 
 
Fig. S1: Donor substrate kinetics of NeuO variants with different numbers of heptad repeats. 
NeuO activity was measured in the spectrophotometric assay at pH 7.5 and 25°C using equimolar 
amounts of purified enzyme variants. Donor kinetics were determined using 0.025-2 mM acetyl-CoA 
with colominic acid at 2 mg/ml. The initial reaction velocity was plotted versus the donor concentration. 
Data were acquired from at least three independent experiments measured in triplicate and values are 
given as mean ± S.D.. The corresponding Lineweaver-Burk plots are shown as inserts. Results 
obtained for NeuO variants encoded by alleles containing 0, 12, 24, and 36 heptanucleotide repeats 
are shown in (A), (B), (C), and (D), respectively. 
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Fig. S2: Acceptor substrate kinetics of NeuO variants with different numbers of heptad repeats. 
NeuO activity was measured in the spectrophotometric assay at pH 7.5 and 25°C using equimolar 
amounts of purified enzyme variants. Acceptor kinetics were determined using 0.015-2 mg/ml 
colominic acid (corresponding to 0.05-8.85 mM sialic acid) with acetyl-CoA at 2 mM. The initial 
reaction velocity was plotted versus the acceptor concentration. Data were acquired from at least 
three independent experiments measured in triplicate and values are given as mean ± S.D.. The 
corresponding Lineweaver-Burk plots are shown as inserts. Results obtained for NeuO variants 
encoded by alleles containing 0, 12, 24, and 36 heptanucleotide repeats are shown in (A), (B), (C), 
and (D), respectively. 
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Fig. S3: Scores and sequence alignments obtained for NeuO homology building using the 
program 3D-PSSM. (A) List of proteins with lowest E-values reflecting best structural matches with 
NeuO. Please note that all four proteins belong to the left-handed beta-helix family of 
acetyltransferases. (B) Sequence alignment between NeuO and MAT. (C) Sequence alignment 
between NeuO and GAT (aa 2-201). Amino acid numbering for NeuO is given on top. Highly 
conserved amino acid residues that are essential for activity are shown in grey boxes. 
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Preface - About the Manuscript 
 
In this study, a population genetics approach was performed to investigate the distribution of 
the O-acetyltransferase gene neuO among E. coli K1 isolates from avian and human 
sources. Therefore, a total number of 184 E. coli K1 strains was analyzed by multilocus 
sequence typing at the Institute for Hygiene and Microbiology of the University of Würzburg. 
Evolutionary aspects concerning the presence of the CUS-3 prophage which harbors neuO 
were determined and the contribution of O-acetylation to desiccation resistance of E. coli K1 
in the inanimate environment was investigated. Sequence analysis of the neuO gene in 103 
K1 strains revealed the presence of five different allelic variants. Three out of the seven 
observed polymorphic sites were non-synonymous, leading to three distinct enzyme variants 
which differ at primary sequence level. My contribution to this study was to investigate 
whether these NeuO variants show different kinetic properties. After recombinant expression 
and purification of all variants, I performed a comparative kinetic analysis by determining the 
steady-state parameters Km and kcat for each variant.  
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SUMMARY  
Escherichia coli K1 causes disease in humans and birds. Its polysialic acid capsule can be O-acetylated via 
the acetyltransferase NeuO encoded by prophage CUS-3. The role of capsule O-acetylation in ecological 
adaptation or pathogenic invasion of E. coli K1 is largely unclear. A population genetics approach was 
performed to study the distribution of neuO among E. coli K1 isolates from human and avian sources. 
Multilocus sequence typing revealed 40 different sequence types (ST) among 184 E. coli K1 strains. The 
proportion of ST95 complex (STC95) was 44%. NeuO was found in 98% of the STC95 strains, but only in 
24% of the strains with other STs. Grouping of multilocus sequence types and prophage genotypes 
revealed a segregation of prophage types according to MLST types, suggesting co-evolution of CUS-3 and 
housekeeping genes. Within the STC95, which is known to harbor both human and avian pathogenic 
isolates, CUS-3 genotypes were shared irrespective of host species. Strains, which expressed functional 
NeuO constitutively better withstood desiccation in vitro than strains expressing a non-functional 
NeuO:H119A mutant, suggesting an environmental role of neuO-mediated K1 capsule O-acetylation. 
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INTRODUCTION  
Escherichia coli K1 strains are intestinal commensals of mammalians and birds, but may cause urinary tract 
infections, newborn meningitis or bacteremia in humans as well as colisepticemia in birds. The capsular 
polysaccharide of E. coli K1, a major pathogenicity factor, is composed of the poorly immunogenic α-2,8-
linked N-acetyl neuraminic acid (also termed polysialic acid) (Barry and Goebel, 1957; Dewitt and Rowe, 
1961; Kundig et al., 1971; Mühlenhoff et al., 1998). In contrast to the structurally identical capsular 
polysaccharide of serogroup B meningococci (Liu et al., 1971), the E. coli K1 polysaccharide is phase-
variably O-acetylated at a high frequency of 1:50 to 1:20 (Ørskov et al., 1979). The O-acetyltransferase 
responsible for this capsule modification is encoded by the gene neuO. Primary sequence analysis of the full 
length translation product revealed that NeuO belongs to the super family of NodL-LacA-CysE hexapeptide 
acyltransferases (Downie, 1989; Jenkins and Pickersgill, 2001; Vaara, 1992).  Phase variation is mediated by 
a poly(ψ) motif prone to DNA slippage and mispairing. This poly(ψ) motif consists of a variable number of 
heptanucleotide tandem repeats (VNTR) (5´-AAGACTC-3´) and is located two nucleotides downstream of the 
start codon (Deszo et al., 2005). Bergfeld et al. showed that the enzymatic activity of purified recombinant 
enzyme increases with repeat numbers, thus supporting large numbers of repeats in the population (Bergfeld 
et al., 2007).  
The biological function of K1 capsule O-acetylation is not fully understood until now. In general, modification 
of the host cell surface by receptor modifying enzymes is a strategy of lysogenic phages to prevent 
superinfection by homologous phages (Allison and Verma, 2000). However, the high frequency of phase 
variation observed for NeuO-dependent capsule O-acetylation may also point to an impact of the capsule 
modification in the rapid adaptation of E. coli K1 to environmental changes (King et al., 2007a). In patients 
with bacteremia, O-acetylated E. coli K1 strains tend to be more virulent (Frasa et al., 1993). Furthermore, in 
the neonatal mouse model, E. coli K1 escapes from killing by anti-K1-antibodies via capsule O-acetylation 
(Colino and Outschoorn, 1999). On the other hand, after oral administration of neuO-positive strains only de-
O-acetylated bacteria were recovered from the blood of rat pups (Zelmer et al., 2008).  
In contrast to oatC and oatWY, the genes encoding polysialic acid specific O-acetyltransferases in Neisseria 
meningitidis serogroups C and W135/Y, respectively (Claus et al., 2004), neuO is not associated with the 
capsular polysaccharide synthesis cluster, but is part of a circa 40.2 kb lambdoid prophage termed CUS-3 
(Deszo et al., 2005; Stummeyer et al., 2006). Mitomycin treatment induced phage release, and subsequent 
infection by phage particles depended on K1 polysaccharide expression, which is the receptor for the phage 
(King et al., 2007b). In vitro studies suggest that horizontal transfer of CUS-3 occurs naturally, although 
phage transduction was strain specific. In a selection of 111 clinical E. coli K1 strains characterized by 
serotyping, more than 60% of the strains harbored neuO (King et al., 2007b). Nevertheless, a phylogenetic 
analysis of the CUS-3 distribution is still lacking, and there is no information, whether CUS-3 is randomly 
distributed among E. coli K1 isolates.    
DNA sequencing has greatly enhanced the understanding of bacterial population structures. Multilocus 
sequence typing (MLST) has resulted in the unique opportunity to construct large internet-databases and 
virtual strain collections (Maiden et al., 1998; Maiden, 2006; Urwin and Maiden, 2003). The data, i.e. partial 
DNA sequences of seven or more housekeeping genes, are phylogenetically informative and allow the 
unequivocal assignment of sequence types (ST) and ST complexes (STC) comprising closely related STs. 
MLST data have been used to study the population biology of heterogeneous and homogenous species of 
diverse pathovars, the extent of horizontal gene transfer, the biological age of species, and the geographic 
spread of bacteria (Falush et al., 2001; Falush et al., 2003; Linz et al., 2007; Lacher et al., 2007; Linz et al., 
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2007; Reid et al., 2000; Sheppard et al., 2008). Several MLST schemes have been introduced for the study 
of E. coli (Adiri et al., 2003; Beutin et al., 2005; Noller et al., 2003). The MLST scheme used in this study has 
been developed by Wirth et al. (Wirth et al., 2006). Since its publication, the number of strains and STs 
deposited in the database has risen to 2114 and 1047, respectively (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Ecoli; as of October 23th, 2008). The K1 capsule was found in several E. coli lineages. 
K1 strains contributed a major share of strains of the phylogenetic group B2, which comprises the STC95 as 
defined by MLST (Wirth et al., 2006). This complex also harbors avian pathogenic E. coli (APEC) strains 
(Johnson et al., 2008).     
A population genetics approach was performed to study the distribution of neuO among E. coli K1 isolates 
from human and avian sources. By grouping STs and phage genotypes, the phylogenetic relationship of E. 
coli K1 and CUS-3 was investigated. Finally, the impact of capsule O-acetylation on environmental survival 
of E. coli K1 was studied. 
 
RESULTS  
E. coli K1 strain collection and multilocus sequence typing 
The E. coli K1 strain collection analyzed in the present study comprised 144 human, one rat, and 39 avian 
isolates, which were collected between 1943 and 2006 in 11 different countries (Tab. 1, Tab. S1).  
 
 
Host Clinical Condition Country* Number (n) 
Bird Colisepticemia DE 24 
Bird Colisepticemia FR 4 
Bird Colisepticemia IL 4 
Bird Colisepticemia NL 3 
Bird Colisepticemia CA 1 
Bird Colisepticemia JO 1 
Bird Colisepticemia unknown 1 
Bird Colisepticemia USA 1 
Human Appendicitis SE 1 
Human # Cervical swab DE 1 
Human # Feces DE 52 
Human Feces UK 3 
Human Feces USA 2 
Human Feces BE 1 
Human Feces unknown 1 
Human # Invasive disease DE 6 
Human Invasive disease unknown 6 
Human Invasive disease USA 5 
Human Invasive disease FI 5 
Human # UTI DE 58 
Human UTI FI 1 
Human UTI SE 1 
Human UTI unknown 1 
Rat Feces DE 1 
 
 
 
Table 1: Summary of the 
E. coli K1 strain collection.  
 
NOTE: The strain collection 
comprises strains collected 
during the course of this 
study (#), as well as isolates 
provided by L.W., U.D., Mark 
Achtman (formerly Berlin, 
Germany), and Lothar Beutin 
(Berlin, Germany).  
 
* BE, Belgium; CA, Canada;  
DE, Germany; FI, Finland; FR, 
France; IL, Israel; JO, 
Jordany; NL, Netherlands; SE, 
Sweden; UK, United Kingdom;
USA, United States of 
America 
 
All 184 E. coli K1 strains were typed by MLST, and a total of 40 different sequence types were identified 
(Tab. 2). The most prevalent STs were ST95 (n=61), ST141 (n=23), ST59 (n=13), and ST357 (n=12). 
According to the E. coli MLST database, five sequence type complexes were present in the collection, i.e. 
STC10 (n=3), STC59 (n=16), STC95 (n=80), STC399 (n=1), and STC568 (n=10) (Tab. 2).  
STC95 strains were recovered from patients with UTI (n=19), human invasive disease (n=14), and healthy 
intestinal carriage (n=17). Furthermore, 29 of 39 APEC K1 strains belonged to the STC95, however; it should 
be noted that APEC strains with ST-95 were actively searched for at some point of the study, so that there 
was an intended sampling bias with regard to APEC strains. The STC59 was mostly associated with human 
intestinal carriage, and ST141 with human UTI (Tab.2).  
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STC (n) ST (n) Source (n) 
neuO-
positive 
(n) 
CUS-3 genotype (n) 
10 (3) 10 (3) hu ca (2), hu UTI (1) 1 NA 
59 (16) 59 (13), 379 (2), 415 (1) hu ca (13), hu UTI (3) 0  
NA 62 (8) hu ca (3), hu id (5) 7 GT 8 (1) 
95 (80) 
95 (61), 140 (5), 142 (1), 368 (1), 
370 (1), 390 (7), 416 (1), 417 (1), 
418 (1), 421 (1) 
hu ca (17), hu UTI (19), hu id (14), hu ap 
(1), av cs (29) 78 
GT1 (1), GT2 (38), GT3 
(1), GT4 (1), GT5 (3), GT8 
(5), GT10 (10), GT11 (1), 
GT16 (1) 
NA 141 (23) hu ca (4), hu UTI (16), av cs (3) 0  
NA 144 (5) hu ca (1), hu UTI (3), id (1) 3 GT17 (1), GT18 (2) 
NA 357 (12) hu ca (6), hu UTI (4), hu id (1), av cs (1) 7 GT12 (1), GT14 (1) 
NA 358 (3) hu ca (1), hu UTI (1), av cs (1) 2 GT13 (1), GT15 (1) 
NA 363 (2) hu ca (1), av cs (1) 0  
399 (1) 399 (1) hu ca (1) 0  
NA 420 (3) hu ca (1), hu UTI (1), hu id (1) 0  
NA 428 (3) hu ca (1), hu UTI (2) 2 GT6 (1), GT9 (1) 
NA 567 (2) hu UTI (2) 0  
568 (10) 80 (8), 143 (1), 568 (1) hu ca (2), hu UTI (6), hu cvs (1), rat ca (1) 1 NA 
NA 115, 126, 131, 139, 364, 419, 427, 429, 430, 569, 573, 577, 579 hu ca (6), hu UTI (3), av cs (4) 2 GT2 (1),  GT7 (1) 
Total 184  103 73 
 
Table 2: STCs and STs of E. coli K1 and their characteristics. 
Abbreviations: STC, sequence type complex; ST, sequence type; hu, human; av, avian; ca, intestinal asymptomatic 
carriage; UTI, urinary tract infection; id, invasive disease (bacteremia and newborn meningitis); cvs, cervical swab; ap, 
appendicitis; cs, colisepticemia; NA, not assigned. 
 
The strain collection represented a large fraction of the expected genetic diversity of E. coli K1 as evidenced 
by exploring the MLST database (data not shown). A large number of strains originated from Germany and 
were isolated in 2005 and 2006 (n=106). These strains were compared with the rest of the collection (n=78) 
with regard to species richness and diversity to test whether these parameters of the collection were 
influenced by inclusion of these strains. Species richness, i.e. the number of different STs, was 28 and 22 for 
Germany 2005/2006 and the rest of the collection, respectively. The Simpson Diversity Index (1-D) was 0.88 
and 0.77, respectively, implying that the Germany 2005/2006 group was even more diverse. 
Networks of concatenated MLST sequences were established using the Neighbor-Net approach. Significant 
splits allowed the definition of five MLST groups designated 1 through 5 with 82, 10, 13, 41, and 33 isolates, 
respectively; only three STs could not be assigned to a group (Fig. 1). The MLST groups were later used to 
compare the E. coli K1 population with CUS-3 genotypes (see below).  
 
Distribution of neuO among E. coli K1 lineages  
The strain collection was analyzed for the presence of neuO encoding the K1 capsule O-acetyltransferase. 
Out of 184 E. coli K1 isolates tested, 103 harbored the neuO gene (Tab. 2), as evidenced by PCR and DNA-
DNA hybridization. 91% of human invasive strains, 77% of avian colisepticemia isolates, 43.3% of human 
fecal isolates and 42.6% of human UTI strains were neuO-positive. The vast majority of all neuO-positive 
strains belonged to the STC95 (n=78), and only two of 80 STC95 strains lacked the gene. Among the 104 
non-STC95 strains, only 25 neuO-positive K1 isolates were identified (Tab. 2).  
Sequencing of neuO revealed five different allelic variants of the gene (Tab. S2). Three of seven polymorphic 
sites were non-synonymous, but none of the amino acid exchanges affected the function of the enzyme, as 
proven by enzyme kinetic analysis (Tab. S2).  
Sequence analysis of CUS-3 
CUS-3 is the prophage harboring neuO. Partial sequencing of CUS-3, i.e. ORF22 (438 bp), fragments of the 
endosialidase gene endoNK1 (933 bp in total), and neuO (648 bp) (Tab. S3) was conducted to investigate 
whether CUS-3 genotypes are grouped along the MLST groups of E. coli K1, or whether MLST groups and 
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Figure 1: Neighbor-Net reconstruction based on concatenated multilocus sequence data of 184 E. coli K1 strains. 
The network identifiers represent STs. Underlined STs harbored at least one neuO-positive strain. Five MLST groups 
were defined according to splits with bootstrap values > 70% in 1000 iterations. Major characteristics of the groups are 
provided in inserted tables. 
 
CUS-3 genotypes are randomly assorted. NeuO and ORF22 have been identified only in CUS-3, but not in 
other phages. The endosialidase of CUS-3 has distant relatives only in other E. coli K1 phages (i.e. the lytic 
phages K1A, K1E, K1F, K1-5). It was expected that this gene selection strategy would avoid the phylogenetic 
signals to be blurred by recombination between various phages. The concatenated partial CUS-3 sequence 
(2,019 bp) was analyzed using the Neighbor-Net approach. 
Among the 103 neuO-positive isolates, 73 could be assigned to one of 18 CUS-3 genotypes (CUS3_GT) 
(Tab. 2 and Tab. S3); the remaining 30 strains were either devoid of ORF22, or lacked parts of endoNK1, or 
harbored an IS629-like sequence in endoNK1. Analysis of the aligned phage sequences using Splitstree and 
Neighbor-Net enabled us to identify four different CUS-3 groups, harboring 43, 18, 3, and 5 isolates (Fig. 2). 
Two CUS-3 genotypes could not be assigned unambiguously to one of the groups. CUS-3 group 
assignments inferred from Neighbor-Net analysis were further confirmed by principal component analysis 
(data not shown). 53 of 78 neuO-positive STC95 strains harbored either CUS3_GT2 (n=38), CUS3_GT10 
(n=10) or CUS3_GT8 (n=5) (Tab. 2).  
Subsequently, CUS-3 groups and MLST groups were compared. MLST group 1, which comprised the 
STC95, was shown to harbor CUS-3 groups 1 (n=41), 2 (n=16), and CUS-3 group 4 (n=1; Tab. 3). 57 of a 
total of 61 isolates of CUS-3 groups 1 and 2 belonged to MLST group 1. On the other hand, only 1 of 8 
isolates of CUS-3 groups 3 and 4 was affiliated to MLST group 1, suggesting segregation of CUS-3 
genotypes corresponding to phylogenetic groupings obtained by MLST analysis. Fisher´s exact test 
confirmed that CUS-3 groups 1 and 2 are associated to MLST group 1 (Tab. 3; p-value = 9.5 x 10-7).  
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Figure 2: Neighbor-Net reconstruction based on CUS-3 genotypes of 73 CUS-3 positive strains. The network 
identifiers represent CUS-3_GTs. Four CUS-3 groups were defined according to splits with bootstrap values > 70% in 
1000 iterations. Major characteristics of the groups are provided in inserted tables. 
 
 
 CUS-3 group 
 
 
 1 2 3 4 
 
1 41 16 0 1 
 
3 0 0 3 2 
 
4 1 1 0 2 
 
M
LS
T 
gr
o
u
p 
5 0 1 0 0 
 
Table 3: Association of E. coli K1 MLST 
groups and CUS-3 groups (as defined by 
Neighbor-Net reconstruction). 
 
 
Of note, some human and avian strains were not distinguishable by sequence analysis. For example, six 
APEC and 21 human strains shared identical ST and CUS-3_GT, i.e. ST95 and CUS-3_GT2. To investigate 
whether these closely related isolates could be distinguished by gene content analyses, the presence or 
absence of ExPEC plasmid-associated traits, i.e. etsA and hlyF, as well as of ExPEC chromosome-
associated traits, i.e. ibeA, hlyD, malX, and fyuA (Johnson et al., 2006; Johnson et al., 2007; Rodriguez-Siek 
et al., 2005) were investigated by DNA-DNA hybridization. Unweighted pair group mean average (UPGMA) 
cluster analysis revealed that the gene content of avian isolates corresponded to that of human strains (data 
not shown).  
 
Functional relevance of NeuO for E. coli K1 
The functional relevance of NeuO-mediated capsule O-acetylation for the interaction of E. coli K1 with its 
host or the inanimate environment is largely unknown. The uropathogenic strain A160 lacking neuO, and the 
neuO knock-out mutant of the neonatal meningitis strain RS218 were complemented in trans with a plasmid 
harboring either a functional NeuO (p4A) or a non-functional NeuO (p4A:H119A) (Bergfeld et al., 2007). 
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Adherence to or invasion of human brain microvascular endothelial cells (HBMEC) was monitored after 240 
min of infection. Neither strain A160 nor strain RS218 depended on NeuO for adherence or invasion of 
HBMEC (data not shown).  
Next, we investigated the role of NeuO-mediated capsule O-acetylation for environmental desiccation 
resistance. Dried chicken feces were used to mimic natural shedding of E. coli K1. Suspensions of chicken 
feces were inoculated with derivatives of the avian strain IMT5155, i.e. IMT5155∆neuO/p4A (O-acetylated 
capsule) and IMT5155∆neuO/p4A:H119A (non-O-acetylated capsule). The viability of the bacteria during 
desiccation was analyzed over a time period of eight weeks. During the first five weeks, similar die-off rates 
were observed for both variants. However, after six weeks, a significant difference was detected suggesting a 
more pronounced desiccation resistance in the variant expressing functional NeuO (Fig. 3A).  
 
 
Figure 3: (A) Survival of the O-acetylated E. coli K1 mutant IMT5155∆neuO/p4A (grey) and the non-O-acetylated E. coli 
K1 mutant IMT5155∆neuO/p4A:H119A (black) in dried chicken feces over a period of eight weeks. Bacterial survival is 
given in means of colony forming units (CFU) ± standard deviation of five or six independent experiments performed in 
duplicates. (B) Confirmation of the results by an additional set of six independent experiments. Bacterial survival was 
determined after eight and twelve weeks. 
P-values determined by 2-tailed paired student´s t-test are provided. 
 
The results were confirmed by a second set of experiments targeting week eight of desiccation (Fig. 3B). 
Taken together, NeuO-mediated capsule O-acetylation had a moderate, but reproducible effect on the 
desiccation resistance of E. coli K1. 
 
DISCUSSION  
Differential distribution of virulence factors among pathovars of E. coli has been shown in various studies 
(reviewed in Dobrindt, 2005). A differential distribution of the K1 phenotype among different STs 
corresponding to the ancestral groups B2 and D has been shown recently (Wirth et al., 2006). In this study, 
the distribution of neuO and the prophage CUS-3 was investigated among E. coli K1 isolates. Despite the 
fact that CUS-3 phage particles have been shown to be inducible and infectious in vitro (King et al., 2007b), 
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CUS-3 and neuO were tightly associated with the STC95, and were not scattered in the E. coli K1 population. 
Furthermore, CUS-3 and housekeeping genes displayed signs of co-evolution. These findings implied that 
early after acquisition of the K1 capsule gene cluster, CUS-3 was imported into several K1 lineages, but that 
the consecutive impact of horizontal phage transfer was only moderate. As it is unlikely that CUS-3 phage 
transduction does not occur in vivo (King et al., 2007b), other mechanisms might contribute to the non-
random distribution of CUS-3, such as recent clonal expansion of CUS-3 positive STC95 strains, or, 
alternatively, selection for this phage in STC95. The putative factor besides the K1 capsule that selects for 
CUS-3 is unknown. For another lambdoid phage encoded gene, i.e. cif, which encodes a protein conferring a 
cytopathic effect, the differential distribution in E. coli is clearly associated with the presence of the locus of 
enterocyte effacement (LEE), which provides the type III secretion system transporting Cif (Loukiadis et al., 
2008). Positive selection for CUS-3 in STC95 might be driven by the environmental conditions in which the 
phage interacts with its host, and which might differ between E. coli K1 lineages. If neuO provides an 
advantage to its host bacterium, the presence of CUS-3 as a temperate prophage will be assured. The broad 
host range of E. coli K1, the dichotomy of carriage and infection displayed by this pathogen, and the various 
routes of transmission (fecal-oral, aerosols, uro-genital, transmission via the inanimate environment) provide 
a plethora of possibilities how neuO expression and subsequent capsule O-acetylation affects the ecology 
and distribution of E. coli K1. Recent evidence from neonatal rat infection experiments suggests that the K1 
capsule was not O-acetylated after systemic invasion of blood and meninges (Zelmer et al., 2008). There are 
currently no data on the impact of the O-acetylated polysaccharide on the establishment of the bacteria in 
complex ecosystems such as the intestinal flora of animals and humans. In the present study, we 
investigated the extraintestinal survival of O-acetylated and non-O-acetylated E. coli K1 in dried chicken 
feces. Strains constitutively expressing NeuO were used to exclude phase variation. Irrespective of O-
acetylation, E. coli K1 survived for more than two months, but after six weeks of desiccation, there was a 
moderate and reproducible difference in the survival rates in favor of the O-acetylated strain. It remains to be 
determined which impact the observed >10-fold benefit has on the survival in natural environments. Of note, 
the capsular polysaccharide colanic acid has been implicated to be involved in desiccation tolerance of E. 
coli (Obadia et al., 2007; Ophir and Gutnick, 1994). The molecule is O-acetylated (Garegg et al., 1971). It is 
tempting to speculate that the O-acetylation of extracellular polymeric substances leads to an increased 
protection against desiccation.    
In this study, six APEC and 21 human isolates were identified with identical sequence type (ST95) and CUS-
3 genotype (CUS3_GT2). The APEC isolates were indistinguishable from human isolates with regard to 
plasmid and chromosomal markers. These results underline the strong relationship between some human 
and avian K1 isolates, which has been proposed previously (Ott et al., 1991; Johnson,T.J. et al., 2007; 
Johnson, T.J. et al. 2008), and which suggests interspecies transmission. The recent publication of an avian 
E. coli K1 genome sequence demonstrated the genomic relatedness of strains from both sources (Johnson 
et al., 2007). Furthermore, a couple of chromosomal and plasmid markers were shown to be shared by 
APEC and human E. coli strains, especially those from human newborn meningitis (Ewers et al., 2007). 
These findings together with the data presented herein suggest that STC95 complex strains comprising 
APEC and human invasive isolates may be considered zoonotic. 
In summary, bacteriophage CUS-3 entered E. coli K1 several times and displayed signs of divergent 
evolution. STC95 may represent a pool of zoonotic agents. NeuO-mediated K1 capsule O-acetylation 
contributes to desiccation resistance in the inanimate environment, but the role of neuO for E. coli K1 
ecology remains only partially understood. 
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EXPERIMENTAL PROCEDURES  
Bacterial strains, growth conditions and capsule typing 
633 E. coli strains were anonymously isolated in 2005 and 2006 from routine diagnostic specimen processed 
at the Institute for Hygiene and Microbiology, Würzburg, Germany, and from fecal samples of healthy 
volunteers (staff of the Institute for Hygiene and Microbiology, Würzburg, and of the Department of Cellular 
Chemistry, Hannover Medical School; students of various University courses in medical microbiology, 
Würzburg). A single colony per sample was analyzed for expression of the K1 capsule by colony-
immunoblotting and slide agglutination with the monoclonal antibody (mAb) 735 (Frosch et al., 1985). 78 E. 
coli K1 strains were obtained from the strain collections of U.D., L.W., Mark Achtman (formerly Max Planck-
Institute for Infection Biology, Berlin, Germany), and Lothar Beutin (formerly Robert Koch-Institute, Berlin, 
Germany). K1 capsule O-acetylation was detected by slide agglutination using the antibody 58-5 specific to 
this capsule modification (Torensma et al., 1991) (Monosan, The Netherlands).  
PCR-analysis, oligonucleotides, and DNA-sequencing 
The gene neuO was detected in E. coli K1 by PCR using the oligonucleotides HC399 and HC400 (for 
oligonucleotide sequences see Tab. S4). The CUS-3 ORF22 and parts of the endosialidase gene endoNK1 
were amplified with IM25/IM26 and IM30/HC404CR, respectively. PCR-products were sequenced with the 
respective oligonucleotides, and additionally with HC402 in the case of neuO, and with IM32, IM33 and 
HC407 in the case of endoNK1 parts. Sequencing was done using the BigDye® terminator v1.1 Cycle 
Sequencing Kit and an Applied Biosystems 377 sequencer (Applied Biosystems, USA). DNA sequences 
were analyzed with the programs EditSeq, MegAlign (DNAStar Inc., USA) and TraceEditPro (Ridom GmbH, 
Germany). Sequences of the neuO alleles determined in this study were submitted to the EMBL Nucleotide 
Sequence Database (accession numbers: FM863923 through FM863927). Concatenated CUS-3 sequences 
were numbered consecutively starting with 1. The sequences are provided in supplementary material S3. 
DNA-DNA hybridization 
The presence of neuO was confirmed by dot blot and Southern blot assays using a probe generated by PCR 
with the oligonucleotides HC402/HC403 (Tab. S4). Oligonucleotides for generating probes specific to the 
extraintestinal pathogenic E. coli (ExPEC) virulence associated traits etsA, hlyF, ibeA, hlyD, malX, and fyuA 
were described recently (Johnson et al., 2006; Johnson et al., 2007; Rodriguez-Siek et al., 2005). 
Multilocus sequence typing  
MLST was performed essentially as described recently (Wirth et al., 2006), however, an alternative forward 
primer for sequencing of the mdh fragment was used (Tartof et al., 2005). Assembly of sequences was 
performed using TraceEditPro. STs and STCs were assigned using the E. coli MLST database hosted at the 
Max Planck-Institute for Infection Biology, Berlin, Germany (http://web.mpiib-berlin.mpg.de/mlst/dbs/Ecoli).  
Sequence analysis 
Sequences were concatenated using the program KonkatMeister written by J.E. (available upon request) and 
aligned by applying ClustalW. Aligned sequences were further analyzed using SplitsTree (Huson and Bryant, 
2006). Networks were calculated based on uncorrected p-distances using the Neighbor-Net method (Bryant 
and Moulton, 2004). Groups of related STs and CUS-3 genotypes were defined on the basis of splits with 
bootstrap values of more than 70% in 1000 iterations. After alignment using MUSCLE (MUltiple Sequence 
Comparison by Log-Expectation) (Edgar, 2004), CUS-3 groups were confirmed by principal component 
analysis using Jalview (Clamp et al., 2004) available at http://www.ebi.ac.uk/Tools/muscle/index.html.  
Knock-out and complementation of neuO 
Dissertation Anne K. Bergfeld  Chapter 3 – Mordhorst et al. 
 
This manuscript has been submitted to Environmental Microbiology Page 43 
 
The flanking regions of neuO were amplified by PCR using the oligonucleotides IM14/15 and IM16/17, 
respectively, and cloned into vector pUC19 (Fermentas GmbH, Germany) using the restriction sites indicated 
in Tab. S4. The CAT gene of vector pTnMax5 (Kahrs et al., 1995) was cloned between IM14/15 (5´-flanking 
region of neuO) and IM16/17 (3´-flanking region of neuO). The neuO-flanking regions together with the CAT 
gene were cloned into the suicide vector pMHH1, resulting in plasmid pIM1, and used for gene inactivation 
as described by Gunzer et al (Gunzer et al., 1998). NeuO-knock out mutants were verified by PCR, DNA 
sequencing, Southern blot analysis, and agglutination with the antibody 58-5. The ∆neuO strains were 
complemented with either plasmid p4A harboring the wild-type neuO gene, or p4A:H119A harboring a non-
functional neuO variant with a single amino acid exchange (Bergfeld et al., 2007). 
Expression, purification, and kinetic characterization of NeuO variants 
Based on a pET22b-derived plasmid harboring neuO-1 with 36 heptanucleotide repeats (Bergfeld et al., 
2007), constructs for expression of neuO-3 and neuO-4 were generated by introducing the required 
nucleotide exchanges to obtain neuO sequences that encode the respective protein variants NeuO-3 and 
NeuO-4. Nucleotide exchanges were introduced by PCR using the QuikChange site-directed mutagenesis 
kit (Stratagene, Germany) with the following primer pairs: AKB116_L2S/AKB117_L2S for introduction of the 
amino acid exchange Leu2Ser, AKB118_V5I/AKB119_V5I to introduce the exchange Val5Ile, and 
AKB120_V13I/AKB121_V13I for introduction of the exchange Val13Ile (Tab. S2 and S4). The identity of all 
constructs was confirmed by sequencing. NeuO variants encoded by neuO-1, neuO-3, and neuO-4 with 36 
heptanucleotide repeats were expressed in E. coli BL21(DE3) with an N-terminal Strep-tag II and a C-
terminal hexahistidine tag. Each variant was purified to homogeneity as described previously for NeuO-1 
and donor kinetics were determined in a spectrophotometric assay as described (Bergfeld et al., 2007). 
Cell culture experiments 
Human Brain Microvascular Endothelial Cells (HBMECs) were kindly provided to the Institute for Hygiene 
and Microbiology by K.S. Kim (Baltimore, USA) (Stins et al., 1997). For strains A160 and RS218, the 
multiplicity of infection (MOI) was 600 and 40, respectively. The infection time was adjusted to 240 min. To 
determine bacterial invasion, cells were treated for 1 h with 200 µg/ml gentamicin, and bacteria were 
released by incubation with 0.1% saponine for 10 min. Gentamicin treatment was omitted for determination of 
both adherent and intracellular bacteria. 
Desiccation experiments 
Dried chicken feces (a commercially available organic fertilizer) (Anton Knoll GmbH, Germany) were sieved, 
sterilized, resuspended in sterile deionized water (14% w/v), and homogenised by ultrasonification for 10 min 
using a Branson Sonifier 450A via a cup horn (Branson Ultrasonic SA, Switzerland) with the following 
settings: constant duty cycle and an output of 8. The prepared chicken feces was mixed with either O-
acetylated or non-O-acetylated bacteria to achieve a bacterial density of 2×1010 CFU/ml. 50 µl of the 
suspension were transferred onto glass disks with a diameter of 15 mm, placed in a 24-well-plate. 
Suspensions were dried for 4 h in a safety cabinet, and subsequently stored at 15-20° C and 40-50% 
humidity in the dark. For determination of the number of surviving bacteria, dried suspensions were 
resuspended in 1 ml PBS and incubated for 15 min at room temperature to resolve the bacteria.  
Statistics 
Two-tailed paired student´s t-test was employed to evaluate differences of CFU at various time points of 
desiccation. Fisher´s exact test was computed at http://www.langsrud.com/fisher.htm. Species richness and 
the Simpson Diversity Index were computed at http://www.changbioscience.com/genetics/shannon.html.  
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SUPPLEMENTAL FIGURES 
 
Table S1:  
Detailed characteristics of all strains investigated in this study. 
 
ORIGINAL ID WUE-ID ST STC 
CUS3
_GT Serotype 
Provided 
by Host 
Clinical 
source Country* Year neuO 
poly(ψ) 
motif 
neuO-
allele 
A247 3223 95 95  O18:H7:K1 M. Achtman Human Appendicitis SE 1943 + 10 neuO-1 
A23 3225 59 59  O1:H-:K1 M. Achtman Human Feces BE 1948    
RS179 3984 62   K1 L. Wieler Human Invasive Disease USA 1974 + 23 neuO-5 
RS167 3972 144   K1 L. Wieler Human Invasive Disease USA  1974    
RS176 3799 62   O2:K1:H7 U. Dobrindt Human Invasive Disease USA  1974 + 23 neuO-5 
IHE3033 (A53) 3788 95 95 2 K1 U. Dobrindt Human Invasive Disease FI 1976 + 17 neuO-1 
IHE3034 (A54) 3789 95 95 2 K1 U. Dobrindt Human Invasive Disease FI 1976 + 13 neuO-1 
A21 (C94) 3804 62   K1 U. Dobrindt Human Invasive Disease USA  1976 + 15 neuO-5 
IHE3036 (A56) 3791 390 95 2 K1 U. Dobrindt Human Invasive Disease FI 1977 + 22 neuO-1 
IHE3035 (A148) 3790 95 95 2 K1 U. Dobrindt Human Invasive Disease FI 1977 + 13 neuO-1 
A50 3983 62   K1 L. Wieler Human Invasive Disease USA 1977 + 34 neuO-5 
A152 3229 142 95 2 O18:H7:K1 M. Achtman Human Feces UK 1977 + 33 neuO-1 
RS226 (78015) 3800 95 95 2 K1 U. Dobrindt Human Feces USA  1978 + 8 neuO-1 
A64 3230 143 568  O7:H7:K1 M. Achtman Rat Feces DE 1979    
A198 3224 139  7 O1:K1 M. Achtman Human Feces UK 1979 + 14 neuO-2 
IMT9698 3835 95 95 5 O2:K1 L. Wieler Chicken Colisepticemia DE 1980 + 34 neuO-1 
IMT4517 3823 95 95  O2:K1:H7 L. Wieler Turkey hen Colisepticemia DE 1990 + 46 neuO-1 
MT78 3832 95 95 2 O2:K1:H+ L. Wieler Chicken Colisepticemia France 1993 + 20 neuO-1 
TK3 3834 95 95  O1:K1:H7 L. Wieler Turkey hen Colisepticemia CA 1993    
IMT2121 3973 357   K1 L. Wieler Turkey hen Colisepticemia DE 1994 + 38 neuO-3 
IMT2097 3812 95 95 8 O1:K1:H7 L. Wieler Laying hen Colisepticemia DE 1997 + 31 neuO-3 
IMT2108 3814 95 95 2 Osp.:H7:K1 L. Wieler Laying hen Colisepticemia DE 1997 + 8 neuO-1 
IMT2099 3813 95 95 2 O18:H7:K1 L. Wieler Laying hen Colisepticemia DE 1997 + 31 neuO-1 
IMT2288 3817 140 95 10 O2:K1:H5 L. Wieler Laying hen Colisepticemia DE 1999 + 17 neuO-3 
IMT2297 3818 95 95 10 O2:K1:H5 L. Wieler Chicken Colisepticemia DE 1999 + 15 neuO-3 
IMT2251 3815 95 95 2 On.t.:K1:H7 L. Wieler Turkey hen Colisepticemia DE 1999 + 44 neuO-1 
IMT2254 3816 126   On.t.:H-:K1 L. Wieler Duck Colisepticemia unknown 1999    
IMT2294 3975 115   O2:K1 L. Wieler Chicken Colisepticemia DE 1999    
IMT2248 3974 358   K1 L. Wieler Laying hen Colisepticemia DE 1999    
IMT2470 3820 95 95 11 O2:K1:H5 L. Wieler Laying hen Colisepticemia DE 2000 + 5 neuO-3 
IMT4534 3826 140 95 10 O2:K1:Hsp L. Wieler Laying hen Colisepticemia DE 2000 + 46 neuO-3 
IMT2491 3821 95 95  O2:H6:K1 L. Wieler Chicken Colisepticemia JO 2000 + 21 neuO-1 
IMT2469 3819 140 95 10 O2:K1:H5 L. Wieler Chicken Colisepticemia DE 2000 + 14 neuO-3 
IMT2532 3822 95 95 4 O18:K1:H7 L. Wieler Laying hen Colisepticemia DE 2000 + 19 neuO-1 
IMT2477 3976 141   K1 L. Wieler Laying hen Colisepticemia DE 2000    
IMT4525 3825 95 95 8 O1:K1:H7 L. Wieler Laying hen Colisepticemia DE 2000 + 26 neuO-3 
IMT4518 3824 95 95 8 O1:K1:H7 L. Wieler Laying hen Colisepticemia DE 2000 + 27 neuO-3 
IMT5155 3827 140 95 10 O2:K1 L. Wieler Laying hen Colisepticemia DE 2001 + 18 neuO-3 
IMT5119 3977 363   K1 L. Wieler Laying hen Colisepticemia DE 2001    
IMT5144 3978 141   K1 L. Wieler Laying hen Colisepticemia DE 2001    
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ORIGINAL ID WUE-ID  ST 
 
STC 
CUS3
_GT Serotype 
Provided 
by Host 
Clinical 
source Country* Year neuO  
poly(ψ) 
motif 
neuO-
allele 
IMT8894 3828 368 95 1 O2:K1:H7 L. Wieler Flamingo Colisepticemia NL 2003 + 25 neuO-1 
IMT8899 3829 95 95  O1:K1 L. Wieler Ostrich Colisepticemia NL 2003 + 10 and 62 neuO-1 
IMT8897 3979 141   K1 L. Wieler Bird Colisepticemia NL 2003    
IMT9241 3831 95 95 2 O2:K1:H4 L. Wieler Laying hen Colisepticemia DE 2004 + 16 neuO-1 
IMT9232 3830 95 95  O1:K1:H7 L. Wieler Chicken Colisepticemia DE 2004 + 14 neuO-1 
 
Delta 
58 95 95 8 K1 this study Human Feces DE 2005 + 35 neuO-3 
 
Delta 
59 357   K1 this study Human Feces DE 2005 + 18 neuO-3 
 
Delta 
60 420   K1 this study Human Feces DE 2005    
 
Delta 
61 59 59  K1 this study Human Feces DE 2005    
 
Delta 
62 95 95  K1 this study Human Feces DE 2005 + 8 neuO-1 
 
Delta 
63 10 10  K1 this study Human Feces DE 2005    
 
Delta 
64 95 95 2 K1 this study Human Feces DE 2005 + 16 neuO-1 
 
Delta 
65 59 59  K1 this study Human Feces DE 2005    
 
Delta 
16 80 568  K1 this study Human Cervical swab DE 2005    
 
Delta 
1 95 95 2 K1 this study Human Feces DE 2005 + 16 neuO-1 
 
Delta 
2 59 59  K1 this study Human Feces DE 2005    
 
Delta 
3 141   K1 this study Human Feces DE 2005    
 
Delta 
4 419   K1 this study Human Feces DE 2005    
 
Delta 
5 357   K1 this study Human Feces DE 2005    
 
Delta 
6 59 59  K1 this study Human Feces DE 2005    
 
Delta 
7 357   K1 this study Human Feces DE 2005    
 
Delta 
8 416 95 2 K1 this study Human Feces DE 2005 + 2 neuO-1 
 
Delta 
9 95 95 2 K1 this study Human Feces DE 2005 + 29 neuO-1 
 
Delta 
13 141   K1 this study Human Feces DE 2005    
 
Delta 
17 59 59  K1 this study Human Feces DE 2005    
 
Delta 
18 95 95 2 K1 this study Human Feces DE 2005 + 40 neuO-1 
 
Delta 
33 62   K1 this study Human Feces DE 2005 + 41 neuO-5 
 
Delta 
34 95 95  K1 this study Human Feces DE 2005 + 32 neuO-1 
 
Delta 
43 59 59  K1 this study Human Feces DE 2005    
 
Delta 
44 357   K1 this study Human Feces DE 2005    
 
Delta 
45 59 59  K1 this study Human Feces DE 2005    
 
Delta 
46 427   K1 this study Human Feces DE 2005    
 
Delta 
47 358  13 K1 this study Human Feces DE 2005 + 19 neuO-3 
 
Delta 
48 399 399  K1 this study Human Feces DE 2005    
 
Delta 
49 144  18 K1 this study Human Feces DE 2005 + 10 neuO-4 
 
Delta 
50 59 59  K1 this study Human Feces DE 2005    
 
Delta 
51 131   K1 this study Human Feces DE 2005    
 
Delta 
52 59 59  K1 this study Human Feces DE 2005    
 
Delta 
55 429   K1 this study Human Feces DE 2005    
 
Delta 
23 420   K1 this study Human 
Invasive 
Disease DE 2005    
 
Delta 
27 95 95 2 K1 this study Human 
Invasive 
Disease DE 2005 + 49 neuO-1 
 
Delta 
29 95 95  K1 this study Human 
Invasive 
Disease DE 2005 + 24 neuO-1 
 
Delta 
39 95 95  K1 this study Human 
Invasive 
Disease DE 2005 + 31 neuO-1 
 
Delta 
10 141   K1 this study Human UTI DE 2005    
 
Delta 
11 95 95  K1 this study Human UTI DE 2005 + 4 neuO-1 
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ORIGINAL ID WUE-ID  ST 
 
STC 
CUS3
_GT Serotype 
Provided 
by Host 
Clinical 
source Country* Year neuO  
poly(ψ) 
motif 
neuO-
allele 
 
Delta 
12 357   K1 this study Human UTI DE 2005 + 36 neuO-2 
 
Delta 
14 141   K1 this study Human UTI DE 2005    
 
Delta 
15 421 95  K1 this study Human UTI DE 2005    
 
Delta 
20 417 95 2 K1 this study Human UTI DE 2005 + 23 neuO-1 
 
Delta 
21 418 95 2 K1 this study Human UTI DE 2005 + 41 neuO-1 
 
Delta 
22 390 95 2 K1 this study Human UTI DE 2005 + 16 neuO-1 
 
Delta 
24 141   K1 this study Human UTI DE 2005    
 
Delta 
25 141   K1 this study Human UTI DE 2005    
 
Delta 
26 420   K1 this study Human UTI DE 2005    
 
Delta 
28 144   K1 this study Human UTI DE 2005    
 
Delta 
30 95 95  K1 this study Human UTI DE 2005 + 24 neuO-1 
 
Delta 
31 415 59  K1 this study Human UTI DE 2005    
 
Delta 
32 390 95 2 K1 this study Human UTI DE 2005 + 3 neuO-1 
 
Delta 
35 141   K1 this study Human UTI DE 2005    
 
Delta 
36 141   K1 this study Human UTI DE 2005    
 
Delta 
37 95 95  K1 this study Human UTI DE 2005 + 42 neuO-1 
 
Delta 
38 80 568  K1 this study Human UTI DE 2005    
 
Delta 
40 80 568  K1 this study Human UTI DE 2005 + 51 neuO-3 
 
Delta 
41 59 59  K1 this study Human UTI DE 2005    
 
Delta 
42 430   K1 this study Human UTI DE 2005    
 
Delta 
53 357   K1 this study Human UTI DE 2005 + 8 neuO-3 
 
Delta 
54 95 95 2 K1 this study Human UTI DE 2005 + 5 neuO-1 
 
Delta 
56 428  6 K1 this study Human UTI DE 2005 + 22 neuO-1 
 
Delta 
57 428   K1 this study Human UTI DE 2005    
 
Delta 
66 357   K1 this study Human UTI DE 2005    
 
Delta 
67 95 95 2 K1 this study Human UTI DE 2005 + 22 neuO-1 
 
Delta 
68 95 95 2 K1 this study Human UTI DE 2005 + 10 neuO-1 
 
Delta 
84 95 95 8 K1 this study Human Feces DE 2006 + 13 neuO-3 
 
Delta 
98 141   K1 this study Human Feces DE 2006    
 
Delta 
99 379 59  K1 this study Human Feces DE 2006    
 
Delta 
100 141   K1 this study Human Feces DE 2006    
 
Delta 
101 80 568  K1 this study Human Feces DE 2006    
 
Delta 
102 80 568  K1 this study Human Feces DE 2006    
 
Delta 
103 357   K1 this study Human Feces DE 2006    
 
Delta 
104 357  12 K1 this study Human Feces DE 2006 + 25 neuO-3 
 
Delta 
105 428  9 K1 this study Human Feces DE 2006 + 9 neuO-3 
 
Delta 
70 357   K1 this study Human 
Invasive 
Disease DE 2006 + 19 neuO-3 
 
Delta 
69 568 568  K1 this study Human UTI DE 2006    
 
Delta 
71 569   K1 this study Human UTI DE 2006    
 
Delta 
72 80 568  K1 this study Human UTI DE 2006    
 
Delta 
73 80 568  K1 this study Human UTI DE 2006    
 
Delta 
74 144  18 K1 this study Human UTI DE 2006 + 30 neuO-4 
 
Delta 
75 95 95 2 K1 this study Human UTI DE 2006 + 4 neuO-1 
 
Delta 
76 357  14 K1 this study Human UTI DE 2006 + 49 neuO-3 
 
Delta 
77 573   K1 this study Human UTI DE 2006    
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ORIGINAL ID WUE-ID  ST 
 
STC 
CUS3
_GT Serotype 
Provided 
by Host 
Clinical 
source Country* Year neuO  
poly(ψ) 
motif 
neuO-
allele 
 
Delta 
78 141   K1 this study Human UTI DE 2006    
 
Delta 
79 141   K1 this study Human UTI DE 2006    
 
Delta 
80 141   K1 this study Human UTI DE 2006    
 
Delta 
81 10 10  K1 this study Human UTI DE 2006    
 
Delta 
82 80 568  K1 this study Human UTI DE 2006    
 
Delta 
83 141   K1 this study Human UTI DE 2006 
Delet-
ion   
 
Delta 
85 141   K1 this study Human UTI DE 2006    
 
Delta 
86 95 95  K1 this study Human UTI DE 2006 + 32 neuO-1 
 
Delta 
87 567   K1 this study Human UTI DE 2006    
 
Delta 
88 95 95  K1 this study Human UTI DE 2006 + 32 neuO-1 
 
Delta 
89 95 95 2 K1 this study Human UTI DE 2006 + 93 neuO-1 
 
Delta 
90 95 95  K1 this study Human UTI DE 2006 + 30 neuO-1 
 
Delta 
91 95 95 3 K1 this study Human UTI DE 2006 + 20 neuO-1 
 
Delta 
92 59 59  K1 this study Human UTI DE 2006    
 
Delta 
93 141   K1 this study Human UTI DE 2006    
 
Delta 
94 358  15 K1 this study Human UTI DE 2006 + 18 neuO-3 
 
Delta 
95 141   K1 this study Human UTI DE 2006    
 
Delta 
96 567   K1 this study Human UTI DE 2006    
 
Delta 
97 95 95 2 K1 this study Human UTI DE 2006 + 34 neuO-1 
 
Delta 
106 95 95 16 K1 this study Human UTI DE 2006 + 25 neuO-3 
 
Delta 
107 141   K1 this study Human UTI DE 2006    
IHE3080 3792 390 95 2 K1 U. Dobrindt Human Invasive Disease FI 
un-
known + 16 neuO-1 
A160 3227 141   O2:H6:K1 M. Achtman Human UTI FI un-known    
BEN79 3793 95 95 2 O18:K1:H7 U. Dobrindt Poultry Colisepticemia FR un-known + 30 neuO-1 
BEN374 3794 95 95 2 O18:K1:H7 U. Dobrindt Poultry Colisepticemia FR un-known + 2 neuO-1 
BEN2908 3795 95 95 5 O2:K1:H7 U. Dobrindt Poultry Colisepticemia FR un-known + 20 neuO-1 
W1827 3803 95 95  O2:K1:H- U. Dobrindt Poultry Colisepticemia DE un-known + 27 neuO-1 
4405/1 3808 95 95 2 O12:K1:H7 U. Dobrindt Human Invasive Disease DE 
un-
known + 19 neuO-1 
1772 3807 577   O2:K1 U. Dobrindt Bird Colisepticemia DE un-known    
RB11 3796 95 95 10 O2:K1 U. Dobrindt Bird Colisepticemia IL un-known + 15 neuO-3 
RB12 3797 95 95 10 O2:K1 U. Dobrindt Bird Colisepticemia IL un-known + 47 neuO-3 
RB14 3798 579  2 O2:K1 U. Dobrindt Bird Colisepticemia IL un-known + 28 neuO-1 
F18 3801 95 95 10 K1 U. Dobrindt Human Feces un-known un-known + 22 neuO-3 
VE239/94 3805 62   K1 U. Dobrindt Human Invasive Disease un-known 
un-
known + 6 neuO-5 
VE1140/94 3806 95 95 2 K1 U. Dobrindt Human Invasive Disease unknown 
un-
known + 11 neuO-1 
VE8793/95 3809 390 95 2 K1 U. Dobrindt Human Invasive Disease unknown 
un-
known + 25 neuO-1 
B13155 3811 390 95 2 K1 U. Dobrindt Human Invasive Disease unknown 
un-
known + 19 neuO-1 
B616/96 3802 390 95 2 K1 U. Dobrindt Human Invasive Disease unknown 
un-
known + 18 neuO-1 
B10363 3810 95 95  K1 U. Dobrindt Human Invasive Disease unknown 
un-
known + 33 neuO-1 
A285 3231 144  17 O16:H6:K1 M. Achtman Human UTI SE un-known + 20 neuO-4 
A211 3226 140 95 10 O2:H5:K1 M. Achtman Human Feces UK un-known + 43 neuO-3 
248 3833 370 95 10 O35:K1 L. Wieler Chicken Colisepticemia USA un-known + 25 neuO-3 
A173 3228 62  8 O7:K1 M. Achtman Human Feces USA un-known + 31 neuO-3 
IMT9090 3980 141   K1 L. Wieler Human UTI unknown un-known    
KK3/2 3430 62   O7:K1:NM L. Beutin Human Feces DE un-known    
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ORIGINAL ID WUE-ID  ST STC 
CUS3
_GT Serotype 
Provided 
by Host 
Clinical 
source Country* Year neuO  
poly(ψ) 
motif 
neuO-
allele 
KK4/2 3431 95 95 2 O2:K1:H7 L. Beutin Human Feces DE un-known + 32 neuO-1 
KK5/14 3432 10 10  O2:K1:NM L. Beutin Human Feces DE un-known + 16 neuO-1 
KK7/1 3433 95 95 2 O2:K1:H4 L. Beutin Human Feces DE un-known + 31 neuO-1 
KK9/10 3434 363   O46:K1:H31 L. Beutin Human Feces DE un-known    
KK11/6 3435 364   O1:K1:NM L. Beutin Human Feces DE un-known    
KK15/1 3436 59 59  O1:K1:NM L. Beutin Human Feces DE un-known    
KK18/10 3437 95 95 2 O2:K1:H7 L. Beutin Human Feces DE un-known + 28 neuO-1 
KK20/2 3438 379 59  O1:K1:NM L. Beutin Human Feces DE un-known    
KK27/1 3439 95 95 2 Orough:K1:H4 L. Beutin Human Feces DE 
un-
known + 31 neuO-1 
 
NOTE: WUE-ID, Würzburg strain collection; ST, sequence type; STC, sequence type complex; CUS3_GT, CUS-3 
genotype; Serotype, as available at the E. coli MLST website; poly(ψ) motif, number of heptanucleotide repeats; * BE, 
Belgium; CA, Canada; DE, Germany; FI, Finland; FR, France; IL, Israel; JO, Jordany; NL, Netherlands; SE, Sweden; 
UK, United Kingdom; USA, United States of America. 
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Table S2: Nucleotide polymorphisms resulting in five allelic variants of neuO.  
Nucleotides that differ between neuO alleles are given in bold. Positions are arranged in vertical direction and the 
numbering disregards the poly(ψ) motif at the 5´-end of the coding sequence. NeuO-1 is the reference allele of neuO 
found also in the genome sequence of strain RS218 (Accession no. CP000711). Kinetic parameters of different NeuO 
variants were analyzed by measuring enzymatic activity in a spectrophotometric assay at pH 7.5 and 25° C. Donor 
substrate kinetics were determined using 0.025-1 mM acetyl-CoA with colominic acid at 2 mg/ml. Reactions were 
initiated by adding 885 ng of purified enzyme variant. The steady-state parameters Km and kcat were determined from 
initial velocity measurements from three independent experiments measured in triplicates and values are given as mean 
± standard deviation. Kinetic parameters of NeuO-2 and NeuO-5 were not determined (n.d.), since these variants have 
the same amino acid sequence as NeuO-3 and NeuO-4, respectively. 
 
 
Allele  Nucleotide position Protein 
variant  
Amino acid 
position  Km [mM] 
kcat 
[s-1] 
  
 
 
 
5 
 
 
1 
3 
 
 
2 
7 
 
 
3 
7 
 
1 
5 
9 
 
4 
5 
9 
 
5 
9 
7 
  
 
 
 
2 
 
 
 
5 
 
 
1 
3 
   
 
neuO-1 
  
T 
 
G 
 
G 
 
G 
 
T 
 
A 
 
G 
 
NeuO-1 
  
Leu 
 
Val 
 
Val 
 0.24 ± 0.02 1.86 ± 0.02 
 
neuO-2 
 
 
C 
 
G 
 
G 
 
A 
 
T 
 
G 
 
G 
 
NeuO-2 
 
Ser 
 
Val 
 
Ile 
 n.d. n.d. 
neuO-3  C G A A T G G NeuO-3 
 
} Ser Val Ile  0.25 ± 0.02 1.88 ± 0.03 
 
neuO-4 
 
 
C 
 
A 
 
G 
 
A 
 
G 
 
G 
 
G 
 
NeuO-4 
 
Ser 
 
Ile 
 
Ile 
 0.27 ± 0.03 1.90 ± 0.06 
neuO-5  C A G A G G A NeuO-5 
 
} Ser Ile Ile 
 n.d. n.d. 
  
 
Leu 
 
Val 
  
Val 
           
  ▼ ▼  ▼            
  
Ser Ile  Ile 
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Table S3:  
Partial concatenated CUS-3 DNA sequence (2,019 bp) comprising ORF22 (438 bp), two fragments of the prophage 
endoNK1 gene (492 bp and 441 bp), and neuO (648 bp without poly(ψ) motif). 
 
>CUS3_GT1 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACAGCTGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGTACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTTTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT2 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACAGCTGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGTACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT3 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACAGCTGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGTACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT4 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACAGCTGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGTACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
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>CUS3_GT5 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT 
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT6 
ATGTTGTTTTCCGTTGATGATAATGGGTCAGGTAATGTTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGAGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACAGCTGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT7 
ATGTCGTTTTCCGTTGATGATAATGGGTCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACGAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTATACAGACGCCGAACTCGCGGACTTCTTTGAAGTTAGCGAGGCAACAATCAACAATTGGAAATTGGAATATCCGGAGTTTTTAGAGTCCATAAAAAA
GGGTAAGGCAGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCTC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATCCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGGTTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAATTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGATTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCTCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCTGCTATGCCTTTCTTTGCTAT 
>CUS3_GT8 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCGTTTCTTTGCTAT 
>CUS3_GT9 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
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>CUS3_GT10 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT 
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCAGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT11 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT12 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGATATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAATTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGCGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGGCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT13 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCACGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAACTTGCTGATTTCTTTGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGATATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAATTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
AGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT14 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCACGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAACTTGCTGATTTCTTTGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGATATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGATAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
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>CUS3_GT15 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCACGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAACTTGCTGATTTCTTTGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGATATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT 
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
AGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAACATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT16 
ATGTCGTTTTCCGTTGATGATAATGGATCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGTGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCACGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAACTTGCTGATTTCTTTGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGATCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGATATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACCGCTGCCATTTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTATTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGATTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAACTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGACTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCGTTTCTTTGCTAT 
>CUS3_GT17 
ATGTCGTTTTCCATTGATGATAATGGGTCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGGGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGAGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGGTTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAATTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGATTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
>CUS3_GT18 
ATGTCGTTTTCCATTGATGATAATGGGTCAGGTAATATTTTTGTATGTGGAGATCTTGTAAATAGCAAAGAGAATAAAGTTCAGTTCAATGGAAACAATAACAAACTTATTATAGA
AGATGATGTTGAGTGTCGATGGCTTACCGTAATATTTAGGGGGGATAATAATTACGTAAGAATACATAAAAACAGTAAGATTAAAGGTGATATTGTCGCAACAAAAGGTTCAAAAG
TTATTATCGGTAGAAGAACGACAATAGGTGCAGGTTTTGAAGTCGTCACTGATAAGTGCAATGTTACAATTGGCCATGACTGCATGATAGCAAGAGATGTTATTTTGCGTGCATCA
GATGGGCATCCTATATTTGATATTCATAGCAAAAAAAGGATTAATTGGGCAAAAGATATCATTATATCTAGTTACGTATGGGTAGGGAGAAATGTCTCTATAATGAAAGGGGTATC
TGTTGGAAGCGGATCTGTCATTGGGTATGGGAGTATTGTAACTAAAGATGTGCCATCTATGTGTGCAGCAGCCGGTAATCCAGCAAAAATAATAAAAAGAAATATAATATGGGCAA
GAACGGATAAAGCGGAGCTAATTAGTGATGACAAGAGATGCTCCAGCTATCATGCGAAGCTCACGCAAATGGCGCGCCCAACAAAGTATCAAGAGGCGTATGCCGAACAGGCACGC
AAACTGTGCTTGCTGGGCTACACCGATGCAGAGCTTGCTGATTTCTTCGAAGTCAGTGAGTCAACTATTAACAAGTGGAAGCTTGATTATCCTGAGTTTTCGGAGTCCATAAAAAA
GGGTAAGGCCGTCGCTGATGCAGAAGTTAGTGACCGTCTTTATCAACGCGCTATGGGCTTCGTGGCTCCAGACATCGATATTCGTGTTATTGAAAACAGAATTGTCGAAACTCCGC
TTGAGAAGTATTACCCGCCTGATACAACTGCCGCCATCTTCTGGCTTAAGAACCGACAGAAGGATAAATGGCGCGACAAGGTTGATCACGAGCTAACAGGCAAAGACGGCGGCGCA
ATTCAGATTGAAACATCACCGATGAGCACTCTGTTCGGAAAATCTGAGCCATGTGTAAAATATTATGATGGCATTCTGTATCTGACGACCAGGGGGACATTAAGTACTCAACCCGG
TAGTTCATTGCACAGAAGCTCTGATTTAGGTACATCATGGAATTCTCTTCGCTTCCCAAATAATGTTCATCACTCAAACCTTCCTTTTGCCAAAGTTGGCGATGAGCTGGTTATTT
TTGGCAGTGAGCGCGCATTTGGTGAGTGGGAAGGAGGAGAACCTGATAACCGTTATGCAGGAAATTATCCAAGAACATTTATGACCAGAGTTAACGTCAATGAGTGGAGTCTGGAT
AATGTAGAGTGGGTTAATGTTACTGATCAGATTTATCAGGGCGGAATAGTTAACTCTGCGGTTGGTGTTGGTTCAGTTTGTATCAAAGACAACTGGCTGTACTACATTTTCGGTGG
GGAAGATTTTCTAAACCCATGGAGCATAGGGGATAACAACAGAAAATATCCTTATGTTCACGATGGTCACAGCGGCGGTGAAACAACGTCTTCAGCAGATGGTGCAATGATAACGT
TGCATGGTTCCGGAAGCAGTACTCCACGTCGCGCGGTATATAACGCACTCGAACATCTTTTTGAGAACGGAGATGTTAAACCTTATCTTGATAATGTAAATGCTCTTGGTGGTCCG
GGAAACAGGTTCTCGACAGTTTATCTTGGCTCCAATCCTGTGGTTACCAGTGACGGAACATTAAAGACAGAGCCGGTCTCTCCTGACGAAGCATTGCTGGATGCCTGGGGTGACGT
CAGGTATATCGCTTATAAATGGCTGAACGCTGTCGCTATAAAGGGGGAAGAAGGGGCGAGGATACATCATGGTGTAATCGCGCAGCAACTTCGTGATGTTCTTATTTCTCACGGAC
TCATGGAAGAAGAAAGCACAACATGCCGCTATGCCTTTCTTTGCTAT 
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Table S4:  
Oligonucleotides used in this study. 
 
 
Oligonucleotide Sequence (5´-3´) Target Position as referred to accession no. 
Accession 
no. 
 
HC399 
 
 
CGCCAGCAGGATCTAGATG 
 
 
CUS-3 neuO 
 
2,647-2,629 
 
CP000711 
HC400 ATTGGCTTGATGAGAAGGTAG CUS-3 neuO 1,324-1,344 CP000711 
HC402 TGAGCTTCGCATGATAGCTG CUS-3 neuO 1,597-1,616 CP000711 
HC403 CCGTTGATGATAATGGGTCAG CUS-3 neuO 2,229-2,209 CP000711 
IM25 TCGAAGCGGTGCTGTAAATC CUS-3 ORF22 22,763-22,745 CP000711 
IM26 CTTTGGCGACTTTGTAGCGA CUS-3 ORF22 22,205-22,224 CP000711 
IM30 CGCAGACGCATACCTGCAG CUS-3 endoNK1 4,049-4,031 CP000711 
HC404CR CGTTGACGTCAATGTTTTTTGC CUS-3 endoNK1 2,449-2,470 CP000711 
IM32 CTTCCTGTTTAATTTTCACCC CUS-3 endoNK1 3,479-3,499 CP000711 
IM33 CGTCATCATATACTGCGGG CUS-3 endoNK1 2,762-2,780 CP000711 
HC407 GATGATGTTACCGCTCAGAG CUS-3 endoNK1 3,260-3,241 CP000711 
IM14 gcgcgcGAGCTCGGGAAACAGGTTCTCGATAG CUS-3 endoNK1 3,069-3,050 CP000711 
IM15 gcgcgcCCCGGGATTAGTATCCTACGTTATTTTACC CUS-3 endoNK1 2,373-2,396 CP000711 
IM16 gcgcgcGGATCCAAAACATCATGCAGACATATTAC CUS-3 integrase 1,584-1,562 CP000711 
IM17 gcgcgcGCATGCATCGTATCGCTCATTGCGAC CUS-3 integrase 846-865 CP000711 
AKB116_L2S GGATCCGATACTATAATGTCTAGACTCAAGACTCAAGAC CUS-3 neuO  2381-2413 CP000711 
AKB117_L2S GTCTTGAGTCTTGAGTCTAGACATTATAGTATCGGATCC CUS-3 neuO  2413-2381 CP000711 
AKB118_V5I CTCAAGACTCGTTTTCCATCGATGATAATGGGTCAGG CUS-3 neuO  2244-2208 CP000711 
AKB119_V5I CCTGACCCATTATCATCGATGGAAAACGAGTCTTGAG CUS-3 neuO  2208-2244 CP000711 
AKB120_V13I GATGATAATGGGTCAGGTAATATTTTTGTATGTGGAGATCTTG CUS-3 neuO  2224-2182 CP000711 
AKB121_V13I CAAGATCTCCACATACAAAAATATTACCTGACCCATTATCATC CUS-3 neuO  2182-2224 CP000711 
HC448 CGCAAAGCAGAAGCACGTC E. coli K1 argW 2,569,840-2,569,858 CP000468 
 
Restriction sites used for subsequent cloning of the PCR products are underlined.  
Nucleotide exchanges in neuO leading to amino acid exchanges are indicated in bold letters. 
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The human pathogen Neisseria meningitidis serogroup C is surrounded by a protective 
capsule composed of α2,9-linked polysialic acid. In almost 90% of all strains, the capsular 
polysaccharide is further modified by O-acetylation of the sialic acid residues at position C7 
or C8. This modification is catalyzed by the capsule specific O-acetyltransferase OatC, which 
shares no sequence similarity to any other protein in the databases. My first aim in this study 
was to establish a successful expression and purification procedure to isolate recombinant 
OatC. After setting up in vitro test systems to monitor OatC activity, I determined the donor 
and acceptor substrate specificity of the enzyme. Using size-exclusion chromatography, I 
showed that OatC assembles into homo-dimers. By generating N-terminally truncated OatC 
variants and OatC hybrid proteins, I showed that the first 34 amino acids of OatC form an 
efficient oligomerization domain that works even in a different protein context. By combining 
bioinformatic methods (motif scanning and secondary structure prediction), a comprehensive 
site-directed mutagenesis approach and in vitro activity assays, I identified a catalytic triad 
composed of Ser-286, Asp-376, and His-399, with the catalytic serine located in a 
nucleophile elbow motif. I confirmed the crucial role of these residues by generating site-
specific mutants and showed that OatC-mediated capsule O-acetylation proceeds via a 
covalent acetyl-enzyme intermediate that strictly depended on the presence of Ser-286. 
These data highlighted that OatC shares the typical features of an α/β hydrolase fold 
enzyme, indicating that OatC evolved apart from all other bacterial sialate O-
acetyltransferases known so far. 
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   Neisseria meningitidis serogroup C is a major cause of 
bacterial meningitis and septicaemia. This human 
pathogen is protected by a capsule composed of α2,9-
linked polysialic acid that represents an important 
virulence factor. In the majority of strains, the capsular 
polysaccharide is modified by O-acetylation at C-7 or C-8 
of the sialic acid residues. The gene encoding the 
capsule modifying O-acetyltransferase is part of the 
capsule gene complex and shares no sequence 
similarities with other proteins. Here, we describe the 
purification and biochemical characterization of 
recombinant OatC. The enzyme was found as a 
homodimer, with the first 34 amino acids forming an 
efficient oligomerization domain that worked even in a 
different protein context. Using acetyl-CoA as donor 
substrate, OatC transferred acetyl groups exclusively 
onto polysialic acid joined by α2,9-linkages and did not 
act on free or CMP-activated sialic acid. Motif scanning 
revealed a nucleophile elbow motif (GXS286XGG), which 
is a hallmark of α/β-hydrolase fold enzymes. In a 
comprehensive site-directed mutagenesis study, we 
identified a catalytic triad composed of Ser-286, Asp-376, 
and His-399. Consistent with a double-displacement 
mechanism common to α/β-hydrolase fold enzymes, a 
covalent acetyl-enzyme intermediate was found. 
Together with secondary structure prediction 
highlighting an α/β-hydrolase fold topology, our data 
provide strong evidence that OatC belongs to the α/β-
hydrolase fold family. This clearly distinguishes OatC 
from all other bacterial sialate O-acetyltransferases 
known so far because these are members of the 
hexapeptide repeat family, a class of acyltransferases 
that adopt a left-handed β-helix fold and assemble into 
catalytic trimers. 
 
 
   Neisseria meningitidis (meningococcus) is a worldwide 
and devastating cause of epidemic meningitis and sepsis 
(1, 2). Despite progress in diagnostics, vaccination, and 
therapy, invasive meningococcal infections remain a  
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prevalent disease with a mortality of 10% and high 
morbidity among survivors (3). Meningococci are usually 
found as commensal bacteria of the human upper 
respiratory tract, and only a minority of isolates cause 
systemic disease (4). Common to these invasive strains 
is the presence of a polysaccharide capsule that serves 
as an important virulence factor (5–7). Based on the 
capsular polysaccharide (CPS) structure, meningococci 
were classified into 13 serogroups. However, only five 
serogroups (A, B, C, W-135, and Y) account for nearly all 
reported invasive diseases worldwide (1, 8). With the 
exception of serogroup A, these clinically important 
serogroups are decorated with polysialic acid (polySia) 
capsules (1, 9). Sialic acid refers to a family of nine-
carbon sugars that are derived from N-acetylneuraminic 
acid (Neu5Ac). They are widely found as terminal sugars 
of glycoproteins and glycolipids on vertebrate cells but 
only in a limited number of pathogenic microorganisms, 
where they might have evolved to mimic host cell 
surfaces and to avoid immune attack (10, 11). The CPS 
of N. meningitidis serogroup B (NmB-CPS) is composed 
of α2,8-linked Neu5Ac, a homopolymer that is structurally 
identical to polySia found as a post-translational 
modification of the neural cell adhesion molecule NCAM 
(12, 13). In the case of serogroup C CPS (NmC-CPS), 
the sialic acid residues are joined by α2,9-linkages, 
whereas the CPS of serogroups W-135 (NmW-CPS) and 
Y (NmY-CPS) are Neu5Ac-containing heteropolymers 
composed of the disaccharide repeating units (6)-α-D-
Galp-(14)-α-Neu5Ac-(2) and (6)-α-D-Glcp-(14)-
α-Neu5Ac-(2), respectively (14, 15). Interestingly, in 
serogroups C, W-135, and Y, but not in serogroup B, the 
Neu5Ac residues can be further modified by O-
acetylation. In NmC-CPS, the acetyl groups are 
distributed exclusively between the hydroxyl groups 
located at C-7 and C-8 of Neu5Ac, whereas in NmW-CPS 
and NmY-CPS, O-acetylation is found at C-7 and C-9 
(15–17). Studies from the United Kingdom showed 
capsule O-acetylation for 88 and 79% of the serogroup C 
and Y strains, respectively, whereas only 8% of the W-
135 strains displayed O-acetylated capsules (18, 19). 
However, the biological impact of this modification with 
regard to pathogenicity is still unclear. For NmC-CPS and 
NmY-CPS, an inverse correlation between 
immunogenicity and the level of O-acetylation was 
observed, whereas no impact on immunogenicity was 
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found for O-acetylation of NmW-CPS (20, 21). These 
findings suggest that for serogroup C and Y 
meningococci, capsule O-acetylation may play a general 
role in masking immunogenic epitopes and thereby 
enabling escape from immune surveillance. The sialate 
O-acetyltransferases that catalyze the capsule O-
acetylation might therefore constitute a virulence or 
fitness factor.  
   O-Acetyltransferases are very common in bacteria and 
modify a diverse set of substrates, including 
carbohydrates, amino acids, and xenobiotics. They are 
found as cytosolic, inner membrane-associated or 
integral membrane proteins and include members of 
different protein families. In 2004, we reported the cloning 
of the genes encoding the capsule-specific O-
acetyltransferases of serogroup C and serogroups W-135 
and Y (oatC and oatWY, respectively), which was at that 
time the first identification of genes that encode sialic 
acid-specific O-acetyltransferases (22). In serogroups W-
135 and Y, an identical O-acetyltransferase gene was 
found, which might reflect the structural similarity 
between NmW-CPS and NmY-CPS, two heteropolymers 
that differ only in the orientation of the C-4 hydroxyl group 
of the hexose moiety. Both oatC and oatWY were located 
downstream of the polySia synthesis genes siaA–D within 
the capsule gene complex of serogroup C and W-135/Y 
meningococci, respectively. Whereas no homology to any 
known protein in the data bases was found for OatC, 
analysis of the primary sequence of OatWY revealed the 
presence of imperfect tandem repeats of the consensus 
sequence (LIV)(GAED)X2(STAV)X, the hallmark of 
enzymes belonging to the hexapeptide repeat family of 
acyltransferases. Members of this family adopt a unique 
left-handed β-helix fold, and three identical subunits 
assemble into a catalytic trimer (23, 24).  
   Since 2004, several genes encoding sialate O-acetyl-
transferases have been identified in bacteria that contain 
sialic acid as a component of their CPS or lipo-oligo-
saccharide, such as Escherichia coli K1, Campylobacter 
jejuni, and type III group B streptococci (25–28). Notably, 
all these enzymes belong to the hexapeptide repeat 
family, suggesting that the specificity for sialic acid 
evolved exclusively within this protein family.  
   To investigate whether OatC is just an estranged 
member of the hexapeptide repeat family that lacks 
sequence homology or whether it is the first example of a 
sialate O-acetyltransferase belonging to a different 
protein family, we started a detailed biochemical 
characterization of this enzyme. Using serogroup C 
meningococcal spheroplast membranes as an enzyme 
source, Vann et al. (29) demonstrated that endogenous 
OatC transfers acetyl groups from acetyl-CoA to 
endogenous membrane-bound as well as to exogenous 
soluble NmC-CPS. However, reports on the isolation and 
further characterization of the enzyme are missing. In this 
study, we succeeded in purifying active recombinant 
OatC, which was found as a homodimer. A 
comprehensive site-directed mutagenesis study revealed 
the presence of a Ser-Asp-His catalytic triad with the 
serine located in a nucleophile elbow motif, a 
characteristic feature of α/β-hydrolase fold enzymes. The 
identification of a covalent acetyl-enzyme intermediate 
gave the first insight into the catalytic mechanism of 
 
 
OatC. Together, our data obtained by biochemical 
analysis of wild-type and mutant OatC provide strong 
evidence that OatC is a polySia-specific O-acetyltrans-
ferase that belongs to the α/β-hydrolase fold superfamily. 
This result demonstrates that OatC evolved apart from all 
other bacterial sialate O-acetyltransferases known so far. 
   
EXPERIMENTAL PROCEDURES 
   Materials - Purified de-O-acetylated CPS from N. 
meningitidis serogroup C was kindly provided by Baxter. 
Purified CPS from N. meningitidis serogroups W-135 and 
Y were kindly donated by Pasteur Mérieux Connaught. 
CPS from E. coli K1 was purified as described (30) and 
kindly provided by T. Scheper (Institut für Technische 
Chemie, Universität Hannover, Hannover, Germany). 
Monoclonal antibody (mAb) P1.2 was kindly provided by 
J. Suker and I. Feavers (National Institute for Biological 
Standards and Control, Hertfordshire, United Kingdom). 
pET expression vectors and E. coli BL21(DE3) were 
obtained from Novagen. CMP-Neu5Ac, Neu5Ac, 
colominic acid, 5,5’-dithiobis(2-nitrobenzoic acid), acetyl-
CoA, propionyl-CoA, and butyryl-CoA were purchased 
from Sigma.  
   Generation of OatC Expression Plasmids - All 
constructs for the expression of OatC variants were 
generated in the prokaryotic expression vector pET22b-
∆Strep, resulting in OatC variants with a C-terminal 
hexahistidine tag. pET22b-∆Strep was generated by 
adapter ligation of oligonucleotides AKB42 and AKB43 
into the BamHI/XbaI sites of pET22b-Strep (26), resulting 
in a vector that lacks the pelB leader sequence of 
pET22b and the Strep tag sequence of pET22b-Strep. 
Wild-type oatC was amplified by PCR using the primer 
pair MM269/MM271 and genomic DNA of N. meningitidis 
serogroup C as template. The PCR product was 
subcloned by the BamHI/XhoI sites into pET22b-∆Strep. 
Constructs for the expression of the N-terminally 
truncated forms ∆N34-OatC and ∆N103-OatC were 
generated by PCR using the primer pairs AKB67/MM271 
and AKB69/MM271, respectively. The PCR products 
obtained were subcloned into pET22b-∆Strep as 
described above.  
   For expression of a hybrid protein composed of the first 
34 amino acids of OatC fused to the maltose-binding 
protein (MBP) from E. coli (N34-MBP), a pET22b-based 
plasmid was generated in a two-step cloning approach. (i) 
The sequence encoding the first 34 amino acids of OatC 
was amplified by PCR using the primer pair 
MM269/AKB81 and wild-type oatC as template. The PCR 
product was subcloned into pET22b-∆Strep by 
BamHI/XhoI sites, resulting in the plasmid pOatCfusion. (ii) 
The MBP gene was amplified by PCR using the primer 
pair AKB72/AKB128 and the vector pMAL-c (New 
England Biolabs) as template. The resulting PCR product 
was subcloned into the HindIII/XhoI sites of pOatCfusion.  
   For expression of MBP alone, the corresponding coding 
sequence was amplified by PCR using the primer pair 
AKB129/AKB128 and subcloned into the BamHI/XhoI 
sites of pET22b-∆Strep. The identity of all generated 
constructs was confirmed by sequencing. The sequences 
of the indicated oligonucleotides are given in 
supplemental Fig. S1.  
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   Site-directed Mutagenesis - Single amino acid 
substitutions were generated by PCR using the 
QuikChange site-directed mutagenesis kit (Stratagene) 
following the manufacturer’s guidelines. Wild-type oatC 
subcloned in pET22b-∆Strep was used as template 
together with the primer pairs listed in supplemental Fig. 
S1. BamHI/XhoI fragments of the PCR products obtained 
were subcloned in pET22b-∆Strep, and the identity of the 
inserted PCR fragments was confirmed by sequencing.  
   Expression and Purification of Recombinant OatC - 
Freshly transformed E. coli BL21(DE3) cells were 
cultivated at 37 °C in 500 ml of Power Broth (AthenaES) 
containing 200 µg/ml carbenicillin. At A600 = 1.4, 
expression was induced by adding 0.1 mM isopropyl β-D- 
thiogalactopyranoside. Thereafter, bacteria were grown at 
15°C for 20 h, harvested, and lysed by sonication. 
Recombinant proteins were isolated by immobilized metal 
affinity chromatography (IMAC) using 1 ml-HisTrap HP 
columns (GE Healthcare) equilibrated with binding buffer 
(50mM Tris-HCl (pH 7.5), 300 mM NaCl, and 20 mM 
imidazole). After washing with 15 ml of binding buffer, 
proteins were eluted with a linear imidazole gradient (20–
500 mM imidazole in binding buffer). Enzyme-containing 
fractions were pooled, concentrated by ultrafiltration, and 
loaded onto a Superdex 200 HR 10/30 column (GE 
Healthcare) equilibrated with 50 mM Tris-HCl (pH 7.5) 
and 100 mM NaCl.  
   Spectrophotometric Activity Assay - The enzymatic 
activity of purified OatC variants was determined in a 
spectrophotometric assay. The reaction was performed at 
25 °C in a total volume of 100 µl containing 50 mM Tris-
HCl (pH 7.5), 50 mM NaCl, 20% (w/v) glycerol, 2 mM 
5,5’-dithiobis(2-nitrobenzoic acid), 200 µg/ml purified 
NmC-CPS, and 1 mM acetyl-CoA. The reaction was 
initiated by adding 1.7 pmol of purified enzyme and 
monitored continuously at 405 nm in half-area 96-well 
plates (Greiner) using a PowerWave 340 microtiter plate 
spectrophotometer (BioTek). 
   Radioactive Incorporation Assay - For determination of 
OatC activity in crude bacterial lysates, a radioactive 
incorporation assay was performed. OatC variants were 
expressed in E. coli BL21(DE3) as described above. 
Bacteria from 1 ml of culture medium with A600 = 1 were 
resuspended in 25 µl of lysis buffer (50 mM Tris-HCl (pH 
8.0), 2 mM EDTA, and 100 µg/ml lysozyme), incubated 
for 15 min at 4 °C, and lysed by sonication. The enzyme 
reaction was performed at 25 °C in a total volume of 50 µl 
containing 20 µl of the soluble lysate fraction, 20 mM Tris-
HCl (pH 7.5), 50 mM NaCl, 20 µg of NmC-CPS, and 9.25 
kBq of [14C]acetyl-CoA (GE Healthcare). The reaction 
was stopped after 15 min by spotting 10 µl of the reaction 
mixture on Whatman No. 3MM paper. Free radioactivity 
was removed by descending paper chromatography with 
running buffer (300 mM ammonium acetate buffer (pH 
7.5) and 70% ethanol), and radioactivity incorporated into 
the chromatographically immobile NmC-CPS was 
quantified by scintillation counting. To determine the 
enzymatic activity of purified wild-type OatC, the reaction 
was performed in a total volume of 200 µl containing the 
same reaction mixture as described for the 
spectrophotometric assay supplemented with 37 kBq of 
[14C]acetyl-CoA. At different time points, aliquots of the 
reaction mixture were analyzed as described above. 
 
   Detection of Acetyl-enzyme Intermediates - Purified 
enzyme (3.2 µg) was incubated in a final volume of 50 µl 
at 25 °C in the presence of 20 mM Tris-HCl (pH 7.5), 50 
mM NaCl, and 9.25 kBq of [14C]acetyl-CoA. After 5 min, 
one-half of the reaction mixture was removed. The 
remaining reaction mixture was supplemented with 20 µg 
NmC-CPS and incubated for 25 min. Enzyme reactions 
were stopped by adding an equal volume of loading 
buffer and separated by SDS-PAGE. Gels were analyzed 
by either phosphorimaging or combined Alcian blue/silver 
staining (31).  
   SDS-PAGE, Staining, and Immunoblotting - SDS-PAGE 
was performed under reducing conditions using 2.5% 
(v/v) β-mercaptoethanol. Silver staining, Coomassie 
staining, and Western blot analysis with anti-penta-His 
antibody (Qiagen) were performed as described 
previously (26).  
   Size-exclusion Chromatography - The quaternary 
structure of OatC variants was determined on a Superdex 
200 HR 10/30 column. The column was equilibrated with 
50 mM Tris-HCl (pH 7.5) and 100 mM NaCl and 
calibrated with the following molecular mass standards 
(Sigma): thyroglobulin (669 kDa), β-amylase (200 kDa), 
alcohol dehydrogenase (150 kDa), bovine serum albumin 
(66 kDa), carbonic anhydrase (29 kDa), and cytochrome 
c (12.4 kDa). Eluted proteins were monitored by 
absorbance at 280 nm. 
   Analysis of OatC Activity in Vivo – Isogenic NmC 
strains carrying different oatC variants were generated by 
homologous recombination. The downstream region of 
oatC that ought to provide the right anchor for 
homologous recombination was amplified using the 
primer pair FS1/FS2. The PCR product was subcloned 
into the ApaI sites of pBluescript II SK(+) (Stratagene), 
resulting in the plasmid pFS1. Subsequently, the SalI 
restricted kanamycin resistance cassette of pUC4K (GE 
Healthcare) was inserted into the XhoI site of pFS1, 
resulting in pFS2. The kanamycin cassette was inserted 
to later select for transformants. Finally, wild-type and 
mutant oatC variants with an additional sequence stretch 
encoding a C-terminal hexahistidine tag were excised 
from the pET-based expression plasmids described 
above by sequential restriction. After restriction with HpaII 
and subsequent blunt ending with T4 DNA polymerase, 
the 1.5-kb fragment obtained was restricted with BamHI 
and inserted into the BamHI and EcoRV sites of pFS2. 
The resulting plasmids were transformed into N. 
meningitidis serogroup C wild-type strain 2120 (32) to 
allow homologous recombination. Correct insertion into 
the oatC locus was confirmed by PCR, Southern blotting, 
and sequence analysis. Meningococci were grown on 
chocolate agar, and 20 µl of a bacterial suspension (A600 
= 0.15) was added to each well of a microtiter plate 
(Greiner) that had been coated with poly-D-lysine 
(Sigma). After drying, bacteria were fixed with 0.05% 
glutaraldehyde in phosphate-buffered saline. Capsule 
expression and modification by O-acetylation were 
analyzed in an enzyme-linked immunosorbent assay as 
described previously (32) using the following mAbs: 
mAb924, which is specific for NmC-CPS (OAc+ and OAc- 
forms); mAb 1125, which is directed exclusively against 
the O-acetylated form of NmC-CPS (OAc+); and mAb 
P1.2, which is directed against the surface protein PorA 
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TABLE 1  
Substrate specificity of OatC 
Relative enzymatic activities of purified OatC were determined in the 
presence of different acceptor and donor substrates. The 
concentration of all acceptor substrates was normalized to equal sialic 
acid content (6.47mM sialic acid residues) and thereby to an equal 
number of acceptor sites. The activity obtained for NmC-CPS and 
acetyl-CoA was set to 100%. Values are means ± S.D. from three 
independent experiments. 
 
 
 Relative enzymatic activity 
 % 
     Acceptor substrate 
  
        NmC-CPS 100.0 ± 2.7  
        Neu5Ac 0.2 ± 0.6  
        CMP-Neu5Ac 0.3 ± 0.2  
        colominic acid 0.4 ± 0.7  
        K1-CPS 0.3 ± 0.6  
        NmW-CPS 0.0 ± 0.4  
        NmY-CPS 0.3 ± 0.1  
     Donor substrate 
  
        Acetyl-CoA 100.0 ± 2.4  
        Propionyl-CoA 21.4 ± 1.2  
        Buturyl-CoA 0.1 ± 0.1  
  
 
 
FIGURE 1. Purification of OatC. A, after expression in E. coli 
BL21(DE3), OatC carrying a C-terminal hexahistidine tag was isolated 
by IMAC on a Ni2+ chelating column followed by size-exclusion 
chromatography.  Purification steps were monitored by 10% SDS-
PAGE and silver staining, including aliquots of bacterial lysate (lane 
1), flow-through of the IMAC column (lane 2), wash fractions (lanes 3 
and 4), OatC-containing fractions eluted from the IMAC column (lanes 
5–8), a pool of fractions 5-8 from the IMAC column (lane 9), and 
purified OatC after size-exclusion chromatography (lane 10). Purified 
OatC after size-exclusion chromatography was also analyzed on a 
Western blot stained with anti-penta-His antibody (lane 11). B, the 
enzymatic activity of purified OatC was determined in a 
spectrophotometric assay (data given as means ± S.D. of three 
independent experiments measured in triplicates) and a radioactive 
incorporation assay (data given as means ± S.D. of two independent 
experiments). A405 measured in the spectrophotometric assay is 
displayed on the left y axis, whereas the incorporated radioactivity is 
given as counts/min on the right y axis. 
 
 
(33), as a loading control. N. meningitidis serogroup C 
strain 2948 lacking a functional oatC gene (22) was used 
as a negative control. 
 
RESULTS 
   Purification of Active OatC - OatC was expressed in E. 
coli BL21(DE) with a C-terminal hexahistidine tag. The 
recombinant protein was isolated by IMAC and size-
exclusion chromatography as described under 
“Experimental Procedures.” Using this two-step 
purification protocol, OatC was purified to homogeneity 
(Fig. 1A), yielding 24 mg of enzyme from 500 ml of 
bacterial culture. Silver staining revealed a single band 
consistent with a calculated molecular mass of 54.3 kDa, 
and the identity of this band was confirmed by Western 
blot analysis using anti-penta-His antibody (Fig. 1A).  
   To determine acetyltransferase activity, isolated OatC 
was incubated with [14C]acetyl-CoA in the presence of 
purified NmC-CPS. After removal of free acetyl-CoA, 
incorporation of radiolabeled acetyl groups was 
measured by scintillation counting (Fig. 1B). In parallel, a 
spectrophotometric assay was established that monitored 
the transfer of acetyl groups from acetyl-CoA onto NmC-
CPS by measuring the appearance of the free sulfhydryl 
  
 
 
group on released CoA with Ellman’s reagent at 405 nm 
(Fig. 1B). In both assays, enzymatic activity was 
detected, and similar time courses were observed for the 
incorporation of acetyl groups and the release of CoA 
(Fig. 1B). 
   Donor and Acceptor Substrate Specificity of OatC - 
Using the spectrophotometric assay, we analyzed the 
acceptor substrate specificity of OatC. The enzymatic 
activity of purified OatC was monitored in the presence of 
monomeric Neu5Ac, activated Neu5Ac (CMP-Neu5Ac), 
the Neu5Ac-containing heteropolymers NmW-CPS and 
NmY-CPS, and polySia homopolymers composed of 
either α2,9-linked Neu5Ac residues (NmC-CPS) or α2,8-
linked Neu5Ac residues (colominic acid and K1-CPS, the 
partially hydrolyzed and full-length CPS of E. coli K1, 
respectively). As summarized in Table 1, no enzymatic 
activity was detected for free Neu5Ac and CMP-Neu5Ac, 
indicating that OatC is specific for oligo- or polySia. 
However, of the tested polymeric substrates, only NmC-
CPS served as an acceptor, demonstrating that OatC is 
highly specific for α2,9-linked polySia.  
   The donor substrate specificity of OatC was determined 
by measuring the enzymatic activity for NmC-CPS in the 
presence of acetyl-CoA and the alternative acyl donors 
propionyl-CoA and butyryl-CoA. Compared with acetyl-
CoA, ~20% residual enzymatic activity was detected in 
the presence of propionyl-CoA, whereas no activity was 
observed with butyryl-CoA (Table 1).  
   OatC Assembles into Dimers Mediated by the First 34 
Amino Acids – To study the oligomerization state of 
OatC, the purified enzyme was analyzed by size-
exclusion chromatography on a Superdex 200 column. A 
single peak was obtained that corresponded to a 
molecular mass of 105 ± 1.6 kDa (Table 2), 
demonstrating that OatC is a homodimer with an 
apparent molecular mass that is in agreement with the 
calculated dimeric mass of 108.6 kDa.  
   Using the program HTH (34) and searching the Pfam 
Database of protein families (35), we identified a putative 
helix-turn-helix motif within the first 34 amino acids and a 
tetratricopeptide repeat spanning amino acids 71–104 of 
OatC. Because both motifs have been associated with 
protein-protein interactions (36–38), we asked whether  
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TABLE 2 
Quaternary structures of OatC variants 
The quaternary structures of purified OatC variants, the hybrid protein 
N34-MBP, and MBP were determined by size-exclusion 
chromatography. The molecular masses of the monomeric species 
were calculated from the respective amino acid sequences. The 
oligomeric state was calculated from the values obtained by gel 
filtration divided by the mass calculated for the monomer. Relative 
enzymatic activities of OatC variants were analyzed in the 
spectrophotometric assay, and the activity obtained for wild-type (WT) 
OatC was set to 100%. Values are means ± S.D. from three 
independent experiments. ND, not determined. 
 
  
Molecular 
mass 
Oligomeric 
state 
Relative 
enzymatic 
activity Protein 
variant Monomer 
(calculated) 
Gel 
filtration 
  
 kDa  % 
WT OatC     54.3 105.0 ± 1.6 2.0 100.0 ± 2.7 
∆N34-OatC     50.2 42.8 ± 0.8 0.9 24.9 ± 1.2 
∆N103-OatC     42.0 46.0 ± 0.9 1.1 0.4 ± 0.3 
N34-MBP     46.0 114.4 ± 6.8 2.5       ND 
MBP     41.9 29.1 ± 1.1 0.7       ND 
OatC-S286A     54.3 100.1 ± 1.2 1.9 0.1 ± 0.3 
OatC-D376A     54.3 92.4 ± 1.3 1.7 0.2 ± 0.1 
OatC-H399A     54.3 92.7 ± 2.3 1.7 0.1 ± 0.4 
 
 
 
 
 
FIGURE 2. Identification of a catalytic histidine. A, shown is a 
schematic representation of OatC with a C-terminal hexahistidine tag. 
The positions of all six histidine residues present in OatC are 
highlighted. B, the single alanine substitutions of the indicated amino 
acids were introduced into OatC. After expression in E. coli 
BL21(DE3) and affinity purification on Ni2+ chelating columns, wild-
type (wt) and mutant forms were analyzed by 10% SDS-PAGE and 
Coomassie staining (upper panel) and Western blotting using anti-
penta-His antibody for detection (lower panel). C, the enzymatic 
activities of wild-type and mutant forms were determined in a 
spectrophotometric assay using equimolar concentrations of each 
purified enzyme variant. Data represent means ± S.D. of three 
independent experiments measured in triplicates, and the value 
obtained for wild-type OatC was set to 100%. 
 
the N-terminal part of OatC is involved in dimer formation. 
To address this question, the ∆N34-OatC and ∆N103-
OatC variants, lacking the first 34 and 103 amino acids, 
respectively, were generated. After expression in E. coli 
BL21(DE3), both variants were purified to homogeneity 
by IMAC and size-exclusion chromatography (data not 
shown). Interestingly, both variants were found as 
monomers (Table 2), indicating that dimerization of OatC 
depends on the first 34 amino acids. Whereas no 
enzymatic activity was found for ∆N103-OatC, ∆N34-
OatC retained 25% of the wild-type activity (Table 2). The 
latter finding demonstrates that dimerization is not an 
absolute requirement for enzymatic activity. However, 
deletion of the first N-terminal amino acids seems to 
affect protein folding and/or stability, leading to the 
observed drop in activity. To further evaluate the role of 
the N-terminal part in providing a dimerization interface, 
we fused the first 34 amino acids of OatC to MBP of E. 
coli, resulting in the hybrid protein N34-MBP. MBP is a 
monomeric protein, and in line with previous reports (39, 
40), an oligomeric state of 0.7 was determined by gel 
filtration. By contrast, a quaternary state of 2.5 was found 
for N34-MBP, providing strong evidence that the first 34 
amino acids of OatC are sufficient to mediate protein 
dimerization even in a different protein context.  
   Identification of a Catalytically Important Histidine 
Residue - For OatC, the identification of functionally 
important residues by visualizing highly conserved 
residues was impeded by a complete lack of sequence 
homology between OatC and any other protein in the 
data bases (22). However, because acetyltransferases of 
a variety of different protein families comprise catalytically 
important histidine residues (24, 41–44), we asked 
whether one of the six histidines found in the primary 
sequence of OatC (Fig. 2A) is involved in enzymatic 
activity. To address this question, single alanine 
substitutions were introduced, resulting in OatC variants 
H31A, H111A, H183A, H267A, H399A, and H456A. All 
proteins were expressed in E. coli BL21(DE3) with a C-
terminal hexahistidine tag and were found at comparable 
levels in the soluble fraction. After isolation by IMAC and 
size-exclusion chromatography (Fig. 2B), equimolar 
amounts of wild-type and mutant enzymes were analyzed 
  
 
 
in the spectrophotometric assay. With the exception of 
OatC-H399A and OatC-H456A, all investigated variants 
showed enzymatic activity similar to that of the wild-type 
protein (Fig. 2C). Alanine substitution of the most C- 
terminal histidine residue (H456A) resulted in reduced 
activity. However, this mutant retained 70% of the wild-
type level, excluding an essential role of His-456 in 
catalysis. By contrast, a complete loss of activity was 
observed for OatC-H399A, demonstrating that His-399 is 
critical for enzymatic activity. 
   OatC Contains a Nucleophile Elbow Motif - Motif 
scanning using the MyHits web server (45) revealed a 
putative nucleophile elbow motif (GXS286XGG) in the 
primary sequence of OatC (Fig. 3A). With the consensus 
sequence Sm-X-Nu-X-Sm-Sm (where Sm is a small 
residue, Nu is a nucleophilic residue, and X is any 
residue), the nucleophile elbow represents a structural 
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FIGURE 3. Identification of a nucleophile elbow motif. A, shown is 
a schematic representation of OatC. The relative positions of the 
identified nucleophile elbow motif and Ser-286 are indicated. B, the 
single amino acid exchanges S286A, S286C, and S285A were 
introduced into OatC. After expression in E. coli BL21(DE3) and 
affinity purification on Ni2+ chelating columns, wild-type (wt) and 
mutant forms were analyzed by 10% SDS-PAGE and Coomassie 
staining (upper panel) and Western blotting using anti-penta-His 
antibody for detection (lower panel). C, the enzymatic activities of 
wild-type and mutant forms were determined in a spectrophotometric 
assay using equimolar concentrations of each purified enzyme 
variant. In parallel, the enzymatic activity of purified wild-type OatC 
was analyzed in the presence of 10 mM phenylmethylsulfonyl fluoride 
(+PMSF). Data represent means ± S.D. of three independent 
experiments measured in triplicates, and the value obtained for wild-
type OatC was set to 100%. 
 
 
motif that places a nucleophile at the tip of a sharp turn to 
allow efficient presentation at the site of attack on the 
substrate. It is a typical feature of α/β-hydrolase fold 
enzymes, where the nucleophile (Ser, Cys, or Asp) within 
the motif is part of a catalytic triad composed of Nu- 
(Asp/Glu)-His (42, 46–50). Members of the α/β-hydrolase 
fold family that use serine as a nucleophile can be 
irreversibly inhibited by the serine-specific reagent 
phenylmethylsulfonyl fluoride, resulting in sulfonylation of 
  
 
the catalytic serine. Preincubation of purified OatC with 
phenylmethylsulfonyl fluoride resulted in an almost 
complete loss of OatC activity (Fig. 3C), indicating the 
presence of a catalytic serine. To determine whether Ser-
286 located in the nucleophile elbow is indeed part of the 
catalytic site of OatC, this residue was exchanged with 
alanine and in parallel by cysteine to introduce an 
alternative nucleophile. Because the nucleophile elbow 
motif identified in OatC contains a second serine (Ser-
285), this residue was also exchanged with alanine. The 
resulting variants, OatC-S285A, OatC-S286A, and 
OatCS286C, were expressed in E. coli BL21(DE3) and 
purified to homogeneity via the C-terminal hexahistidine 
tag by IMAC and size-exclusion chromatography (Fig. 
3B). Enzymatic activity was investigated using the 
spectrophotometric activity assay described above. 
Whereas OatC-S285A retained 80% of the wild-type 
activity, alanine substitution of the adjacent Ser-286 
resulted in a complete loss of activity (Fig. 3C). Replace-
ment by a cysteine did not rescue activity, indicating that 
OatC activity depends on a serine residue that has to be 
properly positioned within the nucleophile elbow.  
   Identification of a Ser-Asp-His Catalytic Triad - To 
investigate whether His-399 and Ser-286 are part of a 
catalytic triad, we searched for an acidic residue that 
would complete the triad. The common order in which the 
catalytic residues appear in the primary sequence of α/β-
hydrolase fold enzymes is Ser- (Asp/Glu)-His (42, 46). 
Therefore, aspartate and glutamate residues located 
between Ser-286 and His-399 of OatC (Fig. 4A) were 
likely candidates for the missing catalytic acid. 
Consequently, we generated OatC variants with the 
single alanine substitutions E336A, E345A, D359A, 
D371A, D376A, and E379A that were expressed in E. coli 
BL21(DE3) with a C-terminal hexahistidine tag. The 
analysis of bacterial lysates by SDS-PAGE combined 
with either Coomassie staining or Western blot analysis 
revealed similar expression levels for all variants (Fig. 
4B). To omit purification of each variant, bacterial lysates 
were analyzed directly for enzymatic activity. Because the 
spectrophotometric assay is not compatible with a high 
background of protein-bound sulfhydryl groups as present 
in crude lysates, the radioactive incorporation assay was 
applied. With the single exception of OatC-D376A, all 
variants showed enzymatic activity similar to that of the 
wild-type enzyme. To confirm the observation that alanine 
substitution of Asp-376 results in a complete loss of 
activity, the respective OatC variant was purified to 
homogeneity (Fig. 4D) and was analyzed in the 
spectrophotometric assay. In this case, identical amounts 
of purified enzyme were used for wild-type OatC and 
OatC-D376A. However, no enzymatic activity was 
observed for OatC-D376A, demonstrating that Asp-376 is 
essential for catalysis (Fig. 4E) and completes the 
catalytic triad as the critical acid. It is noteworthy that all 
three OatC variants in which the catalytic triad was 
destroyed by the single alanine substitution S286A, 
D376A, or H399A were found as dimers (see Table 2), 
suggesting that the introduced mutations did not affect 
the overall folding of these proteins. 
   Capsule O-Acetylation in Serogroup C Meningococci 
Carrying Mutant Forms of oatC - To verify the critical role 
of Ser-286, Asp-376, and His-399 for OatC activity in  
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FIGURE 5. Capsule O-acetylation in isogenic NmC strains with 
different oatC variants. A set of isogenic NmC strains carrying the 
indicated oatC variants was generated by homologous recombination. 
In all cases, genes extended by a sequence encoding a C-terminal 
hexahistidine tag were used. A, shown are the results from Western 
blot analysis of bacterial lysates stained with anti-penta-His antibody. 
As a negative control, an NmC strain lacking oatC was used (NmC-
∆oatC). B, the O-acetylation status of the indicated strains was 
investigated in a whole-cell enzyme-linked immunosorbent assay with 
mAb1125 (black bars), which is specific for the O-acetylated (OAc+) 
form of NmC-CPS. Capsule expression was controlled with mAb 924 
(gray bars), which recognizes NmC-CPS irrespective of the O-
acetylation status (OAc+ and OAc-). As a negative control, bovine 
serum albumin (BSA) was used instead of bacteria. The specificity of 
the primary antibodies was controlled by using the following strains: a 
wild-type (wt) NmC strain carrying a functional oatC gene (NmC), an 
NmC deletion mutant lacking the polysialyltransferase gene (siaD) 
essential for capsule synthesis (NmC-∆siaD), an NmC deletion mutant 
lacking oatC (NmC-∆oatC), and a serogroup B strain (NmB). 
 
 
 
 
 
  
vivo, we generated a set of isogenic NmC strains carrying 
different oatC variants. Wild-type oatC and mutant forms, 
extended by a sequence encoding a C-terminal 
hexahistidine tag, were inserted by homologous 
recombination into the oatC locus of NmC strain 2120 
(32), thereby replacing the endogenous wild-type gene. 
OatC expression was monitored in bacterial lysates by 
Western blot analysis with anti-penta-His antibody. As 
shown in Fig. 5A, all isogenic strains expressed 
comparable amounts of OatC, whereas no enzyme was 
detected in the deletion mutant NmC-∆oatC (22), used as 
a negative control. The capsule O-acetylation 
competence of all strains was monitored in a whole-cell 
enzyme-linked immunosorbent assay using two capsule-
specific antibodies: mAb 924, which binds to α2,9-linked 
polySia irrespective of the presence or absence of O-
acetylation, and mAb 1125, which recognizes exclusively 
the O-acetylated form of NmC-CPS (32). As shown in 
Fig. 5B, both antibodies gave strong signals on oatC-
positive NmC wild-type strain 2120. By contrast, complete 
loss of the OAc-specific signal was observed for the 
 
 
FIGURE 4. Catalytic acid of OatC. A, shown is a schematic 
representation of OatC, highlighting the positions of the six aspartate 
and glutamate residues located between Ser-286 and His-399. B, the 
single amino acid substitutions E336A, E345A, D359A, D371A, 
D376A, and E379A were introduced into OatC. After expression in 
E. coli BL21(DE3), bacterial lysates of all variants were separated by 
10% SDS-PAGE and analyzed by Western blotting using anti-penta-
His antibody for detection (upper panel) and Coomassie staining 
(lower panel). C, the OatC activity of wild-type (wt) and mutant forms 
was determined in bacterial lysates using a radioactive incorporation 
assay. D, wild-type OatC and the variant OatC-D376A were purified 
by IMAC and size-exclusion chromatography. Isolated proteins were 
analyzed by 10% SDS-PAGE followed by Coomassie staining (upper 
panel) and Western blot analysis with anti-penta-His antibody (lower 
panel). E, the enzymatic activities of the wild-type enzyme and OatC-
D376A were determined in a spectrophotometric assay using 
equimolar concentrations of each purified enzyme variant. Data repre-  
 
 
sent means ± S.D. of three independent experiments measured in 
triplicates, and the value obtained for wild-type OatC was set to 100%. 
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FIGURE 6. Identification of an acetyl-enzyme intermediate. 
Purified wild-type OatC and variants containing the single amino acid 
exchanges S286A, D376A, and H399A were incubated with 
[14C]acetyl-CoA. Before (-) and after (+) addition of the acceptor 
substrate NmC-CPS, aliquots of the reaction mixture were analyzed 
by 10% SDS-PAGE followed by phosphorimaging to visualize 
radioactively labeled enzyme and acceptor substrate (A) or combined 
Alcian blue/silver staining to control identical loading of enzyme and 
NmC-CPS (B). Bands representing OatC and NmC-CPS are indicated 
on the right. 
respective null mutant NmC-∆oatC, although capsule 
expression per se was not affected as demonstrated by a 
strong signal obtained with mAb 924. The specificity of 
the antibodies used was confirmed by the absence of 
antibody binding on NmC-∆siaD, which lacks the poly-
sialyltransferase essential for capsule synthesis (51), and 
on NmB, which expresses a polySia capsule composed 
of α2,8-linked Neu5Ac (Fig. 5B). Analysis of the newly 
generated isogenic NmC strains revealed capsule O-
acetylation in those strains that express an enzyme 
variant that was proved active in vitro (here, variants 
H31A, H111A, H183A, H267A, and H456A are shown as 
an example). By contrast, no signal with OAc-specific 
antibody mAb 1125 was obtained for mutant strains com-
prising amino acid substitution H399A, S286A, or D376A. 
The lack of mAb 1125 binding was not due to reduced 
capsule expression because in all cases strong signals 
were obtained with mAb 924. Thus, in line with the in vitro 
findings, no enzymatic activity was found for OatC-
H399A, OatC-S286A, and OatCD376A in vivo. Together, 
these results confirm the presence of a catalytic triad 
composed of Ser-286, Asp-376, and His-399. 
   Secondary Fold Prediction - Members of the α/β-
hydrolase fold family share a conserved eight-stranded 
mostly parallel β-sheet, flanked on both sides by helices. 
The presence of this fold might become evident from the 
arrangement of the secondary structure elements. As 
shown in supplemental Fig. S2, we propose a topology 
diagram for OatC that is based on secondary structure 
prediction (52). Whereas the first helix (αA) and the first 
three β-strands (β1–3) could not be unequivocally 
assigned, secondary structure elements predicted for 
amino acids 259–422 show the typical topology of a 
“canonical” α/β-fold. The positions of the catalytic 
residues Ser-286, Asp-376, and His-399 after strands β5, 
β7, and β8, respectively, also matched the commonly 
found location of the catalytic triad (46, 53, 54).  
   Catalytic Mechanism of OatC - Most α/β-hydrolase fold 
enzymes act via a double-displacement (ping-pong) 
mechanism (42, 55–58). In the case of acetyltransferases 
belonging to the α/β-hydrolase fold family, this involves 
the formation of a covalent acetyl-enzyme intermediate 
that occurs by transfer of the acetyl group from acetyl-
CoA onto the serine residue located in the nucleophile 
elbow (47, 58, 59). In the second half of the reaction, the 
acetyl group is further transferred onto the acceptor 
substrate.  
   To gain the first insight into the catalytic mechanism of 
OatC, we monitored the enzyme reaction for the 
occurrence of a stable acetyl-enzyme intermediate. 
Therefore, purified OatC was incubated with [14C]acetyl-
CoA, and the reaction mixture was analyzed before and 
after addition of the acceptor substrate by SDS-PAGE 
followed by autoradiography (Fig. 6A) or combined Alcian 
blue/silver staining as a loading control (Fig. 6B). For 
wild-type OatC, a radioactively labeled protein band 
migrating with the expected molecular mass of 54.3 kDa 
was observed, indicating the appearance of an acetyl-
enzyme intermediate. Upon addition of NmC-CPS, this 
intermediate collapsed, and radiolabeled NmC-CPS 
appeared (Fig. 6A), which is consistent with the transfer 
of the radioactive acetyl group from the enzyme onto the 
acceptor substrate. By contrast, no acetyl-enzyme 
 
 
  
intermediate was detected for OatC-S286A, suggesting 
that the hydroxyl group of Ser-286 acts as acceptor site 
for the acetyl group. In the case of the site-specific variant 
D376A, the appearance of an acetyl-enzyme intermediate 
could be detected, although the amount of radiolabeled 
enzyme was lower than for the wild-type enzyme. 
However, addition of the acceptor substrate did not result 
in a collapse of the intermediate, and accordingly, no 
transfer onto NmC-CPS was detected (Fig. 6A). This 
result indicates that Asp-376 is dispensable for the first 
half of the reaction but essential for the second half. 
Similar to the S286A exchange, alanine substitution of 
His-399 abolished the formation of an acetyl-enzyme 
intermediate, suggesting an important role of His-399 
during transfer of the acetyl group onto the enzyme. 
Thus, analysis of wild-type and mutant OatC 
demonstrated that O-acetylation of NmC-CPS proceeds 
via a covalent acetyl-enzyme intermediate that involves 
Ser-286. 
 
DISCUSSION 
In this study, we performed the first purification and 
biochemical characterization of OatC, the capsule O-
acetyltransferase of serogroup C meningococci. The 
enzyme proved to be highly specific for polySia joined by 
α2,9-linkages and did not act on α2,8-linked polySia or on 
sialic acid-containing heteropolymers such as CPS of 
serogroups W-135 and Y. Moreover, free Neu5Ac and 
CMP-Neu5Ac were not modified by OatC, indicating that 
in vivo O-acetylation of NmC-CPS occurs exclusively at 
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FIGURE 7. Proposed reaction mechanism of the OatC-catalyzed 
O-acetylation of NmC-CPS. The reaction proceeds through the 
following steps: step 1, nucleophilic attack of the carbonyl group of 
acetyl-CoA by Ser-286 and formation of the first tetrahedral 
intermediate; step 2, decomposition of the tetrahedral intermediate, 
release of free CoA, and formation of an acetyl-enzyme intermediate; 
step 3, nucleophilic attack by the C-7 (or C-8) hydroxyl group of the 
acceptor polysaccharide and formation of a second tetrahedral 
intermediate; and step 4, release of the second product (O-acetylated 
NmC-CPS) and regeneration of free enzyme. 
the polymer level. Similar observations have been made 
for NeuO, a prophage-encoded sialate O-acetyl-
transferase found in E. coli K1 strains that harbor the 
CUS-3 phage (25). NeuO catalyzes the O-acetylation of 
K1-CPS, and the enzyme acts exclusively on α2,8-linked 
polySia with at least 14 sialic acid residues (26, 60).  
   Despite the functional similarity between NeuO and 
OatC, our data presented in this study point out that the 
two enzymes evolved independently and belong to 
structurally diverse protein families. As shown recently by 
homology modeling and site-directed mutagenesis 
studies, NeuO belongs to the hexapeptide repeat family 
of acyltransferases (26). Members of this protein family 
contain a unique triangular left-handed β-helix fold with a 
protruding loop that harbors the catalytic histidine 
residue. They assemble into catalytic trimers in which the 
protruding loop of one subunit embraces the left-handed 
β-helix domain of the adjacent subunit, resulting in three 
identical active sites at the interfaces between the sub-
units (24, 61–63). In the case of NeuO, hexamers were 
found in solution, which might be dimers of trimers (26).  
   In contrast to NeuO, the primary sequence of OatC is 
devoid of hexapeptide repeats. Moreover, BLAST search 
analyses did not reveal significant sequence similarities 
between OatC and any other protein (22), impeding the 
identification of phylogenetic relationships. However, by 
combining bioinformatic approaches (motif scanning and 
secondary structure prediction), site-directed 
mutagenesis, and biochemical analyses, we have now 
identified several features that characterize OatC as a 
new member of the α/β-hydrolase fold family of proteins. 
The α/β-hydrolase fold is a versatile and widespread 
protein architecture that is found in enzymes with diverse 
functions such as proteases, lipases, esterases, 
dehalogenases, haloperoxidases, lyases, and epoxide 
hydrolases (42, 50, 64–70). The various members of this 
large superfamily usually lack significant amino acid 
sequence similarities but share a common fold that gave 
the family the name. The canonical α/β-hydrolase fold is 
composed of an eight-stranded mainly parallel β-structure 
that arranges in a twisted β-sheet, flanked on both sides 
by helices (42, 46). The fold provides a stable scaffold for 
a catalytic triad consisting of a nucleophile (serine, 
cysteine, or aspartate), an acid (aspartate or glutamate), 
and a histidine, with the nucleophile located at the tip of a 
sharp turn, the so-called “nucleophile elbow”. However, 
many variations from the canonical fold have been 
observed mainly due to the absence of particular strands 
or helices and/or insertions that can range from a few 
amino acids to entire domains. Based on the large 
number of solved crystal structures, the essential features 
to identify the fold are the presence of at least five parallel 
β-strands, the order of the catalytic triad (nucleophile-
acid-histidine), and a nucleophile elbow at the top of 
canonical strand β5 (54).  
   Although a three-dimensional structure is required to 
unequivocally confirm the presence of a particular fold, 
our data provide strong evidence that OatC adopts an 
α/β-hydrolase fold. A series of single amino acid 
exchanges led to the identification of a catalytic triad 
composed of Ser-286, Asp-376, and His-399. Ser-286 
was found to be part of a typical nucleophile elbow motif 
(GXSXGG), indicating that similar to other α/β-hydrolase 
 
 
  
fold proteins, the nucleophile is located in a tight turn to 
expose the hydroxyl group of Ser-286 to nucleophilic 
attack of the incoming substrate. Moreover, secondary 
structure prediction suggested for OatC a pattern of β-
strands and α-helices that matches the topology of the 
canonical α/β-hydrolase fold (42, 46, 53, 54). In the 
proposed topology model, the catalytic residues are 
located after strands β5, β7, and β8 for Ser-286, Asp-376, 
and His-399, respectively, which is consistent with the 
common positioning of the catalytic triad in α/β-hydrolase 
fold enzymes.  
   Members of the α/β-hydrolase fold family catalyze a 
variety of transformations. However, for almost all 
enzymes, a double-displacement (ping-pong) kinetic 
mechanism is described that involves a covalent 
substrate-enzyme intermediate with the substrate linked 
to the nucleophile of the catalytic triad (42, 58, 66, 71–
76). In line with this, a stable acetyl-enzyme intermediate 
was observed for OatC that crucially depended on the 
presence of Ser-286. In addition, a CoA burst was 
observed in the absence of polySia (data not shown). 
This indicates that the first substrate is released before 
binding of the second substrate, which confirms a ping-
pong mechanism. On the basis of our data obtained for 
wild-type OatC and mutant forms, we propose the 
following catalytic mechanism (Fig. 7). The carboxyl 
group of Asp-376 forms a salt bridge with the N-δ1 of His-
399, allowing the N-ε2 of the imidazole ring to abstract a 
proton from Ser-286. Thereby, the nucleophilicity of the 
hydroxyl group of Ser-286 is increased, facilitating the 
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α2,3-linked sialic acids capping CPS (28); and (iv) NeuD 
of C. jejuni, catalyzing the O-acetylation of terminal α2,8-
linked sialic acids of the lipo-oligosaccharide (27). 
Compared with α/β-hydrolase fold enzymes, members of 
the hexapeptide repeat family not only adopt an entirely 
different structural fold, the left-handed β-helix fold, but 
also act by a different kinetic mechanism. Although they 
possess a strictly conserved catalytic histidine, this 
residue is not part of a catalytic triad, and kinetic data 
obtained for this enzyme family revealed a sequential 
kinetic mechanism (24, 62, 80, 81).  
   The observed striking differences between OatC and 
other bacterial sialic acid-modifying O-acetyltransferases 
indicate that the enzymatic function of sialate O-
acetylation evolved independently on two distinct 
structural frameworks by convergent evolution. Whereas 
the hexapeptide repeat family of acyltransferases is 
restricted to microorganisms, α/β-hydrolase fold enzymes 
are present in all kingdoms of life. Interestingly, the α/β-
hydrolase fold is also used as the structural basis for viral 
sialic acid-specific acetylesterases, the receptor-
destroying enzymes of influenza C and coronaviruses 
that use O-acetylated sialic acids as host receptor 
structures (82, 83). Thus, this fold appears to be a likely 
candidate for the structural framework of eukaryotic 
sialate O-acetyltransferases, for which the genetic and 
structural bases are still unknown. Attempts to clone the 
respective genes, e.g. by expression cloning, failed, and 
purification and characterization of the enzymatic 
activities proved to be challenging (84–88). The new 
insight in the evolution of sialate O-acetyltransferases 
obtained in bacteria may help to identify similar enzymes 
in eukaryotes by searching for genes encoding potential 
α/β-hydrolase fold proteins with unknown function.  
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attack of the carbonyl carbon of acetyl-CoA. The resulting 
tetrahedral transition state subsequently collapses to an 
acetyl-enzyme intermediate with the acetyl moiety 
covalently attached to Ser-286. During the acetylation 
step, the imidazole group of His-399 transfers the proton 
of the serine hydroxyl to the sulfhydryl leaving group, and 
free CoA is released. The second half-reaction is also 
assisted by His-399 through acid/base catalysis and 
starts with the abstraction of a proton from the C-7 (or C-
8) hydroxyl group of the acceptor polysaccharide. This 
enables the nucleophilic attack of the carbonyl carbon of 
the acetyl group in the acetyl-enzyme intermediate, 
resulting in a second tetrahedral transition state. 
Subsequent decomposition of the tetrahedral 
intermediate leads to release of the second reaction 
product, i.e. O-acetylated NmC-CPS. In this last step, 
Ser-286 is returned to its protonated state, which 
reinitializes OatC for a new catalytic cycle. Further 
studies are required to investigate whether OatC 
transfers acetyl groups to both the C-7 and C-8 hydroxyl 
groups. Using 13C NMR spectroscopy, Bhattacharjee et 
al. (14) detected di-O-acetylated residues (Neu5,7,8Ac3) 
in NmC- CPS, whereas no evidence for di-O-acetylated 
sialic acids was found by Lemercinier and Jones (17). For 
NmC-CPS containing only mono-O-acetylated residues, 
non-enzymatic migration of acetyl groups was observed. 
In freshly prepared CPS, O-acetylation was found 
predominantly at O-8, whereas after storage at room 
temperature, the majority of acetyl groups were shifted to 
O-7 (17, 77, 78). Therefore, OatC might be selective for 
O-8, and acetylation of O-7 might occur exclusively by 
non-enzymatic migration.  
   In agreement with the proposed critical roles of the 
catalytic residues of OatC, single alanine substitutions of 
Ser-286, Asp-376, and His-399 completely abolished 
OatC activity in vitro and in vivo. Replacement of either 
His-399 or Ser-286 already abrogated the ability to form a 
covalent acetyl-enzyme intermediate, which is consistent 
with the proposed crucial function of His-399 as a general 
base catalyst and the central role of Ser-286 as an 
attachment site for the acetyl group. In contrast to OatC-
H399A and OatC-S286A, OatC-D376A was still able to 
form a limited amount of acetyl-enzyme intermediate, 
indicating that Asp-376 is dispensable during the first 
half-reaction but essentially required for catalysis of the 
second half-reaction. This finding is in accordance with 
the less pronounced role of the catalytic acid observed in 
many α/β-hydrolase fold enzymes. In several cases, 
alanine substitution of the catalytic acid was even 
compatible with enzyme catalysis, and considerably high 
levels of activity were observed (66, 76, 79).  
   We conclude that OatC adopts an α/β-hydrolase fold 
structure with a Ser-Asp-His catalytic triad that forms the 
molecular basis for O-acetylation of NmC-CPS by a ping-
pong mechanism. This clearly distinguishes OatC from all 
other bacterial sialate O-acetyltransferases known so far, 
which all belong to the hexapeptide repeat family: (i) 
NeuO, responsible for O-acetylation of the E. coli K1 
capsule; (ii) OatWY, involved in O-acetylation of sialic 
acids within the galactose- and glucose-containing 
heteropolymeric polySia capsules of serogroup W-135 
and Y meningococci, respectively (22); (iii) NeuD of group 
B streptococci, required for O-acetylation of terminal 
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Chapter 5 - Crystallization of the polysialic acid specific 
O-acetyltransferase OatC from Neisseria meningitidis 
serogroup C  
 
5.1 Introduction 
Neisseria meningitidis (N. meningitidis or meningococcus) is a common commensal that 
colonizes the human nasopharynx in up to 30% of healthy carriers at any one time (Claus et 
al., 2005). Nonetheless, meningococci occasionally cause countrywide outbreaks of life-
threatening systemic disease, making the pathogen a leading cause of sepsis and meningitis 
worldwide (van Deuren et al., 2000 ; Stephens, 2007; Caugant, 2008). Although the 
pathogenic potential of the bacterium is associated with only a few hyper-invasive genetic 
clones of the species, the reasons how meningococci become invasive are not yet fully 
understood (Raymond et al., 1997; Swartley et al., 1997; Maiden et al., 1998; Vogel et al., 
2000; Yazdankhah and Caugant, 2004; Caugant, 2008). Meningococci are differentiated into 
thirteen distinct serogroups based on the polysaccharide composition of their capsules 
(Gotschlich et al., 1969). Among the six serogroups that account for nearly all reported 
invasive diseases worldwide, the four serogroups B, C, W-135 and Y are decorated with 
polysialic acid (polySia) capsules (Rosenstein et al., 2001; Jodar et al., 2002; Jazdankhah 
and Caugant, 2004; Boisier et al., 2007; Stephens, 2007). The homopolymeric capsular 
polysaccharide (CPS) of N. meningitidis serogroup C is composed of α2,9-linked polySia and 
the capsular Sia residues have been found to be further modified by O-acetylation in vivo 
(Bhattacharjee et al., 1975). In 2004, the gene encoding the respective O-acetyltransferase 
OatC was identified and shown to undergo phase variation, which explains the high 
variability in this phenotypic trait (Claus et al., 2004). OatC is located downstream of the 
polySia synthesis genes siaA–D within the capsule gene complex of serogroup C 
meningococci. With the notable exception of OatC, primary sequence analyses of all known 
bacterial sialate O-acetyltransferases revealed significant similarities towards the 
hexapeptide repeat family of acyltransferases (Claus et al., 2004; Deszo et al., 2005; Lewis 
et al., 2006; Houliston et al., 2006; Bergfeld et al., 2007). The hallmark of these enzymes is 
the presence of imperfect tandem repeats with the consensus sequence 
(LIV)(GAED)X2(STAV)X which adopt into a unique left-handed β-helix fold that assembles 
into catalytic trimers (Vaara, 1992; Johnson et al., 2005). OatC lacks these tandem repeats 
and biochemical analyses showed that OatC contains several typical features of an α/β-
hydrolase fold enzyme: a Ser-Asp-His catalytic triad, a nucleophile elbow motif containing the 
catalytic serine, a secondary structure topology matching the ”canonical” α/β-hydrolase fold, 
and a double-displacement kinetic mechanism (Bergfeld et al., 2009). However, so far, no 
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structural data are available for any sialic acid-specific O-acetyltransferase and nothing is 
known about the molecular basis of substrate selectivity for sialic and polysialic acid. The first 
successful isolation of polySia-specific O-acetyltransferases was recently described for the 
capsule modifying O-acetyltransferase NeuO of Escherichia coli K1 and for OatC (Bergfeld et 
al., 2007; Bergfeld et al., 2009). The availability of the recombinant enzymes in high yields 
and purity is now forming the basis for comprehensive structural analyses. A currently 
ongoing project is therefore the determination of the 3D-crystal structures of NeuO and OatC.  
This chapter summarizes the recent progress made in crystallizing OatC. First crystallization 
trials were accomplished with an OatC variant carrying a C-terminal hexa-histidine tag and 
initial crystallization conditions were identified. Refinement of the initial hit conditions resulted 
in OatC crystals that diffracted X-rays to almost 3.8 Å. To get better diffracting crystals, 
several optimization strategies, including crystallization of OatC lacking a hexa-histidine tag, 
were implemented and first results are presented. 
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5.2 Materials and methods 
 
5.2.1 Materials  
Purified de-O-acetylated CPS from N. meningitidis serogroup C was kindly provided by 
Baxter. pET expression vectors and E. coli BL21(DE3) were obtained from Novagen. 5,5’-
dithiobis(2-nitrobenzoic acid), dithiothreitol, D-(+)-glucose and acetyl-CoA, were purchased 
from Sigma. Polyethylene glycols (PEGs), PEG-MME 550, 2-methyl-2,4-pentanediol, bicine 
and bistris were obtained from Fluka and  HEPES as well as glycerol were purchased from 
AppliChem. Tris(hydroxymethyl)aminomethane (Tris-HCl), sodium acetate, ammonium 
sulfate and calcium chloride dihydrate were bought from Merck and 2-(N-morpholino)-
ethanesulfonic acid (MES) was obtained from Calbiochem. Sodium chloride, 2-propanol and 
ethanol were purchased from J.T.Baker and Jeffamine ED-2001® as well as pentaerythritol 
ethoxylate (15/4 EO/OH) were obtained from Hampton Research. 
 
5.2.2 Generation of OatC expression plasmids 
All constructs for the expression of OatC variants were generated in the prokaryotic 
expression vector pET22b-∆Strep, allowing the expression of OatC variants with a C-terminal 
hexahistidine tag. Generation of the respective vector pET22b-∆Strep as well as the 
plasmids for expression of OatC, ∆N34-OatC and OatC-H456A was described previously 
(Bergfeld et al., 2009). Constructs for the expression of the N-terminally or C-terminally 
truncated forms ∆N17-OatC and OatC-∆C2 were generated by PCR using the primer pairs 
AKB76/MM271 and MM269/AKB70, respectively. The obtained PCR products were 
subcloned into BamHI/XhoI sites of pET22b-∆Strep. For isolation of untagged OatC, a CRV-
protease cleavage site was introduced between the sequence of OatC and the C-terminal 
hexahistidine tag, allowing to cleave off the affinity tag after purification. Therefore adapter 
ligation of the oligonucleotides AKB135/AKB136 into the XhoI site of the pET22b-∆Strep 
expression plasmid harboring the wild-type oatC gene (Bergfeld et al., 2009) was performed. 
The primers used in the present study are listed in Table 5-1 and the identity of all generated 
constructs was confirmed by sequencing. 
 
construct oligo  sequence 5’-3’ 
AKB 76 s CGGGATCCATGAATTTCGCAGAAATTGCTCGCATTAC 
∆N17-OatC 
MM 271 as GTCCGCTCGAGACATAAGAATTTATGTAATC 
MM 269 s CGGGATCCATGTCAATCAATACGTTTG 
OatC-∆C2 
AKB 70 as GTCCGCTCGAGGAATTTATGTAATCGCATATCAGGATTG 
AKB 135 s TCGAGGTACTGTTCCAGGGCCCGC 
OatC-CRV-His 
AKB 136 as TCGAGCGGGCCCTGGAACAGTACC 
 
Table 5-1: Oligonucleotides used in the present study. Sequences of sense (s) and antisense (as) primers are 
listed in 5’-3’ direction. 
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5.2.3 Large-scale purification of (His)6-tagged OatC 
Freshly transformed E. coli BL21(DE3) cells were cultivated at 37°C in 500 ml of Power Broth 
(AthenaES) containing 200 µg/ml carbenicillin. At OD600 = 1.4, expression was induced by 
adding 0.1 mM isopropyl-β-D-thiogalactopyranoside. Thereafter, bacteria were grown at 
15°C for 20 h, harvested, and lysed by sonication. Recombinant OatC was isolated by 
immobilized metal affinity chromatography (IMAC) using a 5 ml HisTrapHP column (GE 
Healthcare) equilibrated with binding buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl, and 
20 mM imidazole). After washing with 20 ml of binding buffer, proteins were eluted with a 
25 ml linear imidazole gradient (20–500 mM imidazole in binding buffer). Enzyme-containing 
fractions were pooled and desalted on a HiPrepTM26/10 Desalting column (GE Healthcare) 
equilibrated with 50 mM Tris-HCl pH 7.5 and 100 mM NaCl to remove imidazole. Thereafter 
protein containing fractions were pooled and loaded onto a HiLoadTM 16/60 SuperdexTM 200 
preparative size-exclusion chromatography column (GE Healthcare) equilibrated with 50 mM 
Tris-HCl pH 7.5 and 100 mM NaCl at 4°C. OatC-containing fractions were pooled, 
concentrated to 8.4 mg/ml by ultra filtration (Amicon Ultra-15 ultracel-30k, Millipore), 
aliquoted and subsequently flash-frozen in liquid nitrogen.  
Expression and purification of truncated OatC-variants as well as single alanine substitutions 
were performed as described previously (Bergfeld et al., 2009). 
 
5.2.4 Purification of untagged OatC 
Transformed E. coli BL21 gold (DE3) cells were cultivated at 37°C in 500 ml of Power Broth 
(AthenaES) containing 200 µg/ml carbenicillin. At OD600 = 1.5, expression was induced by 
adding 0.1 mM isopropyl-β-D-thiogalactopyranoside. Thereafter, bacteria were grown at 
15°C for 20 h, harvested, and lysed by sonication. Recombinant OatC-CRV-His was isolated 
by immobilized metal affinity chromatography (IMAC) using a 5 ml HisTrapHP column (GE 
Healthcare) equilibrated with binding buffer (50 mM TrisHCl pH 7.5, 300 mM NaCl, and 
20 mM imidazole). After washing with 20 ml of binding buffer, proteins were eluted with a 
30 ml linear imidazole gradient (20–500 mM imidazole in binding buffer). Enzyme-containing 
fractions were pooled and desalted on a HiPrepTM26/10 Desalting column (GE Healthcare) 
equilibrated with 10 mM Tris-HCl pH 7.5 and 150 mM NaCl to remove imidazole. Thereafter 
protein containing fractions were pooled and supplemented with 10 U of (His)6-tagged HRV-
3C-protease (Novagen), whereupon the concentration of the TrisHCl buffer was increased to 
50 mM and the concentration of NaCl was kept at 150 mM. The protease cleavage was 
performed over night at 4°C. Afterwards, the reaction mixture was run through a 1 ml 
HisTrapHP column (GE Healthcare) equilibrated with binding buffer (50 mM Tris-HCl pH 7.5, 
300 mM NaCl, and 20 mM imidazole) to remove the (His)6-tagged protease and residual 
uncleaved OatC-CRV-His. The flow-through which contained the cleaved untagged OatC 
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was subsequently loaded onto a HiLoadTM 16/60 SuperdexTM 200 size-exclusion 
chromatography column (GE Healthcare) equilibrated with 10 mM TrisHCl pH 7.5 and 
150 mM NaCl at 4°C. OatC-containing fractions were pooled, concentrated to 9.5 mg/ml by 
ultra filtration (Amicon Ultra-15 ultracel-30k, Millipore), supplemented with 4 mM DTT, 
aliquoted and subsequently flash-frozen in liquid nitrogen. 
 
5.2.5 SDS-PAGE, staining, and immunoblotting  
SDS-PAGE was performed under reducing conditions using 2.5% (v/v) β-mercaptoethanol. 
Coomassie staining, and Western blot analysis with anti-penta-His antibody (Qiagen) were 
performed as described previously (Bergfeld et al., 2007). 
 
5.2.6 Analytical size-exclusion chromatography 
The quaternary structure of OatC variants was determined on a Superdex 200 HR 10/30 
column. The column was equilibrated with 50 mM TrisHCl pH 7.5 and 100 mM NaCl and 
calibrated with the following molecular mass standards (Sigma): thyroglobulin (669 kDa), β-
amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), 
carbonic anhydrase (29 kDa), and cytochrome c (12.4 kDa). Eluted proteins were monitored 
by absorbance at 280 nm. 
 
5.2.7 Spectrophotometric activity assay 
Enzymatic activity of isolated OatC variants was determined in a spectrophotometric activity 
assay as described previously (Bergfeld et al., 2009). The reaction was performed at 25 °C in 
a total volume of 100 µl containing 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 20% (w/v) glycerol, 
2 mM 5,5’-dithiobis(2-nitrobenzoic acid), 200 ng/ml purified NmC-CPS, and 1 mM acetyl-
CoA. The reaction was initiated by adding 1.7 pmol of purified enzyme and monitored 
continuously at 405 nm in half-area 96-well plates (Greiner) using a PowerWave 340 
microtiter plate spectrophotometer (BioTek). 
 
5.2.8 Initial crystal screening  
Initial screenings for OatC-crystals were performed at Europe’s largest high-throughput 
crystallization facility at the EMBL Hamburg Outstation (Mueller-Dieckmann, 2006) using the 
Cryo I & II sparse matrix and Wizard I & II sparse matrix crystallization screens (Emerald 
BioSystems) as well as Crystal ScreenTM & Crystal Screen 2TM, Grid ScreenTM PEG 6000 & 
Grid ScreenTM Ammonium Sulfate, IndexTM, and SaltRX HTTM (Hampton Research Corp.). In 
addition the crystallization screens The JCSG+ Suite (Qiagen) as well as JBScreen Classic 
1-4 & JBScreen Classic 5-8 (Jena Bioscience) were used. The crystallization conditions were 
assessed as 400 nL sitting drops (200 nL enzyme sample + 200 nL stock solution) in Greiner 
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Low profile crystallization plates. The plates were set up and stored at 19°C and automatic 
imaging of each condition was performed over a period of 6 month. The resulting 16 picture 
sets of each condition taken after 0, 0.5, 1, 3, 6, 10, 13, 17, 24, 38, 52, 59, 81, 109, 137 and 
165 days, respectively, were accessible for downloading via the internet (http://icarus.embl-
hamburg.de:2000). 
 
5.2.9 Refinement of initial hits 
All crystallization experiments which were performed in house to reproduce and optimize the 
initial hit conditions identified by the initial crystal screening described above, were carried 
out in 24-well Cryschem plates (Hampton Research) using the sitting drop vapor-diffusion 
technique. A reservoir volume of 500 µl was provided before 1 µl OatC-containing sample 
(8.4 mg/ml of (His)6-tagged OatC and 9.5 mg/ml of untagged OatC, respectively) was mixed 
with 1 µl of the respective buffer reservoir. Screens stored at 20°C were set up at room 
temperature whereas screens stored at 4°C were prepared on ice using pre-cooled buffer 
solutions.  
 
5.2.10 X-ray diffraction analyses  
X-ray diffraction analyses were performed at the Department of Molecular Structural Biology, 
headed by Prof. Dr. R. Ficner, at the Georg-August-Universität Göttingen. Crystals suitable in 
size for X-ray diffraction measurements were flash-frozen in nylon-fiber loops at 100 K after 
cryo-protection. Initial X-ray diffraction analyses were carried out at the Department of 
Molecular Structural Biology. Promising crystals were kept in liquid nitrogen and reanalyzed 
using the beamline 23.2 (microfocus beamline) at the European Synchrotron Radiation 
Facility (ESRF, Grenoble, France).  
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5.3 Results 
 
5.3.1 Purification of OatC 
The purification of active recombinant OatC with a C-terminal hexahistidine tag has been 
described previously (Bergfeld et al., 2009; see chapter 4). However, since crystallization 
trials require large amounts of chemically and structurally homogenous protein, the original 
purification procedure was scaled-up to obtain higher yields. OatC with a C-terminal (His)6-
tag was expressed in E. coli BL21(DE3) and isolated by immobilized metal affinity 
chromatography (IMAC) using a Ni2+-chelating column. The OatC-containing fractions were 
pooled and further purified by preparative size-exclusion chromatography. Fractions of the 
major peak were pooled (Fig. 5-1 A) and concentrated by ultra-filtration to a final 
concentration of 8.4 mg/ml. This 2-step purification protocol resulted in a total yield of 
82.4 mg OatC from 4 L of expression culture. Analysis of the isolated enzyme by SDS-PAGE 
and Coomassie staining revealed a major band consistent with the calculated molecular 
mass of 54.3 kDa and the identity of this band was confirmed by Western blot analysis using 
an anti-His antibody (Fig. 5-1 B). Additional bands that were still visible in the protein fraction 
obtained by IMAC were almost completely removed by subsequent size-exclusion 
chromatography (compare lanes 1 and 3 in Fig. 5-1 B), leading to an OatC preparation that 
contained only trace amounts of impurities.  
 
 
Figure 5-1: Purification of OatC for crystallization. (A), Elution profile of OatC separated by size-exclusion 
chromatography. OatC carrying a C-terminal (His)6-tag was expressed in E. coli BL21(DE3). After a first isolation 
step by IMAC, OatC-containing fractions were pooled and subsequently loaded onto a HiLoadTM 16/60 
SuperdexTM 200 column. Enzyme containing peak fractions (indicated by dotted lines) were pooled and 
concentrated by ultra filtration to 8.4 mg/ml. (B), Isolated OatC was analyzed by 10% SDS-PAGE followed by 
Coomassie staining (lanes 1 and 3) or Western blot analysis with anti-His antibody (lanes 2 and 4). Shown are the 
pooled OatC-containing fractions after IMAC (lanes 1 and 2) and the pooled peak fractions of the size-exclusion 
chromatography after concentration to 8.4 mg/ml (lanes 3 and 4).  
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5.3.2 Crystallization of (His)6-tagged OatC 
Crystallization is an empirical process in which hundreds of solutions are scrutinized for their 
ability to convert soluble biological macromolecules into well ordered crystals that diffract X-
rays to high resolution. The initial screening for suitable conditions that allow crystallization of 
OatC was done in an automated process at Europe’s largest high-throughput crystallization 
facility at the EMBL Hamburg Outstation (Mueller-Dieckmann, 2006). The crystallization 
robot requires only 200 nL of sample volume per condition, thereby facilitating the testing of a 
multitude of conditions with relatively low amounts of protein. For initial crystallization trials of 
recombinant (His)6-tagged OatC, 864 conditions were tested at 19°C. Over a period of 
6 month, 16 sets of pictures were automatically taken from all conditions, monitoring the 
development of each condition over time. Most of the conditions tested for OatC led to the 
formation of precipitate or pre-crystalline compounds, and a total of 21 conditions resulted in 
needle-shaped crystals. Growth of these crystals started within 6 days and no additional 
positive conditions were identified within the observed timeframe of 6 month. The majority of 
crystals were obtained in the presence of polyethylene glycol (PEG) of different molecular 
masses (Fig. 5-2 A). Five initial hit conditions were based on ethanol (Fig. 5-2 B), one 
contained 2-propanol (Fig. 5-2 C), and one was based on the macromolecular reagent 
Jeffamine ED-2001® (O,O-Bis(2-aminopropyl)-polypropylene-glycol-block polyethylene-
glycol-block poly-propylene-glycol 1,900) (Fig. 5-2 D). 
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Figure 5-2: Initial hit conditions for the crystallization of (His)6-tagged OatC. Purified OatC with a 
concentration of 8.4 mg/ml was used for initial crystallization trials performed at 19°C. Crystal conditions were 
assessed at the high-throughput crystallization facility at the EMBL Hamburg Outstation as 400 nL sitting drops 
(200 nL OatC + 200 nL stock solution) in Greiner Low profile crystallization plates. A total of 864 conditions was 
screened for crystal growth and pictures taken at day 6 are shown for the 21 conditions that contained clearly 
visible crystals. Compositions of the used stock solutions are displayed below each photo. (A) Crystals obtained 
with conditions based on different polyethylene glycols as precipitants; (B) Crystals obtained with ethanol as 
crystallant; (C) Crystals grown in the presence of 2-propanol, and (D) Crystals based on Jeffamine ED-2001® as 
precipitant. 
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5.3.3 Refinement of initial hit conditions 
To achieve crystal sizes sufficient for X-ray diffraction measurements, crystallization of OatC-
(His)6 was repeated in house using the sitting drop vapor-diffusion technique and a drop size 
of 2 µl (1 µl OatC and 1 µl stock solution). With the single exception of the condition based 
on 2-propanol as precipitant (Fig. 5-2 C), all initial hits from the HT-screen could be 
reproduced or at least closely related conditions were found that allowed crystallization of 
OatC. To optimize the morphology of the crystals, conditions were refined by step-wise 
variation of the concentration of the precipitants, iterative testing of different buffers and pH 
values, and by performing additive screens. However, despite intensive screening, all 
crystals obtained in ethanol-containing conditions appeared as very long and extremely thin 
needles which in most cases were found as clusters (Fig. 5-3).  
 
 
Figure 5-3: Optimization of OatC crystals based on ethanol as crystallant. Purified OatC with a concentration 
of 8.4 mg/ml was used for crystallization trials performed at 20°C. Crystal conditions were assessed in house as 
2 µL sitting drops (1 µL OatC + 1 µL stock solution) in 24-well Cryschem plates. Pictures were taken 48 hours 
after the setup. Compositions of the used stock solutions are displayed below each photo. 
 
For crystals obtained under conditions with Jeffamine ED-2001® as precipitant, the 
morphology was improved and crystal sizes sufficient for X-ray diffraction were obtained (Fig. 
5-4).  
 
 
Figure 5-4: Refinement of OatC crystals based on Jeffamine ED-2001® as crystallant. Purified OatC with a 
concentration of 8.4 mg/ml was used for crystallization trials performed at 20°C. Crystal conditions were assessed 
in house as 2 µL sitting drops (1 µL OatC + 1 µL stock solution) in 24-well Cryschem plates. Pictures were taken 
48 hours after the setup. Compositions of the used stock solutions are displayed below each photo. 
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Unfortunately, the subset of crystals grown with Jeffamine ED-2001® did not diffract X-rays. 
Although the crystals appeared uniform when viewed under the microscope, they are most 
likely not well ordered.  
Among the various PEG conditions tested, PEG 1,000 turned out to be most suitable to get 
single crystals of sufficient size for X-ray diffraction analyses. A subset of crystals obtained 
with PEG 1,000 as precipitant is shown in Figure 5-5.  
 
 
Figure 5-5: Optimization of OatC crystals based on PEG 1,000 as crystallant. Purified OatC with a 
concentration of 8.4 mg/ml was used for crystallization trials performed at 20°C. Crystal conditions were assessed 
in house as 2 µL sitting drops (1 µL OatC + 1 µL stock solution) in 24-well Cryschem plates. Pictures were taken 7 
days after the setup. Compositions of the used stock solutions are displayed below each photo. 
 
Various crystals grown in the presence of PEG 1,000 were analyzed and shown to diffract X-
rays. Despite intensive screening to optimize crystallization conditions of (His)6-tagged OatC 
with PEG 1,000 as precipitant, the obtained crystals diffracted X-rays only to a poor 
resolution of > 3.8 Å with 20% glycerol as cryoprotectant.  
 
5.3.4 Crystallization trials with (His)6-tagged OatC at 4°C 
One possible explanation for the formation of poorly ordered crystals might be that OatC is 
not stable over time under the used crystallization conditions at 20°C. In this case, increasing 
incorporation of deranged enzyme molecules into the crystals will prevent regular crystal 
packing (Cudney et al., 1994). To circumvent this problem, the crystallization temperature 
was shifted to 4°C and results are shown in Figure 5-6. At room temperature, OatC crystals 
appeared within 24 h, whereas growth rates were slightly decreased at 4°C and the first 
crystals were visible earliest at day 2.  
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Figure 5-6: Crystals of (His)6-tagged OatC grown at 4°C. Purified OatC with a concentration of 8.4 mg/ml was 
used for crystallization trials. Crystal conditions were assessed in house as 2 µL sitting drops (1 µL OatC + 1 µL 
stock solution) in 24-well Cryschem plates. Screens were set up on ice with pre-cooled reservoir solutions and 
subsequently stored at 4°C. Pictures were taken 9 days after the setup. Compositions of the used stock solutions 
are displayed below each photo. 
 
So far, only a few initial crystals obtained at 4°C were analyzed and for these crystals the 
resolution of the diffraction pattern reached only ~ 4.5 Å.  
 
5.3.5 Crystallization trials with (His)6-tagged OatC in the presence of the donor 
substrate acetyl-coenzyme A 
In the case of enzymes, the formation of co-crystals with substrates or substrate analogs is 
an alternative strategy to improve crystal packing (e.g. by changing the space group, 
stabilizing the enzyme, or inducing a particular conformation). Therefore, additional 
crystallization trials were set up for an OatC sample containing 8.4 mg/ml of enzyme and a 
100-fold molar excess of the donor substrate acetyl-CoA. Because crystallization conditions 
of enzyme-substrate complexes frequently differ from those found for the corresponding apo-
enzyme, a comprehensive initial screening was performed at the high-throughput 
crystallization facility at the EMBL Hamburg Outstation as described above for the apo-
enzyme. Among the 864 conditions tested, seven resulted in crystal growth (Fig. 5-7). Two of 
them resembled crystallization conditions that were already found for the apo-enzyme (Fig 
5-7 A). In addition, novel conditions were identified, such as small PEGs in combination with 
high pH-values of 9.5 (Fig. 5-7 B). Moreover, new conditions based either on PEG or 
propylene glycol as precipitants yielded crystals (Fig. 5-7 C) as well as a condition containing 
3 M ammonium sulfate (Fig. 5-7 D). The presence of substrate during crystallization does not 
necessarily results in the formation of co-crystals. However, the identification of 
crystallization conditions that differ considerably from those found for the apo-enzyme, 
suggests that at least some of these conditions resulted in crystallization of an enzyme-
substrate complex. 
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Figure 5-7: Initial hits of EMBL HT-screenings with (His)6-tagged OatC in the presence of a 100-fold molar 
excess of the donor substrate acetyl-CoA. Purified OatC with a concentration of 8.4 mg/ml was used for initial 
crystallization trials performed at 19°C. Crystal conditions were assessed at the high-throughput crystallization 
facility at the EMBL Hamburg Outstation as 400 nL sitting drops (200 nL OatC supplemented with a 100-fold 
molar excess of acetyl-CoA + 200 nL stock solution) in Greiner Low profile crystallization plates. A total of 864 
conditions was screened for crystal growth and pictures taken at day 6 are shown for the 7 conditions that 
contained clearly visible crystals. Compositions of the used stock solutions are displayed below each photo. (A), 
initial hits obtained with stock solutions that resemble the conditions that were identified for growth of OatC 
crystals in the absence of acetyl-CoA; (B) crystals based on small PEGs as crystallants were found in conditions 
containing CHES-buffer at pH 9.5; (C), crystals based on PEG 8,000 and propylene glycol as precipitants; and (D) 
crystals obtained in the presence of 3 M ammonium sulfate. 
 
5.3.6 Influences of N-terminal and C-terminal truncations on the structural integrity of 
OatC 
Poor crystal packing can also be due to flexible protein parts that contribute to micro-
heterogeneity. Thus, deleting or removing the flexible regions at the termini or within a 
protein may help to get diffraction-quality crystals (Dale et al., 2003). To analyze whether 
truncated OatC-variants are better suitable for crystallization, a set of N- and C-terminally 
truncated enzyme variants was generated and in a first step analyzed with regard to their 
oligomeric state and enzymatic activity. It has been shown previously, that the enzymatic 
activity of OatC containing the single amino acid substitution His456Ala was reduced to 
approximately 70% of the wild-type activity (Bergfeld et al., 2009). As histidine-456 is located 
within the very C-terminal part of OatC (Fig. 5-8 A), this finding indicated that the C-terminus 
might be critical for correct protein folding. To further investigate the influence of the C-
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terminal part in maintaining the overall structure of OatC, the enzyme was C-terminally 
truncated by two amino acids resulting in the variant OatC-∆C2 (Fig. 5-8 A). The truncated 
OatC-variant was purified to homogeneity as demonstrated by SDS-PAGE (Fig. 5-8 B) and 
the oligomerization state was determined by size-exclusion chromatography (Fig. 5-8 C). In 
accordance to wild-type OatC, also OatC-∆C2 was found as a dimer. Compared to wild-type 
OatC, the variant truncated by only two amino acids possessed slightly reduced enzymatic 
activity when analyzed in the spectrophotometric assay system (Fig. 5-8 D). OatC-variants 
that were C-terminally truncated by six or more amino acids were found inactive when 
analyzed in vivo (MD-thesis F. Spielmann, University of Würzburg, in preparation). 
 
Figure 5-8: Analyses of truncated OatC-variants. (A), Overview on the different amino acid sequences at the 
C-termini of wild-type OatC, the single alanine substitution OatC-H456A as well the C-terminally truncated 
enzyme variant OatC-∆C2. All variants comprise the amino acids leucine [L] and glutamine [E] as consequence of 
the translated XhoI cloning site (dark gray) as well the hexahistidine tag (light gray). (B) After expression in E. coli 
BL21(DE3) and affinity purification on Ni2+-chelating columns, OatC variants were analyzed by 10% SDS-PAGE 
followed by Coomassie staining (upper panel) and Western blotting using anti-His antibody for detection (lower 
panel). (C), The quaternary structure of purified OatC variants was analyzed by size-exclusion chromatography 
on a Superdex 200 column, equilibrated with molecular weight standards. The apparent molecular mass and the 
oligomeric state of each protein variant was calculated from the retention volume. (D), The enzymatic activities of 
wild-type and mutant forms were determined in a spectrophotometric assay using equimolar concentrations of 
each purified enzyme variant. Data represent means ± S.D. of three independent experiments, and the value 
obtained for wild-type OatC was set to 100%.  
 
Taken together, these findings strongly suggest an important role of the C-terminal part in 
proper folding of OatC and rule out any benefits from using C-terminally truncated OatC 
variants for crystallization. Concerning the N-terminal part of OatC, strong evidence has been 
provided, that the first 34 amino acids mediate dimerization of OatC (Bergfeld et al., 2009). In 
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addition to ∆N34-OatC described previously (see Chapter 4), another N-terminally truncated 
OatC-variant was generated which lacks only the first 17 amino acids (∆N17-OatC). Both N-
terminally truncated variants were purified to homogeneity as demonstrated by SDS-PAGE 
(Fig. 5-8 B) and were found as monomers when analyzed by size-exclusion chromatography 
(Fig. 5-8 C). Comparative analyses of the enzymatic activity revealed only 6% and 25% of 
the wild-type activity for ∆N17-OatC and ∆N34-OatC, respectively (Fig. 5-8 D). These results 
demonstrated that the N-terminus of OatC is crucial for both dimerization and enzymatic 
activity, thus indicating an important role for the structural integrity of OatC. In summary, 
neither N-terminal nor C-terminal truncations of OatC seem to be applicable to generate 
alternative enzyme variants for crystallization attempts.  
As both protein termini of OatC were found essential for the maintenance of the overall 
structure, the addition of artificial affinity tags to either end might be critical as well. OatC-
variants harboring an N-terminal Strep-tag II and a C-terminal hexahistidine tag exhibited an 
intermediate oligomerization state of 1.6 (data not shown), whereas OatC containing only a 
C-terminal hexahistidine tag was found as a dimer (2.0). The OatC-variant harboring the 
additional N-terminal Strep-tag II also possessed slightly reduced enzymatic activity and the 
expression level of soluble protein was lower compared to (His)6-tagged OatC (data not 
shown). Nevertheless, also the C-terminal hexahistidine tag might influence the structural 
integrity of OatC and moreover, artificial affinity-tags were frequently found to disturb 
crystallization (Chant et al., 2005; Bucher et al., 2002). Since purification of native OatC 
lacking convenient affinity-tags requires the establishment and optimization of a new 
purification procedure, an OatC-variant was generated which harbors a CRV-3C protease 
cleavage site between OatC and the C-terminal affinity tag (OatC-CRV-His). This allows 
removal of the hexa-histidine tag after affinity purification although six artificial amino acids, 
representing remnants of the protease cleavage site, will remain at the C-terminus (Fig. 
5-9 A). 
 
5.3.7 Purification of OatC after proteolytic cleavage of the C-terminal (His)6-tag 
The enzyme variant OatC-CRV-His was expressed in E. coli BL21 gold (DE3) and isolated 
by immobilized metal affinity chromatography (IMAC) using a Ni2+-chelating column. The 
OatC-containing fractions were pooled, desalted, and incubated with (His)6-tagged CRV-3C 
protease to cleave off the C-terminal affinity tag of OatC. After removal of protease and 
residual uncleaved OatC-CRV-His by IMAC, the obtained untagged OatC was further purified 
by size-exclusion chromatography and concentrated by ultra-filtration to a final concentration 
of 9.5 mg/ml. Using this purification scheme, a total amount of 28.5 mg protein was isolated 
from 2 L of expression culture. Analysis of OatC-CRV-His after IMAC by SDS-PAGE and 
Coomassie staining revealed a major band consistent with the calculated molecular mass of 
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54.0 kDa and the identity of this band was confirmed by Western blot analysis using anti-His 
antibody (Fig. 5-9 B). After protease cleavage, removal of protease, and size-exclusion 
chromatography, only minor impurities were detectable in the untagged OatC sample. 
 
Figure 5-9: Isolation of active untagged OatC for crystallization. (A), Overview of the C-terminal primary 
sequences of (His)6-tagged OatC, OatC-CRV-His and untagged OatC. A CRV-3C protease cleavage site is 
present in the variant OatC-CRV-His (dark gray). The first two artificially introduced amino acids (LE) are present 
in all constructs due to translation of an XhoI site used for cloning and are coincidentally part of the protease 
cleavage site. The hexahistidine tag is shown in light gray. Proteolytic cleavage of OatC-CRV-His results in the 
release of untagged OatC. Compared to native OatC, this untagged variant still comprises six additional amino 
acids at the C-terminus which represent remnants of the CRV-3C protease cleavage site. (B), OatC-CRV-His was 
expressed in E. coli gold BL21(DE3). The enzyme was isolated by IMAC on a Ni2+-chelating column followed by 
preparative size-exclusion chromatography on a HiLoadTM 16/60 SuperdexTM 200 column. Isolation of pure 
enzyme was confirmed by analysis on 10% SDS-PAGE followed by coomassie staining and the identity of the 
purified protein as well as the completeness of protease cleavage was verified by Western blotting with anti-His 
antibody. Shown are pooled OatC-containing fractions eluted form the IMAC column (lane 1 coomassie; lane 2 
Western blot) and pooled fractions after protease cleavage followed by size-exclusion chromatography and 
concentration to 9.5 mg/ml (lane 3 coomassie; lane 4 Western blot). (C), Elution profile of untagged OatC from a 
Superdex 200 analytical size-exclusion chromatography column. The oligomeric state of purified untagged OatC 
was analyzed to confirm the dimeric nature of the enzyme which was previously observed for (His)6-tagged OatC. 
Void-volume (V0) and elution positions of standard proteins are indicated by arrows. (D), enzymatic activity of 
purified untagged OatC in comparison to (His)6-tagged OatC was determined in a spectrophotometric assay using 
equimolar enzyme concentrations (data given as means ± S.D. of three independent experiments).  
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In the corresponding Western blot analysis with anti-His antibody, neither the OatC band nor 
any other bands were visible, demonstrating that the (His)6-tag was completely removed from 
OatC and that the untagged enzyme fraction does not contain detectable amounts of (His)6-
tagged CRV-3C protease (Fig. 5-9 B). The oligomerization state of untagged OatC was 
determined by size-exclusion chromatography and the enzyme was found as a dimer with an 
apparent molecular mass of 110.2 kDa (Fig. 5-9 C), which is consistent with the molecular 
mass of 108.0 kDa calculated for an OatC dimer. Enzymatic activity of untagged OatC 
versus (His)6-tagged OatC was determined in the spectrophotometric assay using equimolar 
amounts of enzymes. Untagged OatC revealed a significantly higher enzymatic activity 
compared to the (His)6-tagged variant (Fig. 5-9 D). This finding indicates that the C-terminal 
affinity tag used so far, affects OatC activity and might therefore also impact the overall 
folding of the enzyme. Consequently, untagged OatC is most likely more suitable for further 
crystallization trials. 
 
5.3.8 Crystallization trials with untagged OatC 
Initially, a broad crystal screening of isolated untagged OatC was accomplished that covered 
all positive crystallization conditions which were previously identified for (His)6-tagged OatC. 
Nonetheless, not a single crystal was obtained, indicating that untagged OatC requires 
different crystallization conditions. Therefore, untagged OatC was again screened at the 
high-throughput crystallization facility at the EMBL Hamburg Outstation, as described above 
for the (His)6-tagged enzyme. Among the 864 conditions tested, most of the conditions tested 
for untagged OatC led to the formation of precipitate or pre-crystalline compounds, and a 
total of 11 conditions resulted in crystals. Growth of these crystals started within 6 days and 
no additional positive conditions were identified within the observed timeframe of 6 month. 
Remarkably, comparable to the (His)6-tagged enzyme, most crystals of untagged OatC were 
also based on PEGs as crystallants, whereupon the pH-value was found significantly lower in 
starter conditions of untagged OatC (Fig. 5-2 A and 5-10 A). Crystals of untagged OatC were 
also obtained in two conditions containing ethanol as precipitant, but in contrast to (His)6-
tagged OatC, these conditions also comprised sodium acetate (Fig. 5-2 B and 5-10 B). 
Furthermore, one condition containing crystals of untagged OatC was identified which was 
based on the macromolecular reagent pentaerythritol ethoxylate (15/4 EO/OH) and 
ammonium sulfate as crystallants (Fig. 5-10 C).  
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Figure 5-10: Initial hits of HT-screenings with untagged OatC. Purified untagged OatC with a concentration of 
9.5 mg/ml was used for initial crystallization trials performed at 19°C. Crystal conditions were assessed at the 
high-throughput crystallization facility at the EMBL Hamburg Outstation as 400 nL sitting drops (200 nL untagged 
OatC + 200 nL stock solution) in Greiner Low profile crystallization plates. A total of 864 conditions was screened 
for crystal growth and pictures taken at day 6 are shown for the 11 conditions that contained clearly visible 
crystals. Compositions of the used stock solutions are displayed below each photo. (A) 8 positive conditions 
based on polyethylene glycols as precipitants; (B) 2 positive conditions obtained with ethanol as crystallant and 
(C) crystals based on ammonium sulfate and pentaerythritol ethoxylate (15/4 EO/OH) as precipitants. 
 
5.3.9 Refinement of initial hit conditions of untagged OatC 
Based on the results from the HT-screening, broader screenings were performed in house to 
analyze the reproducibility of the initial crystallization conditions. Whereas crystal growth 
obtained in the presence of ethanol (Fig 5-10 B) was not reproducible in first trials, the 
presence of different PEGs and the combination of pentaerythritol ethoxylate (15/4 EO/OH) 
and ammonium sulfate as crystallants yielded crystals that were in several cases already of 
sufficient size for initial X-ray diffraction measurements (Fig. 5-11). 
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Figure 5-11: Initial refinement of crystallization conditions for untagged OatC. Purified untagged OatC with 
a concentration of 9.5 mg/ml was used for crystallization trials performed at 20°C. Crystal conditions were 
assessed in house as 2 µL sitting drops (1 µL OatC + 1 µL stock solution) in 24-well Cryschem plates. Pictures 
were taken 2 days after the setup. Compositions of the used stock solutions are displayed below each photo. 
 
Although the conditions were not yet refined (e.g. by step-wise varying the concentration of 
the precipitants, iteratively testing of different buffers at various pH values, by performing 
additive screens and by refinement of the cryoprotectant condition), the few crystals 
analyzed so far diffracted already down to a resolution of approximately 4 Å. Additional 
optimization steps are currently in progress to further improve the quality of crystals of 
untagged OatC. 
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5.4 - Discussion 
In the present study, protein crystals of the polysialic acid-specific O-acetyltransferase OatC 
were obtained. For the apo-enzyme with a C-terminal hexa-histidine tag, PEG 1,000 based 
conditions yielded crystals that diffracted X-rays to a resolution of approximately 3.8 Å. 
Several approaches to achieve well diffracting OatC crystals were investigated and initial 
results and further steps towards structure determination of OatC will be discussed.   
Since diffracting OatC crystals have been obtained, further attempts to improve the 
diffraction-quality of these crystals will include the screening for optimal cryo-protection 
conditions as only a small subset of conditions was tested so far (data not shown). Moreover, 
an extensive screen for additives that enhance the formation of well-ordered crystals might 
yield crystals of higher quality. Furthermore, the setup of crystallization experiments with 
freshly purified OatC could be advantageous as the enzyme variants used in the present 
study might have been slightly distorted as a result from the flash-freezing procedure 
followed by storage at -80°C and thawing. Although no significant difference between freshly 
purified OatC and the once frozen enzyme was detectable in the spectrophotometric activity 
assay or by SDS-PAGE analysis (data not shown). An alternative strategy to improve the 
quality of OatC crystals might be achieved by seeding procedures as some OatC crystals 
remained small or formed clusters (e.g. crystals based on ethanol as crystallant). The 
formation of clusters results from additional nucleation processes that occur on the crystal 
surface. Seeding is a powerful tool for the separation of nucleation and growth. In this 
technique, previously nucleated crystals are used as seeds and introduced into new drops 
equilibrated at lower levels of supersaturation, whereupon this crystal might grow to a size 
amenable for data collection (Caylor et al., 1999; Bergfors, 2003; Messick and Marmorstein, 
2004; Bergfors, 2007).  
An important finding of the present study was that the C-terminal hexa-histidine tag used for 
affinity-isolation of OatC impacts enzyme activity and therefore most likely affects the overall 
structure of the enzyme. Removal of the affinity-tag from an OatC variant that contained a 
proteolytic cleavage site in front of the (His)6-tag significantly increased the enzymatic activity  
compared to the (His)6-tagged enzyme. Moreover, (His)6-tagged and untagged OatC did not 
crystallize under the same conditions, indicating that the C-terminal (His)6-tag influenced 
crystal packing. These results implicate that untagged OatC is more suitable for further 
crystallization trials. Nonetheless, the C-terminus of untagged OatC used in the present 
study still contains remnants of the proteolytic cleavage site and it remains unknown whether 
C-terminal addition of this LEVLFQ hexapeptide affects the structural integrity of OatC. 
Therefore, crystallization of native OatC might provide an alternative strategy to yield high-
quality crystals of OatC but so far, no purification protocols have been established for the 
isolation of OatC lacking an affinity tag.  
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For decades, crystallographers have made use of the fact that fragments or domains of 
proteins either crystallize better, or form more well-diffracting crystals, compared to the intact 
protein (Dong et al., 2007). This most likely originates from the loss of flexible protein regions 
which might interfere with the assembly of regular crystals (McPherson et al., 1995; Chayen 
and Saridakis, 2008). Protein fragments lacking flexible parts can be obtained either by 
protease treatment, by identification of domain boundaries on the basis of sequence 
alignments followed by recombinant expression of the corresponding protein fragment or by 
screening a large set of recombinant proteins differing slightly in their N- and C-terminal 
ends. In the present study, N- and C-terminally truncated OatC variants were generated and 
the purified enzymes were analyzed with regard to enzymatic activity and oligomerization 
state. However, already short truncations of either end of the protein impacted the 
maintenance of the overall structure as indicated by a severe drop in enzymatic activity 
and/or shift in the oligomeric state from dimer to monomer. Consequently, none of the 
truncated OatC variants were suitable for crystallization trials. 
Recently, in situ proteolysis was successfully applied for crystallization of several proteins 
that otherwise yielded either no or only poorly diffracting crystals (Dong et al., 2001; Mandel 
et al., 2006; Dong et al., 2007; Xiang et al., 2007). In this method, trace amounts of 
proteases (such as trypsin or chymotrypsin) are added to the crystallization condition, which 
results in the removal of flexible loops and/or unstructured N- or C-terminal extensions. A 
comprehensive approach to evaluate in situ proteolysis resulted in crystal growth for 9 out of 
20 tested proteins that never crystallized before and the quality of crystals from 6 out of 35 
proteins was sufficiently enhanced to solve their 3D-structures (Dong et al., 2007). If flexible 
internal loops hamper the growth of high quality OatC crystals, in situ proteolysis might be 
the method of choice to discard these loops without affecting the overall protein structure and 
to improve crystal packing.  
For many enzymes, binding of substrates induces conformational changes which can involve 
the fixation of otherwise flexible loop regions. Thus, the formation of co-crystals of OatC and 
substrates or substrate analogs provides an alternative strategy to get well-ordered crystals. 
In the present study, initial co-crystallization trials of OatC with the donor substrate acetyl-
CoA were performed. Notably, several of the identified crystallization conditions differed 
considerably from those found for the apo-enzyme, increasing the possibility that crystals 
from these conditions are of better quality. Several acetyltransferases of different protein 
families have already been successfully co-crystallized with acetyl-CoA (Modis and 
Wierenga, 2000; Peneff et al., 2001; Yan et al., 2002; Wang et al., 2002; Sugantino and 
Roderick, 2002; Kursula et al., 2002; Kehoe et al., 2003; Han et al., 2006; Hung et al., 2006; 
Schuetz et al., 2007; Vetting et al., 2008). In the case of OatC, addition of acetyl-CoA results 
in the formation of a covalent acetyl-enzyme intermediate that involves the active site serine 
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residue and thus indicates a double-displacement mechanism (Bergfeld et al., 2009). The 
kinetics as well as the stability of this acetyl-enzyme intermediate are unknown and co-
crystallization conditions may lead to mixture of acetylated and non-acetylated forms of OatC 
and thereby to unfavorable protein heterogeneity. Nevertheless, structures of acetyl-enzyme 
intermediates of related α/β-hydrolase fold enzymes have already been described (Modis 
and Wierenga, 2000; Kursula et al., 2002). To increase the homogeneity of the OatC sample, 
further experiments on growing co-crystals with acetyl-CoA are also planned with the 
enzyme variant OatC-S286A. As described previously, the single alanine substitution OatC-
S286A lacks the acceptor hydroxyl group of the active site serine and was therefore 
incapable to form the acetyl-enzyme intermediate (Bergfeld et al., 2009). Moreover, the 
reaction product CoA and the corresponding derivative desulpho-CoA are considered as 
candidates for additional co-crystallization approaches using wild-type OatC.  
As shown in Chapter 4, OatC catalyzes exclusively O-acetylation of α2,9-linked polysialic 
acid and does not act on α2,8-linked polysialic acid, sialic acid containing heteropolymers or 
monomeric sialic acid. To address the question how OatC gains its high acceptor substrate 
specificity towards α2,9-linked polysialic acid and to investigate the underlying protein-
carbohydrate interactions, co-crystallization of OatC with the acceptor polysaccharide is one 
of the future goals. However, the capsular polysaccharide of N. meningitidis serogroup C 
(NmC-CPS) is a natural product with a high degree of polymerization with up to 200 sialic 
acid residues and is therefore comparatively heterogeneous with respect to polymer size. So 
far, the endosialidase of bacteriophage K1F, which hydrolyses α2,8-linked polysialic acid, is 
the only polysialic acid binding protein that has been crystallized in the presence of acceptor 
substrate (Stummeyer et al. 2005). In this case, crystals were soaked with pentameric α2,8-
linked sialic acid. For α2,9-linked sialic acid, short oligomers of defined length are not 
commercially available and protocols for partial hydrolysis and purification have to be 
established. Thermal degradation of NmC-CPS in the presence of 100 mM trifluoric acid 
followed by separation on a MonoQ anion exchange column resulted in separation of 
oligomers with a degree of polymerization of 1 to 15 (data not shown). This material will be 
sufficient to determine the minimal acceptor size required by OatC. However, to obtain high 
amounts of oligomers of homogenous size as required for co-crystallization trials, the 
procedure needs further optimization and up-scaling. 
Determining the 3D-structures of proteins by X-ray crystallography involves a series of steps: 
cloning, recombinant expression, isolation of pure enzyme in high yields, crystallization, 
collection of diffraction data, and determination of atomic positions. During this process, the 
production of high-quality single crystals remains a major bottleneck (Chayen and Saridakis, 
2008). In the present study the first crystallization of a sialate O-acetyltransferase was 
achieved. Intensive refinement of initial crystallization conditions led to reproducible OatC 
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crystals that diffracted X-rays already down to approximately 3.8 Å. Several strategies were 
pointed out which are currently accomplished to further improve the quality of OatC crystals 
and preliminary results were presented. The promising outcome of the actual study is now 
forming the basis for further optimization trials that will hopefully result in the determination of 
the first 3D crystal structure of a sialate O-acetyltransferase.  
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Chapter 6 - General Discussion 
 
Surface sialic acids are a common component and virulence factor of a variety of pathogenic 
bacteria (Vimr and Lichtensteiger, 2002). In many cases, modification by O-acetylation has 
been observed and might play an important role in immunogenicity and survival in the host 
organism (Bhattacharjee et al., 1976; Ørskov et al., 1979; Gamian et al., 1992; Lemercinier 
and Jones, 1996; Lewis et al., 2004; Feng et al., 2005; Houliston et al., 2006). The present 
study describes the first purification and biochemical characterization of NeuO and OatC, the 
polySia-specific capsule O-acetyltransferases of E. coli K1 and N. meningitidis serogroup C 
(NmC), respectively. Both enzymes proved highly specific for their endogenous acceptor 
substrates, α2,8- and α2,9-linked sialic acid, respectively. Free Neu5Ac or CMP-Neu5Ac was 
not modified and a minimal substrate length of >14 residues was found for NeuO. This 
indicates that in vivo, O-acetylation of the polySia capsules of NmC and E. coli K1 occurs 
exclusively at the polymer level. Despite the functional similarity between NeuO and OatC, 
the data presented in this study point out that the two enzymes evolved independently and 
belong to structurally diverse protein families (see Figure 6-1). 
 
Figure 6-1: The sialate O-acetyltransferases NeuO and OatC belong to structurally diverse protein 
families. A, the predicted three-dimensional structure of NeuO was obtained by using the program 3D-PSSM 
(Kelley et al., 2000) with the structure of the maltose O-Acetyltransferase (MAT) of E. coli (PDB accession 
number 1ocx) as a template. The NeuO monomer (purple) was modeled into the trimer of MAT (gray). B, side 
view on the three-dimensional model of a NeuO monomer. The model highlights the presence of a left-handed β-
helix fold for NeuO with one protruding loop carrying a catalytic histidine and a conserved tryptophan is located at 
the opposite site of the β-helix. The position of the two active site residues His-119 and Trp-143 of NeuO are 
indicated by arrows. All structural data were visualized by PyMOL. C, Predicted topology of OatC based on 
secondary structure prediction (Combet et al., 2000). For amino acids 259-422 the typical topology of a 
‘canonical’ α/β-hydrolase fold could be assigned. The position of the catalytic residues Ser-286, Asp-376 and His-
399 (purple) after β-strands 5, 7 and 8, respectively, also matched the commonly found localization of a catalytic 
triad which is the hallmark of α/β-hydrolase fold enzymes.  
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6.1. The sialate O-acetyltransferase NeuO is a member of the left-handed 
β-helix family of acyltransferases 
In the first part of this work, the prophage encoded O-acetyltransferase NeuO, which is 
essential for O-acetylation of the capsular polysaccharide of E. coli K1 was purified to 
homogeneity using a C-terminal hexahistidine tag. Previous attempts to isolate endogenous 
NeuO required detergent extraction and resulted in only partially purified enzyme as all 
further isolation steps abolished activity (Higa and Varki, 1988). By contrast, recombinant 
NeuO was obtained from the soluble protein fraction, and the isolated enzyme was 
enzymatically active as demonstrated in a spectrophotometric assay and by transfer of 
radioactively labeled acetyl groups from acetyl-CoA to α2,8-linked polySia. A possible 
explanation for the different outcome during purification of endogenous and recombinant 
NeuO is that, in vivo, the O-acetyltransferase might be associated with the polySia 
biosynthesis and export machinery (Vimr and Steenbergen, 2006). In this case, detergent 
might be required to dissociate NeuO from the membrane-bound protein complex, a step that 
can be omitted if NeuO is expressed in an E. coli strain lacking the K1 capsule gene 
complex.  
Using homology modeling followed by mutational analysis, NeuO was characterized as a 
typical member of the superfamily of hexapeptide acyltransferases. Enzymes of this family 
use phosphopantothenyl-based cofactors to transfer acetyl, succinyl, or long chain fatty acyl 
groups to free hydroxyl or amino groups of a variety of acceptor substrates. The unique 
feature of this protein family is the presence of tandem-repeated imperfect copies of a 
hexapeptide repeat sequence with the consensus motif [LIV]-[GAED]-X2-[STAV]-X (Vaara, 
1992; Jenkins and Pickersgill, 2001). Several members of the family have been crystallized, 
and the solved crystal structures revealed that this characteristic hexapeptide repeat 
sequence encodes folding of a left-handed parallel β-helix domain (Raetz and Roderick, 
1995; Beaman et al., 1997; Beaman et al., 1998; Brown et al., 1999; Olsen and Roderick, 
2001; Sulzenbacher et al., 2001; Sugantino and Roderick, 2002; Wang et al., 2002; Lo et al., 
2003). In all known cases, hexapeptide acyltransferases assemble into catalytic trimers with 
three symmetrical active sites, which are located at the interfaces of two subunits formed by 
a loop protruding out of one LβH-domain embracing the LβH-domain of the adjacent 
monomer. Based on the structural characteristics, the hexapeptide repeat family is also 
called LβH family and includes not only acyltransferases but also a zinc-dependent γ-
carbonic anhydrase (Kisker et al., 1996). 
The homology modeling performed in the present study indicated close structural similarity of 
NeuO to the maltose and galactoside O-acetyltransferases (GAT and MAT, respectively) of 
E. coli (Lo et al., 2003; Wang et al., 2002; see Figure 6-1). Similar to MAT and GAT, the 
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predicted 3D-model of NeuO was found to contain a short LβH domain with five and one-
third triangular coils and one protruding loop. To amino acids, which are critical for activity of 
MAT and GAT, were found in equivalent positions in the NeuO model: His-119 located in the 
protruding loop and Trp-143 located within a β-sheet of the LβH domain (see Figure 6-1). 
Subsequent alanine substitutions completely abolished NeuO activity in vitro and in vivo, 
indicating important roles in catalysis. All crystallized acyltransferases of the LβH family 
possess a catalytic histidine located in a loop embracing the neighboring subunit. The 
predicted role of this residue is to abstract a proton from the acceptor hydroxyl group, 
facilitating the attack of the resulting carbonyl by the acyl-donor (Lewendon et al., 1995; 
Dunn et al., 1996). The second critical amino acid identified in the model of NeuO, Trp-143, 
is conserved only in a subset of acetyltransferases, including MAT, GAT, xenobiotic 
acetyltransferases, and the Rhizobium leguminosarum nodulation factor NodL (Lewendon et 
al., 1995; Dunn et al., 1996; Beaman et al., 1998; Lo et al., 2003). In GAT, replacement of 
the corresponding Trp-139 by phenylalanine abolished the intrinsic fluorescence quench 
observed on acetyl-CoA binding (Lewendon et al., 1995), and the crystal structure of the 
binary complex of GAT with acetyl-CoA revealed a direct contact between the indole side 
chain of Trp-139 and the phosphopantothenyl arm of the cofactor (Wang et al., 2002). In 
addition to donor binding, Trp-139 may serve to position the catalytic histidine relative to the 
hydroxyl group of the acceptor and alter its pKa (Wang et al., 2002). In line with this dual role 
in donor binding and positioning of the catalytic histidine, a complete loss of NeuO activity 
was observed in vitro and in vivo when Trp-143 was substituted by alanine. Taken together, 
these results provide convincing evidence that NeuO consists primarily of an LβH fold with 
His-119 and Trp-143 as part of the active site. 
Size-exclusion chromatography of recombinant NeuO demonstrated that the enzyme 
assembles into hexamers. So far, the only example of an LβH-acyltransferase with a 
quaternary structure other than trimeric is the serine O-acetyltransferase (SAT) (Johnson et 
al., 2005). Similar to NeuO, SAT of E. coli and H. influenzae adopts a hexameric structure, 
and the solved crystal structures revealed that two SAT trimers assemble into hexamers with 
the dimer of trimers interface formed by N-terminal α-helices (Pye et al., 2004, Olsen et al., 
2004). The observation that a Strep tag II placed at the N-terminus of NeuO was not 
accessible for purification might indicate that, also in NeuO, the N-terminal domain is 
involved in dimerization of NeuO trimers.  
In addition to neuO, four sialate O-acetyltransferase genes have been cloned so far: (i) oatC 
responsible for O-acetylation of the α2,9-linked polySia capsule of N. meningitidis serogroup 
C (Claus et al., 2004); (ii) oatWY, involved in O-acetylation of sialic acids within the galactose 
and glucose containing heteropolymeric polySia capsules of serogroup W-135 and Y 
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meningococci, respectively (Claus et al., 2004); (iii) neuD of group B streptococci required for 
O-acetylation of terminal α2,3-linked sialic acids capping the group B streptococci capsule 
(Lewis et al., 2006); and (iv) neuD of Campylobacter jejuni, which was shown to O-acetylate 
terminal α2,8-linked sialic acids of the bacterial lipo-oligosaccharide (Houliston et al., 2006). 
With the single exception of OatC, all other sialate O-acetyltransferases were found to 
contain hexapeptide repeat sequences, indicating that they are all members of the LβH 
family. However, NeuD proteins might form a separate branch within the family, because 
amino acid sequence alignments revealed the lack of a potential catalytic histidine, which 
might be substituted by a lysine residue (Claus et al., 2004).  
Although NeuO shares the typical features of the LβH family, the present study revealed a 
unique regulatory mechanism based on changes in VNTR-encoded N-terminal protein 
extensions. The neuO gene is characterized by the presence of a variable number of 
heptanucleotide repeats (VNTRs of the sequence 5’-AAGACTC-3’) within the 5’-end of the 
coding region (Deszo et al., 2005). Because only repeat numbers that are divisible by three 
allow full-length translation and thereby capsule O-acetylation, changes in the overall number 
of repeats provide a reversible switch between an O-acetylated on phase and a non O-
acetylated off phase. Oscillation between OAc+ and OAc- variants might permit adaptation to 
changes in environmental conditions. However, findings of the present study demonstrated 
that this is not a simple “all-or-none” mechanism. The expression of neuO alleles containing 
0, 12, 24, and 36 heptanucleotide repeats showed that VNTRs are translated into stable N-
terminal protein extensions that affect enzymatic activity of the translation product. Every 
three heptanucleotide repeats encode an RLKTQDS heptad. Remarkably, the presence of 
RLKTQDS heptads was not essential for NeuO activity but the catalytic efficiency 
(kcat/Kmdonor) increased linearly with the number of heptads. These results suggest that the 
presence of heptad repeats results in gradual changes in enzyme conformation allowing an 
increase in enzyme-donor substrate affinity and facilitation of the reaction rate. 
The N-terminal heptad repeats of NeuO were previously suggested to assemble into a triple 
coiled-coil (Deszo et al., 2005). In the hexameric NeuO complex, variation in the length of 
such a coil might gradually change the subunit arrangement and, thereby, the conformation 
of the active sites formed at the subunit interfaces of each trimer. However, a solved crystal 
structure is required to unravel the definite arrangement of all six subunits of the NeuO 
complex and the influence of the number of N-terminal repeats on the overall structure of the 
enzyme.  
The influence of N-terminal protein extension on NeuO activity was also analyzed in vivo, 
although it has to be taken into account that direct analysis of NeuO activity is hampered due 
to the occurrence of phase variation. However, comparison of 10 different OAc+ K1 strains 
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indicated that the highest enzymatic activities were found in strains expressing neuO alleles 
with >21 heptanucleotide repeats (Deszo et al., 2005). Moreover, analysis of the capsular 
polysaccharide from four OAc+ K1 strains revealed that the degree of O-acetylation varied 
between 5 and 85 %, whereupon the lowest O-acetyl content and lowest activity were found 
in a strain without detectable phase variation (Ørskov et al., 1979; Higa and Varki, 1988). 
These studies indicate that modulation of NeuO activity impacts the degree of capsule O-
acetylation in vivo. In addition to allelic variation caused by VNTRs, sequencing of the neuO 
gene in 102 strains of a diverse E. coli K1 strain collection revealed the occurrence of five 
distinct allelic variants due to seven polymorphic sites. Translation of these five allelic 
variants results in three NeuO enzyme variants with altered amino acid sequences. However, 
kinetic characterization of the respective isolated NeuO variants performed in the present 
study, demonstrated that none of the amino acid exchanges significantly affected NeuO 
activity. 
 
6.2 The capsule O-acetyltransferase OatC belongs to the α/β hydrolase 
fold family 
In the second part of this thesis, structure-function relationships of the sialate O-
acetyltransferase OatC from Neisseria meningitis serogroup C (NmC) were investigated. 
Endogenous OatC was previously shown to transfer acetyl groups from acetyl-CoA to 
endogenous membrane-bound as well as to exogenous soluble capsular polysaccharide 
(CPS) of NmC by using serogroup C meningococcal spheroplast membranes as an enzyme 
source (Vann et al., 1978). However, reports on the isolation and further characterization of 
the enzyme were missing. For the first time, a successful expression and purification 
procedure for recombinant OatC was established that allowed a detailed biochemical 
characterization of the enzyme.  
In contrast to all other bacterial sialate O-acetyltransferases known so far, the primary 
sequence of OatC is devoid of hexapeptide repeats, indicating that the enzymes does not 
belong to the LβH family of acyltransferases. Moreover, BLAST search analyses did not 
reveal significant sequence similarities between OatC and any other protein (Claus et al., 
2004), impeding the identification of phylogenetic relationships. However, by combining 
bioinformatic approaches (motif scanning and secondary structure prediction), site-directed 
mutagenesis, and biochemical analyses, several features were identified in the present study 
that characterize OatC as a new member of the α/β-hydrolase fold family of proteins. The 
α/β-hydrolase fold is a versatile and widespread protein architecture that is not restricted to 
acyltransferases but is found in enzymes with diverse functions such as proteases, lipases, 
esterases, dehalogenases, haloperoxidases, lyases, and epoxide hydrolases (Argiriadi et al., 
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1999; Holmquist, 2000; Nandhagopal et al., 2001; Mirza et al., 2005; Polgar, 2005; Fujino et 
al., 2006; Kolkenbrock et al., 2006; Lee et al., 2006; Srivatsan, 2006). The members of this 
large superfamily usually lack significant sequence similarities but share a common fold that 
gave the family its name. Various solved crystal structures allowed a detailed insight into the 
architecture and common features of α/β-hydrolase fold enzymes (Brady et al., 1990; Pathak 
and Ollis, 1990; Sussman et al., 1991; Verschueren et al., 1993; Hecht et al., 1994; Lawson 
et al., 1994; Wagner et al., 1996; Silton et al., 1997; Medrano et al., 1998; Argiriadi et al., 
1999; Nandhagopal et al., 2001; Kashiwagi et al., 2002; Lo et al., 2003; Campobasso et al., 
2004; Mirza et al., 2005; Larsen et al., 2006 ; Byun et al., 2007; Wang et al., 2007). The 
canonical α/β-hydrolase fold is composed of an eight-stranded mainly parallel β-sheet, 
flanked on both sides by α-helices. The fold provides a stable scaffold for a highly conserved 
catalytic triad consisting of a nucleophile (serine, cysteine or aspartate) which is located at 
the tip of a sharp turn called the “nucleophile elbow”, an acidic residue (aspartate or 
glutamate) and a histidine (Nardini and Dijkstra, 1999; Heikinheimo et al., 1999; Holmquist 
2000). However, many variations from the ‘canonical’ fold have been observed mainly due to 
the absence of particular strands or helices and/or insertions that can range from a few 
amino acids to entire domains.  
For OatC, a comprehensive site-directed mutagenesis approach led to the identification of a 
catalytic triad, composed of Ser-286, Asp-376, and His-399, consistent with the conserved 
order of the catalytic triad residues (nucleophile-acid-histidine) found in α/β-hydrolase fold 
enzymes (see Figure 6-1). Moreover, Ser-286 was found to be located in a typical 
nucleophile elbow motif (GXS286XGG), indicating that, similar to other α/β-hydrolase fold 
proteins, the nucleophile is positioned in a tight turn to expose the hydroxyl group of Ser-286 
to nucleophilic attack of the incoming substrate. Furthermore, secondary structure prediction 
(Combet et al., 2000) suggested a pattern of β-strands and α-helices for OatC which 
matches that of the canonical α/β-hydrolase fold (Heikinheimo et al., 1999; Nardini and 
Dijkstra 1998; Ollis et al., 1992; Holmquist 2000; see Figure 6-1). In the proposed topology 
model, the identified catalytic triad residues are located after strands β5, β7, and β8 for Ser-
286, Asp-376, and His-399, respectively, which is consistent with the common positioning of 
the catalytic triad in α/β-hydrolase fold enzymes (see Figure 6-1). Moreover, OatC was found 
to assemble into dimers, which is in line with the oligomeric state found for a wide variety of 
α/β-hydrolase fold enzyme (Argiriadi et al., 1999; Born et al., 2000;  Campobasso et al., 
2004; Mirza et al., 2005; Wahab et al., 2006; Byun et al., 2007; Wang et al., 2007). 
Nonetheless, a three-dimensional structure is required to unequivocally confirm the presence 
of a particular fold. In the present study, first successful crystallization attempts were 
accomplished with OatC and crystals were obtained that diffracted X-rays already down to 
approximately 3.8 Å. 
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Almost all enzymes of the α/β-hydrolase fold family follow a double-displacement (ping-pong) 
kinetic mechanism involving a covalent substrate-enzyme intermediate (Dodson and 
Wlodawer, 1998; Holmquist 2000; Ishida and Kato, 2003; Campobasso et al., 2004; Nazi and 
Wright, 2005; Ishida, 2006; Lee et al., 2006; Wahab et al., 2006). In line with this, a stable 
acetyl-enzyme intermediate was observed for OatC that crucially depended on the presence 
of Ser-286. In addition, a CoA burst was observed in the absence of polySia (data not 
shown). This indicates that the first product, CoA, is released before binding of the second 
substrate, α2,9-linked polySia, occurs which confirms the presence of a ping-pong kinetic 
mechanism. Based on the biochemical data for wild-type OatC and mutant forms, the 
following catalytic mechanism was proposed (Chapter 4, Fig. 7): The formation of a salt 
bridge between the carboxyl group of Asp-376 and the imidazolium group of His-399 allows 
the N-ε2 of the imidazole ring to abstract a proton from Ser-286. Therewith, the 
nucleophilicity of the hydroxyl group of Ser-286 increases, facilitating the attack of the 
carbonyl carbon of the acetyl group of acetyl-CoA. The resulting first tetrahedral transition 
state subsequently collapses to a covalent acetyl-enzyme intermediate while free CoA is 
released. In the second half-reaction the proposed salt bridge between the carboxyl group of 
Asp-376 and the imidazolium group of His-399 allows the imidazole ring to abstract a proton 
from the C7 (or C8) hydroxyl group of a sialic acid residue within the acceptor NmC-CPS. 
This enables the hydroxyl group of the sialic acid residue to attack the carbonyl carbon of the 
acetyl-group in the acetyl-enzyme intermediate resulting in a second tetrahedral transition 
state. Subsequent decomposition of the transition state leads to release of the second 
reaction product, i.e. O-acetylated NmC-CPS, and thereby returns Ser-286 back to its 
protonated state which reinitializes OatC for a new catalytic cycle.  
It remains to be investigated whether or not OatC transfers acetyl groups on both, the C7 
and the C8 hydroxyl group. The presence of di-O-acetylated sialic acids (Neu5,7,8Ac3) in 
NmC-CPS was demonstrated by 13C NMR spectroscopy (Bhattacharjee et al., 1975), 
whereas no evidence for di-O-acetylated sialic acids was found in another study (Lemercinier 
and Jones, 1996). For NmC-CPS containing only mono-O-acetylated residues, non-
enzymatic migration of acetyl groups was observed. In freshly prepared CPS, O-acetylation 
was found predominantly at O8, whereas after storage at room temperature, the majority of 
acetyl groups were shifted to O7 (Lemercinier and Jones, 1996; Ho et al., 2001; Ravenscroft 
et al., 1999). Therefore, OatC might be selective for O8, and acetylation of O7 might occur 
exclusively by non-enzymatic migration. 
In line with the proposed critical roles of the catalytic triad residues of OatC, single alanine 
substitutions of Ser-286, Asp- 376, and His-399 completely abrogated OatC activity in vitro 
and in vivo. Replacement of either Ser-286 or His-399 by alanine abolished the ability of 
OatC to form a covalent acetyl-enzyme intermediate, which is consistent with the proposed 
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function of His-399 as the crucial general base catalyst and the role of Ser-286 as the 
acceptor site for the acetyl group. By contrast, single alanine substitution of Asp-376 resulted 
in an enzyme variant that was still able to produce limited amounts of acetyl-enzyme 
intermediate, indicating that Asp-376 is dispensable during the first half-reaction but 
essentially required for catalysis of the second half-reaction. In several α/β-hydrolase fold 
enzymes, alanine substitution of the catalytic acid was even compatible with considerably 
high levels of residual activity, indicating a less pronounced role of this catalytic triad residue 
(Wajant and Pfitzenmaier, 1996; Lee et al., 2006; Weadge and Clarke, 2007). Interestingly, 
replacement of the catalytic Ser-286 by the alternative nucleophile cysteine did not rescue 
enzymatic activity of OatC, demonstrating that the enzyme crucially depends on a properly 
positioned serine residue in the nucleophile elbow. So far, all characterized O-
acetyltransferases within the α/β-hydrolase fold family comprise a serine residue in the 
nucleophile elbow motif (Born et al., 2000; Mirza et al., 2005; Nazi and Wright, 2005; Wang 
et al., 2007), whereas several other α/β-hydrolase fold enzymes catalyzing different reactions 
accommodate a cysteine residue (Pathak and Ollis, 1990; Sfakianos et al., 2002; Amara and 
Rehm, 2003; Campobasso et al., 2004; Sandy et al., 2005; Wang et al., 2005). However, 
corresponding substitutions of the nucleophile (serine by cysteine and vice versa) was 
analyzed for various α/β-hydrolase fold enzymes resulting in a reduction or complete loss of 
enzymatic activity (Higaki et al., 1989; Leuveling et al., 1994; Witkowski et al., 1994; Li et al., 
1996; Sfakianos et al., 2002; Amara and Rehm, 2003; Nazi and Wright, 2005).  
The identification of a double-displacement (ping-pong) kinetic mechanism clearly 
distinguishes OatC from all other bacterial sialate O-acetyltransferases known so far which 
all belong to the hexapeptide repeat family. Compared with α/β-hydrolase fold enzymes, 
members of the hexapeptide repeat family act via sequential kinetic mechanisms (Wyckoff 
and Raetz, 1999; Hindson and Shaw, 2003; Olsen et al., 2004; Johnson et al., 2005). 
Although a highly conserved catalytic histidine residue is required in both protein families as 
a general base catalyst, this residue is not part of a catalytic triad in the hexapeptide repeat 
family.  
The detailed biochemical analysis of OatC performed in the present study revealed striking 
differences between OatC and all other known bacterial sialate O-acetyltransferases. 
Together these findings strongly indicate that the enzymatic function of sialate O-acetylation 
evolved independently on two distinct structural frameworks by convergent evolution. The 
specificity of NeuO and OatC for polySia might have emerged from two distinct ancestral 
enzymes belonging to the LβH and α/β-hydrolase fold family, respectively, that already used 
acetyl-CoA as donor substrate but transferred the acetyl group to different polysaccharide 
acceptors. In meningococci, O-acetylation of the capsular polysaccharide is not restricted to 
serogroups carrying sialic acid containing capsules. Among the clinically important 
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serogroups, also N. meningitidis serogroup A (NmA) is able to modify the capsular 
polysaccharide composed of repeating units of α1,6-linked N-acetyl-D-mannosamine-1-
phosphate by O-acetylation of the N-acetylmannosamine at position O3 and O4 (Liu et al., 
1971; Gudlavalleti et al., 2004). The mynC gene encoding the respective capsule O-
acetyltransferase is, like oatC, located downstream of the polysaccharide polymerase within 
the capsule gene complex (Swartley et al., 1998; Gudlavalleti et al., 2004). Although the two 
O-acetyltransferases MynC and OatC share no significant similarities on the primary 
sequence level, both enzymes posses a nucleophile elbow motif with the sequence 
GSSKGG and might share a common α/β-hydrolase fold. 
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6.3 Outlook 
The identification of a sialate O-acetyltransferase that belongs to the α/β-hydrolase fold 
family of enzymes might have direct implications on the identification of related enzymes in 
eukaryotes. Whereas the hexapeptide repeat family of acyltransferases is restricted to 
microorganisms, α/β-hydrolase fold enzymes are present in all kingdoms of life. Interestingly, 
the α/β-hydrolase fold is also used as the structural basis for viral sialic acid-specific 
acetylesterases, the receptor-destroying enzymes of influenza C and coronaviruses that use 
O-acetylated sialic acids as host receptor structures (Rosenthal et al., 1998; de Groot, 2006; 
Zeng et al., 2008). Thus, the α/β-hydrolase fold appears to be a likely candidate for the 
structural framework of eukaryotic sialate O-acetyltransferases, for which the genetic and 
structural bases are still unknown. In eukaryotes, O-acetylation of sialic acids is found on the 
outer most part of the carbohydrate moiety of membrane-bound and secreted 
glycoconjugates (Klein and Roussel, 1998). O-acetylation of hydroxyl groups at the C9 
position of sialic acids is a tissue-specific, tightly regulated modification, which is involved in 
a variety of physiological and pathological processes, such as cell-cell and host-pathogen 
interactions, immunology, as well as development (Varki, 1992; Schauer and Kamerling, 
1997; Varki, 1997; Klein and Roussel, 1998; Varki and Varki, 2007). However, attempts to 
clone the respective sialate O-acetyltransferase genes, e.g. by expression cloning, failed, 
and purification and characterization of the enzymatic activities proved to be challenging 
(Butor et al., 1993; Shen et al., 2002; Iwersen et al., 2003; Shen et al., 2004; Lrhorfi et al., 
2007).  
By searching for genes encoding potential α/β-hydrolase fold proteins with unknown function, 
CASD1 was identified as a candidate gene encoding a putative human sialate O-
acetyltransferase. CASD1 represents a homologue of the cas1 gene of the fungus 
Cryptococcus neoformans. The Cas1 enzyme was previously reported to be an O-
acetyltransferase involved in O-acetylation of mannose residues in the cryptococcal capsule 
composed of glucuronoxylomannan (Janbon et al., 2001; Kozel et al., 2003). The human 
CASD1 gene encodes a protein of 797 amino acids which appears to be composed of two 
distinct parts: an N-terminal catalytic domain for which homology modeling predicted an α/β-
hydrolase fold with a Ser-Asp-His catalytic triad and a C-terminal part with 12 predicted 
transmembrane domains (data not shown). CASD1 is currently investigated with regard to 
sialate O-acetyltransferase activity. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 106 
 
 
Chapter 7 - References 
 
Allison,G.E., Verma,N.K. (2000) Serotype-converting bacteriophages and O-antigen modification in Shigella 
flexneri Trends Microbiol. 8: 17-23. 
 
Amara,A.A., Rehm,B.H. (2003) Replacement of the catalytic nucleophile cysteine-296 by serine in class II 
polyhydroxyalkanoate synthase from Pseudomonas aeruginosa-mediated synthesis of a new polyester: 
identification of catalytic residues Biochem.J. 374: 413-421. 
 
Angata,T., Varki,A. (2002) Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary 
perspective Chem.Rev. 102: 439-469. 
 
Argiriadi,M.A., Morisseau,C., Hammock,B.D., and Christianson,D.W. (1999) Detoxification of environmental 
mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase 
Proc.Natl.Acad.Sci.U.S.A 96: 10637-10642. 
 
Barrett,B., Ebah,L., and Roberts,I.S. (2002) Genomic structure of capsular determinants 
Curr.Top.Microbiol.Immunol. 264: 137-155. 
 
Beaman,T.W., Binder,D.A., Blanchard,J.S., and Roderick,S.L. (1997) Three-dimensional structure of 
tetrahydrodipicolinate N-succinyltransferase Biochemistry 36: 489-494. 
 
Beaman,T.W., Sugantino,M., and Roderick,S.L. (1998) Structure of the hexapeptide xenobiotic acetyltransferase 
from Pseudomonas aeruginosa Biochemistry 37: 6689-6696. 
 
Bentley,S.D., Vernikos,G.S., Snyder,L.A., Churcher,C., Arrowsmith,C., Chillingworth,T., Cronin,A., Davis,P.H., 
Holroyd,N.E., Jagels,K., Maddison,M., Moule,S., Rabbinowitsch,E., Sharp,S., Unwin,L., Whitehead,S., Quail,M.A., 
Achtman,M., Barrell,B., Saunders,N.J., and Parkhill,J. (2007) Meningococcal genetic variation mechanisms 
viewed through comparative analysis of serogroup C strain FAM18 PLoS.Genet. 3: e23. 
 
Bergfeld,A.K., Claus,H., Lorenzen,N.K., Spielmann,F., Vogel,U., and Mühlenhoff,M. (2009) The polysialic acid-
specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial 
sialate O-acetyltransferases J.Biol.Chem. 284: 6-16. 
 
Bergfeld,A.K., Claus,H., Vogel,U., and Mühlenhoff,M. (2007) Biochemical characterization of the polysialic acid-
specific O-acetyltransferase NeuO of Escherichia coli K1 J.Biol.Chem. 282: 22217-22227. 
 
Bergfors,T. (2003) Seeds to crystals J.Struct.Biol. 142: 66-76. 
 
Bergfors,T. (2007) Screening and optimization methods for nonautomated crystallization laboratories Methods 
Mol.Biol. 363: 131-151. 
 
Bhattacharjee,A.K., Jennings,H.J., Kenny,C.P., Martin,A., and Smith,I.C. (1975) Structural determination of the 
sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic 
resonance J.Biol.Chem. 250: 1926-1932. 
 
Bhattacharjee,A.K., Jennings,H.J., Kenny,C.P., Martin,A., and Smith,I.C. (1976) Structural determination of the 
polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1 Can.J.Biochem. 54: 1-8. 
 
Bliss,J.M., Silver,R.P. (1996) Coating the surface: a model for expression of capsular polysialic acid in 
Escherichia coli K1 Mol.Microbiol. 21: 221-231. 
 
Boisier,P., Nicolas,P., Djibo,S., Taha,M.K., Jeanne,I., Mainassara,H.B., Tenebray,B., Kairo,K.K., Giorgini,D., and 
Chanteau,S. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in 
Niger Clin.Infect.Dis. 44: 657-663. 
 
Bonacorsi,S., Clermont,O., Houdouin,V., Cordevant,C., Brahimi,N., Marecat,A., Tinsley,C., Nassif,X., Lange,M., 
and Bingen,E. (2003) Molecular analysis and experimental virulence of French and North American Escherichia 
coli neonatal meningitis isolates: identification of a new virulent clone J.Infect.Dis. 187: 1895-1906. 
 
Born,T.L., Franklin,M., and Blanchard,J.S. (2000) Enzyme-catalyzed acylation of homoserine: mechanistic 
characterization of the Haemophilus influenzae met2-encoded homoserine transacetylase Biochemistry 39: 8556-
8564. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 107 
 
Borrow,R., Longworth,E., Gray,S.J., and Kaczmarski,E.B. (2000) Prevalence of de-O-acetylated serogroup C 
meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom 
FEMS Immunol.Med.Microbiol. 28: 189-191. 
 
Bortolussi,R., Ferrieri,P., Bjorksten,B., and Quie,P.G. (1979) Capsular K1 polysaccharide of Escherichia coli: 
relationship to virulence in newborn rats and resistance to phagocytosis Infect.Immun. 25: 293-298. 
 
Brady,L., Brzozowski,A.M., Derewenda,Z.S., Dodson,E., Dodson,G., Tolley,S., Turkenburg,J.P., Christiansen,L., 
Huge-Jensen,B., Norskov,L., and . (1990) A serine protease triad forms the catalytic centre of a triacylglycerol 
lipase Nature 343: 767-770. 
 
Brandtzaeg,P., Van Deuren,M. (2002) Current concepts in the role of the host response in Neisseria meningitidis 
septic shock Curr.Opin.Infect.Dis. 15: 247-252. 
 
Brown,K., Pompeo,F., Dixon,S., Mengin-Lecreulx,D., Cambillau,C., and Bourne,Y. (1999) Crystal structure of the 
bifunctional N-acetylglucosamine 1-phosphate uridyltransferase from Escherichia coli: a paradigm for the related 
pyrophosphorylase superfamily EMBO J. 18: 4096-4107. 
 
Bucher,M.H., Evdokimov,A.G., and Waugh,D.S. (2002) Differential effects of short affinity tags on the 
crystallization of Pyrococcus furiosus maltodextrin-binding protein Acta Crystallogr.D.Biol.Crystallogr. 58: 392-
397. 
 
Butor,C., Diaz,S., and Varki,A. (1993) High level O-acetylation of sialic acids on N-linked oligosaccharides of rat 
liver membranes. Differential subcellular distribution of 7- and 9-O-acetyl groups and of enzymes involved in their 
regulation J.Biol.Chem. 268: 10197-10206. 
 
Byun,J.S., Rhee,J.K., Kim,N.D., Yoon,J., Kim,D.U., Koh,E., Oh,J.W., and Cho,H.S. (2007) Crystal structure of 
hyperthermophilic esterase EstE1 and the relationship between its dimerization and thermostability properties 
BMC.Struct.Biol. 7: 47. 
 
Campobasso,N., Patel,M., Wilding,I.E., Kallender,H., Rosenberg,M., and Gwynn,M.N. (2004) Staphylococcus 
aureus 3-hydroxy-3-methylglutaryl-CoA synthase: crystal structure and mechanism J.Biol.Chem. 279: 44883-
44888. 
 
Cartwright,K.A., Ala'Aldeen,D.A. (1997) Neisseria meningitidis: clinical aspects J.Infect. 34: 15-19. 
 
Caugant,D.A. (2008) Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of 
meningococcal disease Infect.Genet.Evol. 8: 558-565. 
 
Caugant,D.A., Hoiby,E.A., Magnus,P., Scheel,O., Hoel,T., Bjune,G., Wedege,E., Eng,J., and Froholm,L.O. (1994) 
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population J.Clin.Microbiol. 32: 323-330. 
 
Caylor,C.L., Dobrianov,I., Lemay,S.G., Kimmer,C., Kriminski,S., Finkelstein,K.D., Zipfel,W., Webb,W.W., 
Thomas,B.R., Chernov,A.A., and Thorne,R.E. (1999) Macromolecular impurities and disorder in protein crystals 
Proteins 36: 270-281. 
 
Chant,A., Kraemer-Pecore,C.M., Watkin,R., and Kneale,G.G. (2005) Attachment of a histidine tag to the minimal 
zinc finger protein of the Aspergillus nidulans gene regulatory protein AreA causes a conformational change at the 
DNA-binding site Protein Expr.Purif. 39: 152-159. 
 
Chayen,N.E., Saridakis,E. (2008) Protein crystallization: from purified protein to diffraction-quality crystal 
Nat.Methods 5: 147-153. 
 
Claus,H., Borrow,R., Achtman,M., Morelli,G., Kantelberg,C., Longworth,E., Frosch,M., and Vogel,U. (2004) 
Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci Mol.Microbiol. 51: 227-239. 
 
Claus,H., Maiden,M.C., Wilson,D.J., McCarthy,N.D., Jolley,K.A., Urwin,R., Hessler,F., Frosch,M., and Vogel,U. 
(2005) Genetic analysis of meningococci carried by children and young adults J.Infect.Dis. 191: 1263-1271. 
 
Combet,C., Blanchet,C., Geourjon,C., and Deleage,G. (2000) NPS@: network protein sequence analysis Trends 
Biochem.Sci. 25: 147-150. 
 
Connolly,M., Noah,N. (1999) Is group C meningococcal disease increasing in Europe? A report of surveillance of 
meningococcal infection in Europe 1993-6. European Meningitis Surveillance Group Epidemiol.Infect. 122: 41-49. 
 
Cross,A.S., Kim,K.S., Wright,D.C., Sadoff,J.C., and Gemski,P. (1986) Role of lipopolysaccharide and capsule in 
the serum resistance of bacteremic strains of Escherichia coli J.Infect.Dis. 154: 497-503. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 108 
 
Cudney,R., Patel,S., Weisgraber,K., Newhouse,Y., and McPherson,A. (1994) Screening and optimization 
strategies for macromolecular crystal growth Acta Crystallogr.D.Biol.Crystallogr. 50: 414-423. 
 
Curreli,S., Arany,Z., Gerardy-Schahn,R., Mann,D., and Stamatos,N.M. (2007) Polysialylated neuropilin-2 is 
expressed on the surface of human dendritic cells and modulates dendritic cell-T lymphocyte interactions 
J.Biol.Chem. 282: 30346-30356. 
 
Curtis,M.A., Slaney,J.M., and Aduse-Opoku,J. (2005) Critical pathways in microbial virulence J.Clin.Periodontol. 
32 Suppl 6: 28-38. 
 
Dale,G.E., Oefner,C., and D'Arcy,A. (2003) The protein as a variable in protein crystallization J.Struct.Biol. 142: 
88-97. 
 
Davidsen,T., Tonjum,T. (2006) Meningococcal genome dynamics Nat.Rev.Microbiol. 4: 11-22. 
 
de Groot,R.J. (2006) Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and 
toroviruses Glycoconj.J. 23: 59-72. 
 
Deghmane,A.E., Giorgini,D., Larribe,M., Alonso,J.M., and Taha,M.K. (2002) Down-regulation of pili and capsule 
of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein Mol.Microbiol. 
43: 1555-1564. 
 
Deghmane,A.E., Larribe,M., Giorgini,D., Sabino,D., and Taha,M.K. (2003) Differential expression of genes that 
harbor a common regulatory element in Neisseria meningitidis upon contact with target cells Infect.Immun. 71: 
2897-2901. 
 
Deszo,E.L., Steenbergen,S.M., Freedberg,D.I., and Vimr,E.R. (2005) Escherichia coli K1 polysialic acid O-
acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus 
Proc.Natl.Acad.Sci.U.S.A 102: 5564-5569. 
 
Djibo,S., Nicolas,P., Alonso,J.M., Djibo,A., Couret,D., Riou,J.Y., and Chippaux,J.P. (2003) Outbreaks of 
serogroup X meningococcal meningitis in Niger 1995-2000 Trop.Med.Int.Health 8: 1118-1123. 
 
Dobrindt,U. (2005) (Patho-)Genomics of Escherichia coli Int.J.Med.Microbiol. 295: 357-371. 
 
Dodson,G., Wlodawer,A. (1998) Catalytic triads and their relatives Trends Biochem.Sci. 23: 347-352. 
 
Dong,A., Xu,X., Edwards,A.M., Chang,C., Chruszcz,M., Cuff,M., Cymborowski,M., Di Leo,R., Egorova,O., 
Evdokimova,E., Filippova,E., Gu,J., Guthrie,J., Ignatchenko,A., Joachimiak,A., Klostermann,N., Kim,Y., 
Korniyenko,Y., Minor,W., Que,Q., Savchenko,A., Skarina,T., Tan,K., Yakunin,A., Yee,A., Yim,V., Zhang,R., 
Zheng,H., Akutsu,M., Arrowsmith,C., Avvakumov,G.V., Bochkarev,A., Dahlgren,L.G., Dhe-Paganon,S., Dimov,S., 
Dombrovski,L., Finerty,P., Jr., Flodin,S., Flores,A., Graslund,S., Hammerstrom,M., Herman,M.D., Hong,B.S., 
Hui,R., Johansson,I., Liu,Y., Nilsson,M., Nedyalkova,L., Nordlund,P., Nyman,T., Min,J., Ouyang,H., Park,H.W., 
Qi,C., Rabeh,W., Shen,L., Shen,Y., Sukumard,D., Tempel,W., Tong,Y., Tresagues,L., Vedadi,M., Walker,J.R., 
Weigelt,J., Welin,M., Wu,H., Xiao,T., Zeng,H., and Zhu,H. (2007) In situ proteolysis for protein crystallization and 
structure determination Nat.Methods 4: 1019-1021. 
 
Dong,A., Yoder,J.A., Zhang,X., Zhou,L., Bestor,T.H., and Cheng,X. (2001) Structure of human DNMT2, an 
enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA Nucleic Acids Res. 
29: 439-448. 
 
Dunn,S.M., Moody,P.C., Downie,J.A., and Shaw,W.V. (1996) Crystallization and preliminary diffraction studies of 
NodL, a rhizobial O-acetyl-transferase involved in the host-specific nodulation of legume roots Protein Sci. 5: 538-
541. 
 
Feng,L., Sechenkova,S.N., Tao,J., Shashkov,A.S., Liu,B., Shevelev,S.D., Reeves,P.R., Xu,J., Knirel,Y.A., and 
Wang.L. (2005) Structural and genetic characterization of enterohemorrhagic Escherichia coli O145 O antigen 
and development of an O145 serogroup-specific PCR assay J. Bacteriol. 187: 758-764. 
 
Finne,J., Finne,U., Deagostini-Bazin,H., and Goridis,C. (1983) Occurrence of alpha 2-8 linked polysialosyl units in 
a neural cell adhesion molecule Biochem.Biophys.Res.Commun. 112: 482-487. 
 
Frasa,H., Procee,J., Torensma,R., Verbruggen,A., Algra,A., Rozenberg-Arska,M., Kraaijeveld,K., and Verhoef,J. 
(1993) Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated 
K1 strains J.Clin.Microbiol. 31: 3174-3178. 
 
Freitag,T., Squires,R.A., Schmid,J., and Elliott,J. (2005) Feline uropathogenic Escherichia coli from Great Britain 
and New Zealand have dissimilar virulence factor genotypes Vet.Microbiol. 106: 79-86. 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 109 
 
Frosch,M., Weisgerber,C., and Meyer,T.F. (1989) Molecular characterization and expression in Escherichia coli of 
the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B 
Proc.Natl.Acad.Sci.U.S.A 86: 1669-1673. 
Fujino,S., Akiyama,D., Akaboshi,S., Fujita,T., Watanabe,Y., and Tamai,Y. (2006) Purification and characterization 
of phospholipase B from Candida utilis Biosci.Biotechnol.Biochem. 70: 377-386. 
 
Fusco,P.C., Farley,E.K., Huang,C.H., Moore,S., and Michon,F. (2007) Protective meningococcal capsular 
polysaccharide epitopes and the role of O acetylation Clin.Vaccine Immunol. 14: 577-584. 
 
Galanakis,E., Di Cello,F., Paul-Satyaseela,M., and Kim,K.S. (2006) Escherichia coli K1 induces IL-8 expression in 
human brain microvascular endothelial cells Eur.Cytokine Netw. 17: 260-265. 
 
Gamian A., Romanowska E., Ulrich J., and Defaye J. (1992) The structure of the sialic acid-containing 
Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide 
Carbohydr Res. 236: 195-208. 
 
Gascon,E., Vutskits,L., and Kiss,J.Z. (2007) Polysialic acid-neural cell adhesion molecule in brain plasticity: from 
synapses to integration of new neurons Brain Res.Rev. 56: 101-118. 
 
Gotschlich,E.C., Liu,T.Y., and Artenstein,M.S. (1969) Human immunity to the meningococcus. 3. Preparation and 
immunochemical properties of the group A, group B, and group C meningococcal polysaccharides J.Exp.Med. 
129: 1349-1365. 
 
Greenfield,S., Sheehe,P.R., and Feldman,H.A. (1971) Meningococcal carriage in a population of "normal" families 
J.Infect.Dis. 123: 67-73. 
 
Gudlavalleti,S.K., Datta,A.K., Tzeng,Y.L., Noble,C., Carlson,R.W., and Stephens,D.S. (2004) The Neisseria 
meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase J.Biol.Chem. 279: 42765-42773. 
 
Gudlavalleti,S.K., Lee,C.H., Norris,S.E., Paul-Satyaseela,M., Vann,W.F., and Frasch,C.E. (2007) Comparison of 
Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate 
activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide Vaccine 25: 7972-
7980. 
 
Gudlavalleti,S.K., Szymanski,C.M., Jarrell,H.C., and Stephens,D.S. (2006) In vivo determination of Neisseria 
meningitidis serogroup A capsular polysaccharide by whole cell high-resolution magic angle spinning NMR 
spectroscopy Carbohydr.Res. 341: 557-562. 
 
Guerry,P., Szymanski,C.M. (2008) Campylobacter sugars sticking out Trends Microbiol. 16: 428-435. 
 
Hammerschmidt,S., Hilse,R., van Putten,J.P., Gerardy-Schahn,R., Unkmeir,A., and Frosch,M. (1996a) 
Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element 
EMBO J. 15: 192-198. 
 
Hammerschmidt,S., Müller,A., Sillmann,H., Mühlenhoff,M., Borrow,R., Fox,A., van Putten,J., Zollinger,W.D., 
Gerardy-Schahn,R., and Frosch,M. (1996b) Capsule phase variation in Neisseria meningitidis serogroup B by 
slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the 
outbreak of meningococcal disease Mol.Microbiol. 20: 1211-1220. 
 
Han,B.W., Bingman,C.A., Wesenberg,G.E., and Phillips,G.N., Jr. (2006) Crystal structure of Homo sapiens 
thialysine Nepsilon-acetyltransferase (HsSSAT2) in complex with acetyl coenzyme A Proteins 64: 288-293. 
 
Hecht,H.J., Sobek,H., Haag,T., Pfeifer,O., and van Pee,K.H. (1994) The metal-ion-free oxidoreductase from 
Streptomyces aureofaciens has an alpha/beta hydrolase fold Nat.Struct.Biol. 1: 532-537. 
 
Heikinheimo,P., Goldman,A., Jeffries,C., and Ollis,D.L. (1999) Of barn owls and bankers: a lush variety of 
alpha/beta hydrolases Structure. 7: R141-R146. 
 
Henderson,I.R., Owen,P., and Nataro,J.P. (1999) Molecular switches--the ON and OFF of bacterial phase 
variation Mol.Microbiol. 33: 919-932. 
 
Higa,H.H., Varki,A. (1988) Acetyl-coenzyme A: polysialic acid O-acetyltransferase from K1-positive Escherichia 
coli. The enzyme responsible for the O-acetyl plus phenotype and for O-acetyl form variation J.Biol.Chem. 263: 
8872-8878. 
 
Higaki,J.N., Evnin,L.B., and Craik,C.S. (1989) Introduction of a cysteine protease active site into trypsin 
Biochemistry 28: 9256-9263. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 110 
 
Hildebrandt,H., Mühlenhoff,M., and Gerardy-Schahn,R. (2008) Polysialylation of NCAM Neurochem.Res. 
 
Hildebrandt,H., Mühlenhoff,M., Weinhold,B., and Gerardy-Schahn,R. (2007) Dissecting polysialic acid and NCAM 
functions in brain development J.Neurochem. 103 Suppl 1: 56-64. 
 
Hindson,V.J., Shaw,W.V. (2003) Random-order ternary complex reaction mechanism of serine acetyltransferase 
from Escherichia coli Biochemistry 42: 3113-3119. 
Ho,M.M., Lemercinier,X., Bolgiano,B., Crane,D., and Corbel,M.J. (2001) Solution stability studies of the subunit 
components of meningococcal C oligosaccharide-CRM197 conjugate vaccines Biotechnol.Appl.Biochem. 33: 91-
98. 
 
Hoffman,J.A., Wass,C., Stins,M.F., and Kim,K.S. (1999) The capsule supports survival but not traversal of 
Escherichia coli K1 across the blood-brain barrier Infect.Immun. 67: 3566-3570. 
 
Holmquist,M. (2000) Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms Curr.Protein 
Pept.Sci. 1: 209-235. 
 
Hotopp,J.C., Grifantini,R., Kumar,N., Tzeng,Y.L., Fouts,D., Frigimelica,E., Draghi,M., Giuliani,M.M., Rappuoli,R., 
Stephens,D.S., Grandi,G., and Tettelin,H. (2006) Comparative genomics of Neisseria meningitidis: core genome, 
islands of horizontal transfer and pathogen-specific genes Microbiology 152: 3733-3749. 
 
Houliston,R.S., Endtz,H.P., Yuki,N., Li,J., Jarrell,H.C., Koga,M., van Belkum,A., Karwaski,M.F., Wakarchuk,W.W., 
and Gilbert,M. (2006) Identification of a sialate O-acetyltransferase from Campylobacter jejuni: demonstration of 
direct transfer to the C-9 position of terminalalpha-2, 8-linked sialic acid J.Biol.Chem. 281: 11480-11486. 
 
Hung,M.N., Rangarajan,E., Munger,C., Nadeau,G., Sulea,T., and Matte,A. (2006) Crystal structure of TDP-
fucosamine acetyltransferase (WecD) from Escherichia coli, an enzyme required for enterobacterial common 
antigen synthesis J.Bacteriol. 188: 5606-5617. 
 
Ishida,T. (2006) Low-barrier hydrogen bond hypothesis in the catalytic triad residue of serine proteases: 
correlation between structural rearrangement and chemical shifts in the acylation process Biochemistry 45: 5413-
5420. 
 
Ishida,T., Kato,S. (2003) Theoretical perspectives on the reaction mechanism of serine proteases: the reaction 
free energy profiles of the acylation process J.Am.Chem.Soc. 125: 12035-12048. 
 
Iwersen,M., Dora,H., Kohla,G., Gasa,S., and Schauer,R. (2003) Solubilisation and properties of the sialate-4-O-
acetyltransferase from guinea pig liver Biol.Chem. 384: 1035-1047. 
 
Janbon,G., Himmelreich,U., Moyrand,F., Improvisi,L., and Dromer,F. (2001) Cas1p is a membrane protein 
necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide Mol.Microbiol. 42: 453-
467. 
 
Jann,K., Jann,B. (1992) Capsules of Escherichia coli, expression and biological significance Can.J.Microbiol. 38: 
705-710. 
 
Jarvis,G.A., Vedros,N.A. (1987) Sialic acid of group B Neisseria meningitidis regulates alternative complement 
pathway activation Infect.Immun. 55: 174-180. 
 
Jenkins,J., Pickersgill,R. (2001) The architecture of parallel beta-helices and related folds Prog.Biophys.Mol.Biol. 
77: 111-175. 
 
Jennings,H.J., Bhattacharjee,A.K., Bundle,D.R., Kenny,C.P., Martin,A., and Smith,I.C. (1977) Strucutres of the 
capsular polysaccharides of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance 
spectroscopy J.Infect.Dis. 136 Suppl: S78-S83. 
 
Jodar,L., Feavers,I.M., Salisbury,D., and Granoff,D.M. (2002) Development of vaccines against meningococcal 
disease Lancet 359: 1499-1508. 
 
Johnson,C.M., Roderick,S.L., and Cook,P.F. (2005) The serine acetyltransferase reaction: acetyl transfer from an 
acylpantothenyl donor to an alcohol Arch.Biochem.Biophys. 433: 85-95. 
 
Johnson,J.R., Russo,T.A. (2002) Extraintestinal pathogenic Escherichia coli: "the other bad E. coli" J.Lab 
Clin.Med. 139: 155-162. 
 
Johnson,J.R., Russo,T.A. (2005) Molecular epidemiology of extraintestinal pathogenic (uropathogenic) 
Escherichia coli Int.J.Med.Microbiol. 295: 383-404. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 111 
 
Kahler,C.M., Blum,E., Miller,Y.K., Ryan,D., Popovic,T., and Stephens,D.S. (2001) exl, an exchangeable genetic 
island in Neisseria meningitidis Infect.Immun. 69: 1687-1696. 
 
Kehoe,L.E., Snidwongse,J., Courvalin,P., Rafferty,J.B., and Murray,I.A. (2003) Structural basis of Synercid 
(quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens J.Biol.Chem. 278: 29963-29970. 
 
Kelley,L.A., MacCallum,R.M., and Sternberg,M.J. (2000) Enhanced genome annotation using structural profiles in 
the program 3D-PSSM. J. Mol. Biol., 299, 499-520. 
 
Kim,B.Y., Kang,J., and Kim,K.S. (2005) Invasion processes of pathogenic Escherichia coli Int.J.Med.Microbiol. 
295: 463-470. 
 
Kim,K.S. (2001) Escherichia coli translocation at the blood-brain barrier Infect.Immun. 69: 5217-5222. 
 
Kim,K.S. (2002) Strategy of Escherichia coli for crossing the blood-brain barrier J.Infect.Dis. 186 Suppl 2: S220-
S224. 
 
Kim,K.S. (2003) Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury Nat.Rev.Neurosci. 4: 
376-385. 
 
Kim,K.S., Itabashi,H., Gemski,P., Sadoff,J., Warren,R.L., and Cross,A.S. (1992) The K1 capsule is the critical 
determinant in the development of Escherichia coli meningitis in the rat J.Clin.Invest 90: 897-905. 
 
Kim,Y.V., Pearce,D., and Kim,K.S. (2008) Ca(2+)/calmodulin-dependent invasion of microvascular endothelial 
cells of human brain by Escherichia coli K1 Cell Tissue Res. 332: 427-433. 
 
King,M.R., Steenbergen,S.M., and Vimr,E.R. (2007) Going for baroque at the Escherichia coli K1 cell surface 
Trends Microbiol. 15: 196-202. 
 
King,M.R., Vimr,R.P., Steenbergen,S.M., Spanjaard,L., Plunkett,G., III, Blattner,F.R., and Vimr,E.R. (2007) 
Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic 
acid O acetylation J.Bacteriol. 189: 6447-6456. 
 
Klein,A., and Roussel,P. (1998) O-Acetylation of sialic acids Biochimie 80: 49-57. 
 
Kolkenbrock,S., Parschat,K., Beermann,B., Hinz,H.J., and Fetzner,S. (2006) N-acetylanthranilate amidase from 
Arthrobacter nitroguajacolicus Ru61a, an alpha/beta-hydrolase-fold protein active towards aryl-acylamides and -
esters, and properties of its cysteine-deficient variant J.Bacteriol. 188: 8430-8440. 
 
Kozel,T.R., Levitz,S.M., Dromer,F., Gates,M.A., Thorkildson,P., and Janbon,G. (2003) Antigenic and biological 
characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains 
Infect.Immun. 71: 2868-2875. 
 
Krinos,C.M., Coyne,M.J., Weinacht,K.G., Tzianabos,A.O., Kasper,D.L., and Comstock,L.E. (2001) Extensive 
surface diversity of a commensal microorganism by multiple DNA inversions Nature 414: 555-558. 
 
Kursula,P., Ojala,J., Lambeir,A.M., and Wierenga,R.K. (2002) The catalytic cycle of biosynthetic thiolase: a 
conformational journey of an acetyl group through four binding modes and two oxyanion holes Biochemistry 41: 
15543-15556. 
 
Larsen,N.A., Lin,H., Wei,R., Fischbach,M.A., and Walsh,C.T. (2006) Structural characterization of enterobactin 
hydrolase IroE Biochemistry 45: 10184-10190. 
 
Lawson,D.M., Derewenda,U., Serre,L., Ferri,S., Szittner,R., Wei,Y., Meighen,E.A., and Derewenda,Z.S. (1994) 
Structure of a myristoyl-ACP-specific thioesterase from Vibrio harveyi Biochemistry 33: 9382-9388. 
 
Lee,L.C., Lee,Y.L., Leu,R.J., and Shaw,J.F. (2006) Functional role of catalytic triad and oxyanion hole-forming 
residues on enzyme activity of Escherichia coli thioesterase I/protease I/phospholipase L1 Biochem.J. 397: 69-76. 
 
Lemercinier,X., Jones,C. (1996) Full 1H NMR assignment and detailed O-acetylation patterns of capsular 
polysaccharides from Neisseria meningitidis used in vaccine production Carbohydr.Res. 296: 83-96. 
 
Lewendon,A., Ellis,J., and Shaw,W.V. (1995) Structural and mechanistic studies of galactoside acetyltransferase, 
the Escherichia coli LacA gene product J.Biol.Chem. 270: 26326-26331. 
 
Lewis,A.L., Hensler,M.E., Varki,A., and Nizet,V. (2006) The group B streptococcal sialic acid O-acetyltransferase 
is encoded by neuD, a conserved component of bacterial sialic acid biosynthetic gene clusters J.Biol.Chem. 281: 
11186-11192. 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 112 
 
Lewis,A.L., Nizet,V., and Varki,A. (2004) Discovery and characterization of sialic acid O-acetylation in group B 
Streptococcus Proc.Natl.Acad.Sci.U.S.A 101: 11123-11128. 
 
Li,J., Szittner,R., Derewenda,Z.S., and Meighen,E.A. (1996) Conversion of serine-114 to cysteine-114 and the 
role of the active site nucleophile in acyl transfer by myristoyl-ACP thioesterase from Vibrio harveyi Biochemistry 
35: 9967-9973. 
 
Liu,T.Y., Gotschlich,E.C., Jonssen,E.K., and Wysocki,J.R. (1971) Studies on the meningococcal polysaccharides. 
I. Composition and chemical properties of the group A polysaccharide J.Biol.Chem. 246: 2849-2858. 
 
Lo,L.L., Dal Degan,F., Poulsen,P., Andersen,S.M., and Larsen,S. (2003a) The structure and specificity of 
Escherichia coli maltose acetyltransferase give new insight into the LacA family of acyltransferases Biochemistry 
42: 5225-5235. 
 
Lo,Y.C., Lin,S.C., Shaw,J.F., and Liaw,Y.C. (2003b) Crystal structure of Escherichia coli thioesterase I/protease 
I/lysophospholipase L1: consensus sequence blocks constitute the catalytic center of SGNH-hydrolases through a 
conserved hydrogen bond network J.Mol.Biol. 330: 539-551. 
 
Longworth,E., Fernsten,P., Mininni,T.L., Vogel,U., Claus,H., Gray,S., Kaczmarski,E., and Borrow,R. (2002) O-
Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK 
FEMS Immunol.Med.Microbiol. 32: 119-123. 
 
Lrhorfi,L.A., Srinivasan,G.V., and Schauer,R. (2007) Properties and partial purification of sialate-O-
acetyltransferase from bovine submandibular glands Biol.Chem. 388: 297-306. 
 
Lukacova,M., Barak,I., and Kazar,J. (2008) Role of structural variations of polysaccharide antigens in the 
pathogenicity of Gram-negative bacteria Clin.Microbiol.Infect. 14: 200-206. 
 
Maiden,M.C., Bygraves,J.A., Feil,E., Morelli,G., Russell,J.E., Urwin,R., Zhang,Q., Zhou,J., Zurth,K., 
Caugant,D.A., Feavers,I.M., Achtman,M., and Spratt,B.G. (1998) Multilocus sequence typing: a portable approach 
to the identification of clones within populations of pathogenic microorganisms Proc.Natl.Acad.Sci.U.S.A 95: 
3140-3145. 
 
Mandel,C.R., Gebauer,D., Zhang,H., and Tong,L. (2006) A serendipitous discovery that in situ proteolysis is 
essential for the crystallization of yeast CPSF-100 (Ydh1p) Acta Crystallogr.Sect.F.Struct.Biol.Cryst.Commun. 62: 
1041-1045. 
 
McGuire,E.J., Binkley,S.B. (1964) The structure and chemistry of colominic acid Biochemistry 3: 247-251. 
 
McPherson,A., Malkin,A.J., and Kuznetsov,Y.G. (1995) The science of macromolecular crystallization Structure. 
3: 759-768. 
 
Medrano,F.J., Alonso,J., Garcia,J.L., Romero,A., Bode,W., and Gomis-Ruth,F.X. (1998) Structure of proline 
iminopeptidase from Xanthomonas campestris pv. citri: a prototype for the prolyl oligopeptidase family EMBO J. 
17: 1-9. 
 
Messick,T., Marmorstein,R. (2004) Crystallization of macromolecules Curr.Protoc.Protein Sci. Chapter 17: Unit 
17.4. 
 
Michon,F., Huang,C.H., Farley,E.K., Hronowski,L., Di,J., and Fusco,P.C. (2000) Structure activity studies on 
group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the 
protective epitope Dev.Biol.(Basel) 103: 151-160. 
 
Milkowski,C., Strack,D. (2004) Serine carboxypeptidase-like acyltransferases Phytochemistry 65: 517-524. 
 
Mirza,I.A., Nazi,I., Korczynska,M., Wright,G.D., and Berghuis,A.M. (2005) Crystal structure of homoserine 
transacetylase from Haemophilus influenzae reveals a new family of alpha/beta-hydrolases Biochemistry 44: 
15768-15773. 
 
Modis,Y., Wierenga,R.K. (2000) Crystallographic analysis of the reaction pathway of Zoogloea ramigera 
biosynthetic thiolase J.Mol.Biol. 297: 1171-1182. 
 
Moxon,E.R., Kroll,J.S. (1990) The role of bacterial polysaccharide capsules as virulence factors 
Curr.Top.Microbiol.Immunol. 150: 65-85. 
 
Mueller-Dieckmann,J. (2006) The open-access high-throughput crystallization facility at EMBL Hamburg Acta 
Crystallogr.D.Biol.Crystallogr. 62: 1446-1452. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 113 
 
Mühlenhoff,M., Eckhardt,M., and Gerardy-Schahn,R. (1998) Polysialic acid: three-dimensional structure, 
biosynthesis and function Curr.Opin.Struct.Biol. 8: 558-564. 
 
Mushtaq,N., Redpath,M.B., Luzio,J.P., and Taylor,P.W. (2004) Prevention and cure of systemic Escherichia coli 
K1 infection by modification of the bacterial phenotype Antimicrob.Agents Chemother. 48: 1503-1508. 
 
Mushtaq,N., Redpath,M.B., Luzio,J.P., and Taylor,P.W. (2005) Treatment of experimental Escherichia coli 
infection with recombinant bacteriophage-derived capsule depolymerase J.Antimicrob.Chemother. 56: 160-165. 
 
Nandhagopal,N., Yamada,A., Hatta,T., Masai,E., Fukuda,M., Mitsui,Y., and Senda,T. (2001) Crystal structure of 
2-hydroxyl-6-oxo-6-phenylhexa-2,4-dienoic acid (HPDA) hydrolase (BphD enzyme) from the Rhodococcus sp. 
strain RHA1 of the PCB degradation pathway J.Mol.Biol. 309: 1139-1151. 
 
Nardini,M., Dijkstra,B.W. (1999) Alpha/beta hydrolase fold enzymes: the family keeps growing 
Curr.Opin.Struct.Biol. 9: 732-737. 
 
Nazi,I., Wright,G.D. (2005) Catalytic mechanism of fungal homoserine transacetylase Biochemistry 44: 13560-
13566. 
 
Ninomiya,T., Sugiura,N., Tawada,A., Sugimoto,K., Watanabe,H., and Kimata,K. (2002) Molecular cloning and 
characterization of chondroitin polymerase from Escherichia coli strain K4 J.Biol.Chem. 277: 21567-21575. 
 
Ollis,D.L., Cheah,E., Cygler,M., Dijkstra,B., Frolow,F., Franken,S.M., Harel,M., Remington,S.J., Silman,I., 
Schrag,J., and . (1992) The alpha/beta hydrolase fold Protein Eng 5: 197-211. 
 
Olsen,L.R., Huang,B., Vetting,M.W., and Roderick,S.L. (2004) Structure of serine acetyltransferase in complexes 
with CoA and its cysteine feedback inhibitor Biochemistry 43: 6013-6019. 
 
Olsen,L.R., Roderick,S.L. (2001) Structure of the Escherichia coli GlmU pyrophosphorylase and acetyltransferase 
active sites Biochemistry 40: 1913-1921. 
 
Ørskov,F. (1978) Virulence factors of the bacterial cell surface J.Infect.Dis. 137: 630-633. 
 
Ørskov,F., Ørskov,I., Sutton,A., Schneerson,R., Lin,W., Egan,W., Hoff,G.E., and Robbins,J.B. (1979) Form 
variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide J.Exp.Med. 149: 669-
685. 
 
Pace,D., Pollard,A.J. (2007) Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines 
Arch.Dis.Child 92: 909-915. 
 
Parkhill,J., Achtman,M., James,K.D., Bentley,S.D., Churcher,C., Klee,S.R., Morelli,G., Basham,D., Brown,D., 
Chillingworth,T., Davies,R.M., Davis,P., Devlin,K., Feltwell,T., Hamlin,N., Holroyd,S., Jagels,K., Leather,S., 
Moule,S., Mungall,K., Quail,M.A., Rajandream,M.A., Rutherford,K.M., Simmonds,M., Skelton,J., Whitehead,S., 
Spratt,B.G., and Barrell,B.G. (2000) Complete DNA sequence of a serogroup A strain of Neisseria meningitidis 
Z2491 Nature 404: 502-506. 
 
Pathak,D., Ollis,D. (1990) Refined structure of dienelactone hydrolase at 1.8 A J.Mol.Biol. 214: 497-525. 
 
Pelkonen,S., Hayrinen,J., and Finne,J. (1988) Polyacrylamide gel electrophoresis of the capsular polysaccharides 
of Escherichia coli K1 and other bacteria J.Bacteriol. 170: 2646-2653. 
 
Peneff,C., Mengin-Lecreulx,D., and Bourne,Y. (2001) The crystal structures of Apo and complexed 
Saccharomyces cerevisiae GNA1 shed light on the catalytic mechanism of an amino-sugar N-acetyltransferase 
J.Biol.Chem. 276: 16328-16334. 
 
Petit,C., Rigg,G.P., Pazzani,C., Smith,A., Sieberth,V., Stevens,M., Boulnois,G., Jann,K., and Roberts,I.S. (1995) 
Region 2 of the Escherichia coli K5 capsule gene cluster encoding proteins for the biosynthesis of the K5 
polysaccharide Mol.Microbiol. 17: 611-620. 
 
Polgar,L. (2005) The catalytic triad of serine peptidases Cell Mol.Life Sci. 62: 2161-2172. 
 
Pong,A., Bradley,J.S. (1999) Bacterial meningitis and the newborn infant Infect.Dis.Clin.North Am. 13: 711-33, viii. 
 
Pye,V.E., Tingey,A.P., Robson,R.L., and Moody,P.C. (2004) The structure and mechanism of serine 
acetyltransferase from Escherichia coli J.Biol.Chem. 279: 40729-40736. 
 
Raetz,C.R., Roderick,S.L. (1995) A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine 
acyltransferase Science 270: 997-1000. 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 114 
 
Ravenscroft,N., Averani,G., Bartoloni,A., Berti,S., Bigio,M., Carinci,V., Costantino,P., D'Ascenzi,S., Giannozzi,A., 
Norelli,F., Pennatini,C., Proietti,D., Ceccarini,C., and Cescutti,P. (1999) Size determination of bacterial capsular 
oligosaccharides used to prepare conjugate vaccines Vaccine 17: 2802-2816. 
 
Raymond,N.J., Reeves,M., Ajello,G., Baughman,W., Gheesling,L.L., Carlone,G.M., Wenger,J.D., and 
Stephens,D.S. (1997) Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease 
J.Infect.Dis. 176: 1277-1284. 
 
Roberts,I.S. (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria 
Annu.Rev.Microbiol. 50: 285-315. 
 
Rodriguez,M.L., Jann,B., and Jann,K. (1988) Structure and serological characteristics of the capsular K4 antigen 
of Escherichia coli O5:K4:H4, a fructose-containing polysaccharide with a chondroitin backbone Eur.J.Biochem. 
177: 117-124. 
 
Rohr,T.E., Troy,F.A. (1980) Structure and biosynthesis of surface polymers containing polysialic acid in 
Escherichia coli J.Biol.Chem. 255: 2332-2342. 
 
Rosenstein,N.E., Perkins,B.A., Stephens,D.S., Popovic,T., and Hughes,J.M. (2001) Meningococcal disease 
N.Engl.J.Med. 344: 1378-1388. 
 
Rosenthal,P.B., Zhang,X., Formanowski,F., Fitz,W., Wong,C.H., Meier-Ewert,H., Skehel,J.J., and Wiley,D.C. 
(1998) Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus Nature 396: 92-96. 
 
Russo,T.A., Johnson,J.R. (2000) Proposal for a new inclusive designation for extraintestinal pathogenic isolates 
of Escherichia coli: ExPEC J.Infect.Dis. 181: 1753-1754. 
 
Russo,T.A., Johnson,J.R. (2003) Medical and economic impact of extraintestinal infections due to Escherichia 
coli: focus on an increasingly important endemic problem Microbes.Infect. 5: 449-456. 
 
Rutishauser,U. (2008) Polysialic acid in the plasticity of the developing and adult vertebrate nervous system 
Nat.Rev.Neurosci. 9: 26-35. 
 
Schauer,R., anf Kamerling,J.R. (1997) Chemistry, biochemistry and biology of sialic acids Glycoproteins II, 
Montreuil,J., Vliegenthart,J.F.G., and Schachter,H., eds. (Amsterdam, The Netherlands: Elsevier), pp. 243-402. 
 
Schauer,R. (2000) Achievements and challenges of sialic acid research Glycoconj.J. 17: 485-499. 
 
Schoen,C., Joseph,B., Claus,H., Vogel,U., and Frosch,M. (2007) Living in a changing environment: insights into 
host adaptation in Neisseria meningitidis from comparative genomics Int.J.Med.Microbiol. 297: 601-613. 
 
Schuetz,A., Bernstein,G., Dong,A., Antoshenko,T., Wu,H., Loppnau,P., Bochkarev,A., and Plotnikov,A.N. (2007) 
Crystal structure of a binary complex between human GCN5 histone acetyltransferase domain and acetyl 
coenzyme A Proteins 68: 403-407. 
 
Sfakianos,M.K., Wilson,L., Sakalian,M., Falany,C.N., and Barnes,S. (2002) Conserved residues in the putative 
catalytic triad of human bile acid Coenzyme A:amino acid N-acyltransferase J.Biol.Chem. 277: 47270-47275. 
 
Shen,Y., Tiralongo,J., Iwersen,M., Sipos,B., Kalthoff,H., and Schauer,R. (2002) Characterization of the sialate-
7(9)-O-acetyltransferase from the microsomes of human colonic mucosa Biol.Chem. 383: 307-317. 
 
Shen,Y., Tiralongo,J., Kohla,G., and Schauer,R. (2004) Regulation of sialic acid O-acetylation in human colon 
mucosa Biol.Chem. 385: 145-152. 
 
Silver,R.P., Finn,C.W., Vann,W.F., Aaronson,W., Schneerson,R., Kretschmer,P.J., and Garon,C.F. (1981) 
Molecular cloning of the K1 capsular polysaccharide genes of E. coli Nature 289: 696-698. 
 
Smith,J.L., Fratamico,P.M., and Gunther,N.W. (2007) Extraintestinal pathogenic Escherichia coli 
Foodborne.Pathog.Dis. 4: 134-163. 
 
Spinosa,M.R., Progida,C., Tala,A., Cogli,L., Alifano,P., and Bucci,C. (2007) The Neisseria meningitidis capsule is 
important for intracellular survival in human cells Infect.Immun. 75: 3594-3603. 
 
Srivatsan,M. (2006) An analysis of acetylcholinesterase sequence for predicting mechanisms of its non-catalytic 
actions Bioinformation. 1: 281-284. 
 
 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 115 
 
Stein,D.M., Robbins,J., Miller,M.A., Lin,F.Y., and Schneerson,R. (2006) Are antibodies to the capsular 
polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? 
Vaccine 24: 221-228. 
 
Stephens,D.S. (1999) Uncloaking the meningococcus: dynamics of carriage and disease Lancet 353: 941-942. 
 
Stephens,D.S. (2007) Conquering the meningococcus FEMS Microbiol.Rev. 31: 3-14. 
 
Stephens,D.S., Farley,M.M. (1991) Pathogenic events during infection of the human nasopharynx with Neisseria 
meningitidis and Haemophilus influenzae Rev.Infect.Dis. 13: 22-33. 
 
Stummeyer,K., Schwarzer,D., Claus,H., Vogel,U., Gerardy-Schahn,R., and Mühlenhoff,M. (2006) Evolution of 
bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages Mol.Microbiol. 
60: 1123-1135. 
 
Sugantino,M., Roderick,S.L. (2002) Crystal structure of Vat(D): an acetyltransferase that inactivates streptogramin 
group A antibiotics Biochemistry 41: 2209-2216. 
 
Sulzenbacher,G., Gal,L., Peneff,C., Fassy,F., and Bourne,Y. (2001) Crystal structure of Streptococcus 
pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel 
active site architecture J.Biol.Chem. 276: 11844-11851. 
 
Sussman,J.L., Harel,M., Frolow,F., Oefner,C., Goldman,A., Toker,L., and Silman,I. (1991) Atomic structure of 
acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein Science 253: 872-879. 
 
Swartley,J.S., Liu,L.J., Miller,Y.K., Martin,L.E., Edupuganti,S., and Stephens,D.S. (1998) Characterization of the 
gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule 
of serogroup A Neisseria meningitidis J.Bacteriol. 180: 1533-1539. 
 
Swartley,J.S., Marfin,A.A., Edupuganti,S., Liu,L.J., Cieslak,P., Perkins,B., Wenger,J.D., and Stephens,D.S. (1997) 
Capsule switching of Neisseria meningitidis Proc.Natl.Acad.Sci.U.S.A 94: 271-276. 
 
Tettelin,H., Saunders,N.J., Heidelberg,J., Jeffries,A.C., Nelson,K.E., Eisen,J.A., Ketchum,K.A., Hood,D.W., 
Peden,J.F., Dodson,R.J., Nelson,W.C., Gwinn,M.L., DeBoy,R., Peterson,J.D., Hickey,E.K., Haft,D.H., 
Salzberg,S.L., White,O., Fleischmann,R.D., Dougherty,B.A., Mason,T., Ciecko,A., Parksey,D.S., Blair,E., 
Cittone,H., Clark,E.B., Cotton,M.D., Utterback,T.R., Khouri,H., Qin,H., Vamathevan,J., Gill,J., Scarlato,V., 
Masignani,V., Pizza,M., Grandi,G., Sun,L., Smith,H.O., Fraser,C.M., Moxon,E.R., Rappuoli,R., and Venter,J.C. 
(2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58 Science 287: 1809-1815. 
 
Troy,F.A. (1992) Polysialylation: from bacteria to brains Glycobiology 2: 5-23. 
 
Tzeng,Y.L., Stephens,D.S. (2000) Epidemiology and pathogenesis of Neisseria meningitidis Microbes.Infect. 2: 
687-700. 
 
Vaara,M. (1992) Eight bacterial proteins, including UDP-N-acetylglucosamine acyltransferase (LpxA) and three 
other transferases of Escherichia coli, consist of a six-residue periodicity theme FEMS Microbiol.Lett. 76: 249-
254. 
 
van Belkum,A., Scherer,S., van Alphen,L., and Verbrugh,H. (1998) Short-sequence DNA repeats in prokaryotic 
genomes Microbiol.Mol.Biol.Rev. 62: 275-293. 
 
Van Deuren,M., Brandtzaeg,P., and van der Meer,J.W. (2000) Update on meningococcal disease with emphasis 
on pathogenesis and clinical management Clin.Microbiol.Rev. 13: 144-66. 
 
Vann,W.F., Liu,T.Y., and Robbins,J.B. (1978) Cell-free biosynthesis of the O-acetylated N-acetylneuraminic acid 
capsular polysaccharide of group C meningococci J.Bacteriol. 133: 1300-1306. 
 
Vann,W.F., Schmidt,M.A., Jann,B., and Jann,K. (1981) The structure of the capsular polysaccharide (K5 antigen) 
of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin Eur.J.Biochem. 116: 
359-364. 
 
Varki,A. (1992) Diversity in the sialic acids Glycobiology 2: 25-40. 
 
Varki,A. (1997) Sialic acids as ligands in recognition phenomena FASEB J. 4:248-55. 
 
Varki,N.M., Varki,A. (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease 
Lab Invest 87: 851-857. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 116 
 
Verschueren,K.H., Franken,S.M., Rozeboom,H.J., Kalk,K.H., and Dijkstra,B.W. (1993) Refined X-ray structures of 
haloalkane dehalogenase at pH 6.2 and pH 8.2 and implications for the reaction mechanism J.Mol.Biol. 232: 856-
872. 
 
Vetting,M.W., Bareich,D.C., Yu,M., and Blanchard,J.S. (2008) Crystal structure of RimI from Salmonella 
typhimurium LT2, the GNAT responsible for N(alpha)-acetylation of ribosomal protein S18 Protein Sci. 17: 1781-
1790. 
 
Villwock,A., Schmitt,C., Frosch,M., and Kurzai,O. (2008) Capsule acetylation does not impair recognition of 
serogroup C, W-135 and Y meningococci by human dendritic cells Int.J.Med.Microbiol. 298: 591-597. 
 
Vimr,E.R., Steenbergen,S.M. (2006) Mobile contingency locus controlling Escherichia coli K1 polysialic acid 
capsule acetylation Mol.Microbiol. 60: 828-837. 
 
Vimr,E.R., Steenbergen,S.M. (2009) Early molecular-recognition events in the synthesis and export of group 2 
capsular polysaccharides Microbiology 155: 9-15. 
 
Vogel,U., Claus,H., and Frosch,M. (2000) Rapid serogroup switching in Neisseria meningitidis N.Engl.J.Med. 342: 
219-220. 
 
Vogel,U., Claus,H., and Frosch,M. (2004) Genetic lineages and their traits in Neisseria meningitidis 
Int.J.Med.Microbiol. 294: 75-82. 
 
Vogel,U., Hammerschmidt,S., and Frosch,M. (1996) Sialic acids of both the capsule and the sialylated 
lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the 
infant rat Med.Microbiol.Immunol. 185: 81-87. 
 
Wagner,U.G., Hasslacher,M., Griengl,H., Schwab,H., and Kratky,C. (1996) Mechanism of cyanogenesis: the 
crystal structure of hydroxynitrile lyase from Hevea brasiliensis Structure. 4: 811-822. 
 
Wahab,H.A., Ahmad Khairudin,N.B., Samian,M.R., and Najimudin,N. (2006) Sequence analysis and structure 
prediction of type II Pseudomonas sp. USM 4-55 PHA synthase and an insight into its catalytic mechanism 
BMC.Struct.Biol. 6: 23. 
 
Wajant,H., Pfizenmaier,K. (1996) Identification of potential active-site residues in the hydroxynitrile lyase from 
Manihot esculenta by site-directed mutagenesis J.Biol.Chem. 271: 25830-25834. 
 
Wang,H., Liu,L., Hanna,P.E., and Wagner,C.R. (2005) Catalytic mechanism of hamster arylamine N-
acetyltransferase 2 Biochemistry 44: 11295-11306. 
 
Wang,M., Liu,L., Wang,Y., Wei,Z., Zhang,P., Li,Y., Jiang,X., Xu,H., and Gong,W. (2007) Crystal structure of 
homoserine O-acetyltransferase from Leptospira interrogans Biochem.Biophys.Res.Commun. 363: 1050-1056. 
 
Wang,X.G., Olsen,L.R., and Roderick,S.L. (2002) Structure of the lac operon galactoside acetyltransferase 
Structure. 10: 581-588. 
 
Weadge,J.T., Clarke,A.J. (2007) Neisseria gonorrheae O-acetylpeptidoglycan esterase, a serine esterase with a 
Ser-His-Asp catalytic triad Biochemistry 46: 4932-4941. 
 
Weinhold,B., Seidenfaden,R., Röckle,I., Mühlenhoff,M., Schertzinger,F., Conzelmann,S., Marth,J.D., Gerardy-
Schahn,R., and Hildebrandt,H. (2005) Genetic ablation of polysialic acid causes severe neurodevelopmental 
defects rescued by deletion of the neural cell adhesion molecule J.Biol.Chem. 280: 42971-42977. 
 
Whitfield,C. (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli 
Annu.Rev.Biochem. 75: 39-68. 
 
Whitfield,C., Roberts,I.S. (1999) Structure, assembly and regulation of expression of capsules in Escherichia coli 
Mol.Microbiol. 31: 1307-1319. 
 
Witkowski,A., Witkowska,H.E., and Smith,S. (1994) Reengineering the specificity of a serine active-site enzyme. 
Two active-site mutations convert a hydrolase to a transferase J.Biol.Chem. 269: 379-383. 
 
Wyckoff,T.J., Raetz,C.R. (1999) The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase. 
Chemical modification and site-directed mutagenesis J.Biol.Chem. 274: 27047-27055. 
 
Xiang,S., Usunow,G., Lange,G., Busch,M., and Tong,L. (2007) Crystal structure of 1-deoxy-D-xylulose 5-
phosphate synthase, a crucial enzyme for isoprenoids biosynthesis J.Biol.Chem. 282: 2676-2682. 
 
Dissertation Anne K. Bergfeld  Chapter 7 – References 
 
  Page 117 
 
Xie,Y., Kim,K.J., and Kim,K.S. (2004) Current concepts on Escherichia coli K1 translocation of the blood-brain 
barrier FEMS Immunol.Med.Microbiol. 42: 271-279. 
 
Yabe,U., Sato,C., Matsuda,T., and Kitajima,K. (2003) Polysialic acid in human milk. CD36 is a new member of 
mammalian polysialic acid-containing glycoprotein J.Biol.Chem. 278: 13875-13880. 
 
Yan,Y., Harper,S., Speicher,D.W., and Marmorstein,R. (2002) The catalytic mechanism of the ESA1 histone 
acetyltransferase involves a self-acetylated intermediate Nat.Struct.Biol. 9: 862-869. 
 
Yazdankhah,S.P., Caugant,D.A. (2004) Neisseria meningitidis: an overview of the carriage state J.Med.Microbiol. 
53: 821-832. 
Yazdankhah,S.P., Kriz,P., Tzanakaki,G., Kremastinou,J., Kalmusova,J., Musilek,M., Alvestad,T., Jolley,K.A., 
Wilson,D.J., McCarthy,N.D., Caugant,D.A., and Maiden,M.C. (2004) Distribution of serogroups and genotypes 
among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and 
Norway J.Clin.Microbiol. 42: 5146-5153. 
 
Zelmer,A., Bowen,M., Jokilammi,A., Finne,J., Luzio,J.P., and Taylor,P.W. (2008) Differential expression of the 
polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1 Microbiology 154: 2522-
2532. 
 
Zeng,Q., Langereis,M.A., van Vliet,A.L., Huizinga,E.G., and de Groot,R.J. (2008) Structure of coronavirus 
hemagglutinin-esterase offers insight into corona and influenza virus evolution Proc.Natl.Acad.Sci.U.S.A 105: 
9065-9069. 
 
Zuber,C., Lackie,P.M., Catterall,W.A., and Roth,J. (1992) Polysialic acid is associated with sodium channels and 
the neural cell adhesion molecule N-CAM in adult rat brain J.Biol.Chem. 267: 9965-9971. 
 
 
Dissertation Anne K. Bergfeld  Appendix 1 – Abbreviations 
 
  Page 118 
 
 
Appendix 1 - Abbreviations 
 
anti-His  monoclonal antibody directed against the hexahistidine tag 
BBB   blood-brain-barrier 
BSA   bovine serum albumin 
CoA   coenzyme A 
CPS   capsular polysaccharide 
DP   degree of polymerization 
E. coli   Escherichia coli 
ExPEC  extraintestinal E. coli 
(His)6   hexahistidine tag 
IMAC   immobilized metal affinity chromatography 
kps   capsule gene complex 
LPS   lipo-polysaccharide 
mAb   monoclonal antibody 
MBP   maltose-binding protein 
MLST   multilocus sequence typing 
MynC   capsule-specific O-acetyltransferase of N. meningitidis serogroup A 
NCAM   neural cell adhesion molecule 
n.d.   not determined 
Neu5Ac  5-N-acetylneuraminic acid 
NeuO   sialate O-acetyltransferase of E. coli K1 
N. meningitidis Neisseria meningitidis 
NmB   N. meningitidis serogroup B 
NmC   N. meningitidis serogroup C 
NmW   N. meningitidis serogroup W-135 
NmY   N. meningitidis serogroup Y 
OAc   O-acetylation 
OatC   sialate O-acetyltransferase of N. meningitidis serogroup C 
OatWY  sialate O-acetyltransferase of N. meningitidis serogroup W-135 and Y  
PMSF   phenylmethylsulfonyl fluoride 
polySia  polysialic acid 
Sia   sialic acid 
Strep   Strep tag II 
VNTR   variable number of tandem repeats 
wt   wild-type 
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